Quarterlytics / Technology / Software - Infrastructure / VirnetX Holding Corp

VirnetX Holding Corp

vhc · NASDAQ Technology
Claim this profile
Ticker vhc
Exchange NASDAQ
Sector Technology
Industry Software - Infrastructure
Employees 23
← All annual reports
FY2020 Annual Report · VirnetX Holding Corp
Sign in to download
Loading PDF…
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-K

(Mark One)

☒

ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the fiscal year ended December 31, 2020

or

☐

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from                    to                   

Commission File Number: 001-33852

VirnetX Holding Corporation

(Exact name of registrant as specified in its charter)

Delaware
(State or other jurisdiction of incorporation or organization)

77-0390628
(I.R.S. Employer Identification No.)

308 Dorla Court, Suite 206
Zephyr Cove, Nevada
(Address of principal executive offices)

89448
(Zip Code)

Registrant’s telephone number, including area code: 775-548-1785
Securities registered pursuant to Section 12(b) of the Act:

Title of each class

Trading Symbol(s)

Common Stock, par value $0.0001 per share

VHC

Name of each exchange on which
registered
NYSE

Securities registered pursuant to section 12(g) of the Act:
None

Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes  ☐ No ☒

Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act. Yes  ☐ No ☒

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of
1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing
requirements for the past 90 days. Yes ☒ No  ☐

Indicate by check mark whether the registrant has submitted electronically, every Interactive Data File required to be submitted pursuant to Rule 405 of
Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).
Yes ☒ No  ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an
emerging  growth  company.  See  the  definitions  of  “large  accelerated  filer,”  “accelerated  filer,”  “smaller  reporting  company,”  and  “emerging  growth
company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer ☐
Emerging growth company  ☐

Accelerated filer ☐
Smaller reporting company ☒

Non-accelerated filer ☒

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any

new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant has filed a report on and attestation to its management’s assessment of the effectiveness of its internal
control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared
or issued its audit report. ☒

The  aggregate  market  value  of  the  voting  and  non-voting  common  equity  held  by  non-affiliates  of  the  Registrant  as  of  June  30,  2020,  was
$412,305,224 based upon the closing price of the common shares of the Registrant on June 30, 2020. This calculation does not reflect a determination that
certain persons are affiliates of the Registrant for any other purpose.

 
 
 
 
 
 
 
 
 
Indicate by check mark whether the Registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒

71,058,570 shares of Registrant’s Common Stock were outstanding as of March 11, 2021.

DOCUMENTS INCORPORATED BY REFERENCE

The information required by Part III of this Annual Report on Form 10-K, to the extent not set forth herein, is incorporated by reference from the
Registrant’s definitive proxy statement to be filed with the Securities and Exchange Commission not later than 120 days after December 31, 2020 relating
to the Registrant’s 2021 Annual Meeting of Stockholders.

 
 
Business
Risk Factors
Unresolved Staff Comments
Properties
Legal Proceedings
Mine Safety Disclosure

INDEX

PART I

PART II

Market for the Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity
Securities
Selected Financial Data
Management’s Discussion and Analysis of Financial Condition and Results of Operations
Quantitative and Qualitative Disclosures about Market Risk
Financial Statements and Supplementary Data
Changes in and Disagreements with Accountants on Accounting and Financial Disclosure
Controls and Procedures
Other Information

PART III

Directors, Executive Officers and Corporate Governance
Executive Compensation
Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters
Certain Relationships and Related Transactions, and Director Independence
Principal Accountant Fees and Services

Item 1.
Item 1A.
Item 1B.
Item 2.
Item 3.
Item 4.

Item 5.

Item 6.
Item 7.
Item 7A.
Item 8.
Item 9.
Item 9A.
Item 9B.

Item 10.
Item 11.
Item 12.
Item 13.
Item 14.

Item 15.

Exhibits and Financial Statement Schedules

PART IV

1

Page

3
10
24
24
24
24

25
25
25
34
35
56
56
56

57
57
57
57
57

58

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Index

SPECIAL NOTE REGARDING FORWARD LOOKING STATEMENTS

We  have  included  or  incorporated  by  reference  in  this  Annual  Report  on  Form  10-K  (including  in  the  section  entitled  Management’s  Discussion  and
Analysis  of  Financial  Condition  and  Results  of  Operations),  and  from  time  to  time  we  may  make  statements  that  may  constitute  “forward-looking
statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as
amended.  These  forward-looking  statements  are  based  upon  our  current  expectations,  estimates,  assumptions,  and  beliefs  concerning  future  events  and
conditions and may discuss, among other things, anticipated future performance (including sales and earnings), expected growth, future business plans and
costs and the impact of potential and ongoing litigation. Any statement that is not historical in nature is a forward-looking statement and may be identified
by  the  use  of  words  and  phrases  such  as  “anticipates,”  “believes,”  “estimates,”  “expects,”  “intends,”  “plans,”  “predicts,”  “projects,”  “will  be,”  “will
continue,”  “will  likely  result  in,”  and  similar  expressions.  These  statements  include  our  beliefs  and  statements  regarding  general  industry  and  market
conditions  and  growth  rates,  as  well  as  general  domestic  and  international  economic  conditions.  Readers  are  cautioned  not  to  place  undue  reliance  on
forward-looking statements. Forward-looking statements are necessarily subject to risks, uncertainties, and other factors, many of which are outside our
control, which could cause actual results to differ materially from such statements and from our historical results and experience. These risks, uncertainties
and other factors include, but are not limited to those described in Item 1A - Risk Factors of this Quarterly Report and elsewhere in this Quarterly Report
and those described from time to time in our future reports filed with the Securities and Exchange Commission. Readers are cautioned that it is not possible
to predict or identify all the risks, uncertainties and other factors that may affect future results and that the risks described herein should not be considered a
complete list. Any forward-looking statement speaks only as of the date on which such statement is made, and we undertake no obligation to update or
revise any forward-looking statement, whether as a result of new information, future events or otherwise.

Among others, the forward-looking statements appearing in this Annual Report that may not occur include statements that:

●           In  the  VirnetX  Inc.  v.  Apple,  Inc.  (Case  Nos.  6:11-cv-00563-RWS, 6:12-cv-00855-RWS)  (“Apple  II”)  litigation,  the  United  States  Court  of
Appeals for the Federal Circuit (the “Federal Circuit”) in November 2019, affirmed-in-part and reversed-in-part the judgment issued by the United States
District Court for the Eastern District of Texas (the “district court”) in the case awarding VirnetX damages of $595.9 million. On October 30, 2020, after a
trial in the district court, a jury returned a verdict in favor of VirnetX, awarding VirnetX with over $502 million in damages. On January 15, 2021, the
district court denied Apple’s motion for judgment as a matter of law and affirmed the jury findings. This may imply that VirnetX may soon receive over
$500  million  in  cash,  however,  on  February  4,  2021,  Apple  has  filed  a  notice  of  appeal  to  the  Federal  Circuit  with  regards  to  this  judgement  from  the
district court. In addition, the patents in this case are being challenged in the United States Patent and Trademark Office. If those challenges are successful,
the award in the case may be reduced, eliminated and/or delayed for a lengthy period. The continuation of this litigation is distracting to our management, 
expensive, and these distractions and expenses may continue.

●          We have undertaken activities to commercialize our products and patent portfolio in and outside the United States. These statements may imply
that the worldwide market for our commercialized products is large and will result in significant future revenues for us. However, commercialization of
products such as ours are subject to significant obstacles and risks, including but not limited to a perception by some potential partners and customers that
they should await the outcome of the Apple II litigation before entering or considering to enter any agreement with us, and that or other factors may lead us
to be unsuccessful in obtaining further licensing agreements or making arrangements or entering contracts which create significant future revenues for us.

EXCEPT  AS  REQUIRED  BY  LAW,  WE  UNDERTAKE  NO  OBLIGATION  TO  UPDATE  OR  REVISE  ANY  FORWARD-LOOKING
STATEMENT AS A RESULT OF NEW INFORMATION, FUTURE EVENTS OR OTHERWISE.

2

 
 
Index

Item 1.

Business

PART I

The Company
We are an Internet security software and technology company with patented technology for various types of secure network communications, including 5G
and  4G  LTE  network  security.  Our  patented  Secure  Domain  Name  Registry  and  GABRIEL  Connection  Technology™,  are  the  foundation  for  our
GABRIEL Secure Communication Platform™ that protects communications using Zero Trust Network Access (ZTNA). Our technology generates secure
connections on a “zero-click” or “single-click” basis, significantly simplifying the deployment of secure real-time communication solutions by eliminating
the need for end-users to enter any encryption information. Our portfolio of intellectual property is the foundation of our business model. We currently own
approximately  194  total  patents  and  pending  applications,  including  70  U.S.  patents/patent  applications  and  124  foreign  patents/validations/pending
applications. Our patent portfolio is primarily focused on securing real-time communications over the Internet, and related services, and is used in all our
technology and products, some of which were acquired by our principal operating subsidiary; VirnetX, Inc., from Leidos, Inc., or Leidos, (f/k/a Science
Applications International Corporation, or SAIC) in 2006.

Our  product  portfolio  includes  sophisticated  technologies,  products  and  services  that  are  available  for  sale  worldwide.  Our  GABRIEL  Secure
Communication Platform™ includes a set of software libraries with application interfaces available for securing third-party applications seamlessly across
multiple operating systems. It enables individuals and organizations to maintain complete ownership and control over their personal and confidential data,
secured within their own private network, while enabling authorized secure encrypted access from anywhere at any time.

Our GABRIEL Gateway product extends our Secure Communication Platform™ by allowing existing networked devices and services to seamlessly join
the “GABRIEL SECURED” network without requiring any modifications. All these devices or services, including on-premise or cloud-based services, can
now be assigned a VirnetX Secure Domain Name and use fully authenticated, secure communication channels for its communications.

Our  GABRIEL  Collaboration  Suite™  is  a  set  of  communication  applications  and  tools  that  use  our  GABRIEL  Secure  Communication  Platform™.  It
enables  seamless  and  secure  cross-platform  communications  between  devices  that  are  enrolled  in  our  “GABRIEL  SECURED”  network  and  have  our
software  installed.  Our  GABRIEL  Collaboration  Suite™  is  available  for  download  and  free  trial,  for  Android,  iOS,  Windows,  Linux,  and  Mac  OS  X
platforms, at https://virnetx.com.

We continue to enhance our products and add new functionality. We will provide updates to new and existing customers as they are released to the public.
Many small and medium businesses have installed our GABRIEL Secure Communication Platform™ and GABRIEL Collaboration Suite™ products in
their corporate networks. We intend to continue to expand our customer base with targeted promotions and direct sales initiatives.

We have an ongoing GABRIEL Licensing Program under which we offer licenses to a portion of our patent portfolio, technology, and software, including
our  secure  domain  name  registry  service,  to  domain  infrastructure  providers,  communication  service  providers  as  well  as  to  system  integrators.  Our
GABRIEL Connection Technology™ License is offered to OEM customers who want to adopt the GABRIEL Connection Technology™ as their solution
for establishing secure connections using secure domain names within their products. We have developed GABRIEL Connection Technology™ Software
Development Kit (SDK) to assist with rapid integration of these techniques into existing software implementations. Customers who want to develop their
own implementation of the VirnetX patented techniques for supporting secure domain names, or other techniques that are covered by our patent portfolio
for establishing secure communication links, can purchase a patent license. The number of patents licensed, and therefore the cost of the patent license to
the customer, will depend upon which of the patents are used in a particular product or service. These licenses will typically include an initial license fee, as
well as an ongoing royalty.

Our employees include the core development team behind our patent portfolio, technology, and software. Some members of this team have worked together
for  over  twenty  years  and  were  on  same  team  that  invented  and  developed  this  technology  while  working  at  Leidos,  Inc.  (“Leidos”).  The  team  has
continued its research and development work and expanded the set of patents we acquired in 2006 from Leidos, into a larger patent portfolio. This portfolio
now serves as the foundation of our products, services, and our licensing business. It is expected to generate most of our future revenue in license fees and
royalties. We intend to continue our efforts to develop new products and technologies and further strengthen and expand our patent portfolio. We intend to
continue using an outsourced and leveraged model to maintain efficiency and manage costs as we grow our licensing business by, for example, offering
incentives to early licensing targets or asserting our rights for use of our patents.

3

 
 
Index

Industry Overview & Trends

We believe that the rapid growth in remote work has accelerated digital business transformation initiatives that would have taken years, into a matter of
months.  The demand to work remotely, explosive growth of video conferencing tools and rapid growth in the cloud has created an opportunity to secure
communications regardless of a user’s location, network, or BYOD (bring your own device).

The shift to remote work and expansion of the enterprise network perimeter has driven the growth of ZTNA solutions.  The Zero Trust concept treats all
networks like the Internet, where all users and devices are untrusted by default.  Their location within the network is not a factor for deciding trust.  Each
user and device on the network require authentication and authorization, based on policy, prior to accessing any applications or resources on the network.
ZTNA  facilitates  security  around  remote  work,  because  Zero  Trust  policies  enable  granular  access  control,  end-to-end  encryption  of  network
communications and remove application visibility from the public Internet reducing the attack surface. Based on our research and estimates, we believe that
the Zero-Trust Security Market size is projected to grow from USD 15.6 billion in 2019 to USD 38.6 billion by 2024, at a Compound Annual Growth Rate
(CAGR) of 19.9% from 2019 to 2024.  We believe Zero Trust represents a growing market and an ideal fit for our technology and products.

With large portions of the global population now living under some form of lockdown, the global coronavirus pandemic has forced many organizations to
shift  their  business  processes  –  and  their  employees  are  having  to  embrace  a  work-from-home  culture  on  a  scale  never  attempted.  Remote  work  has
accelerated the adoption of video conferencing and meeting applications across all industries making it an essential tool to connect with remote customers,
workforces, and employees to prevent direct contact. Based on our estimates, we believe that the worldwide Video Conferencing Market size is projected to
grow from USD 14 billion in 2019 to USD 35 billion by 2026, at a CAGR of 16.5% from 2020 to 2026. This rapid adoption, learning curve and demand to
continue working remotely has created significant security concerns and breaches for enterprises.  Our market research has focused on security conscious
verticals such as healthcare, banking, legal and government where security breaches can significantly impact outcomes.  In many cases, these enterprises
adopted  industry  standard  video  conferencing  tools  and  are  now  looking  at  more  secure  alternative  solutions.    Enterprises  want  video  conferencing
solutions that protect their information and allow them greater security control and visibility, while continuing to be reliable, easy to use and cost effective.
Enterprises in these verticals are also looking for video conferencing solutions that integrate into their existing workflows and better align with specific use
cases  instead  of  forcing  them  to  adapt  to  more  one  size  fits  all  solutions  on  the  market.  We  believe  our  GABRIEL  Collaboration  Suite™  represents  a
starting point to offer secure video conferencing tools built on a zero-trust architecture.

Cloud  computing  growth  has  rapidly  expanded  as  enterprises  continue  to  move  applications  and  services  to  the  cloud.  The  cloud  offers  scalability,
operations and development efficiency and remote access benefits for their workforce. Based on our estimates, we believe that the global cloud computing
market size is expected to grow from approximately USD 293 billion in 2020 to over USD 810 billion by 2026, at a CAGR of 18.5% during the forecast
period. The cloud technology adoption is expected to increase quite significantly in industries where the Work-From-Home (WFH) initiative is helping to
sustain enterprise business functions. However, shifting critical data to the cloud has resulted in security concerns and the need for enterprises to control
access  and  gain  visibility  into  how  information  is  being  used,  who  is  accessing  it  and  where  it  is  going.  We  believe  our  scalable  technology  allows
enterprises to secure applications and services regardless of whether hosting is on-premise or in the cloud.

As billions of connected Internet of Things (IoT) devices come online in support of enterprise operations, products, and industrial controls they will need to
be secured and integrated into the enterprise. Facilitated by advancements in 4G/Advanced LTE and high-speed 5G networks, IoT devices will be able to
operate from any network, transmit higher volumes of data including video streaming and sensor data collection and require real-time decisions based on
that data. Without next generation security, these IoT devices represent a large attack surface that manages and control critical enterprise infrastructure.
These IoT devices can operate from anywhere, will need to be secured with the same level of network security and ZTNA solutions enterprises are already
deploying for their remote workforce. We believe that the market opportunity for our software and technology solutions is large and expanding as secure
domain  names  are  now  an  integral  part  of  securing  the  next  generation  5G  and  4G/LTE  Advanced  wireless  networks  and  IoT  communications  in  areas
including Smart City, Connected Car and Connected Home. Based on our estimates, we believe that the size of global Industrial Internet of Things (IIoT)
market is projected to grow from USD 83.6 billion in 2020 to approximately USD 254 billion by 2027 at a CAGR of 20.35% during this forecasted period
with a growing investment in securing the infrastructure around these devices.

4

Index

Our Approach & Strategy

Our portfolio of intellectual property is the foundation of our business model. We currently own approximately 194 total patents and pending applications,
including 70 U.S. patents/patent applications and 124 foreign patents/validations/pending applications.  This portfolio now serves as the foundation of our
products, services, and our licensing business. It is expected to generate the majority of our future revenue in license fees and royalties.

Our  strategy  is  to  become  the  market  leader  in  securing  real-time  communications  over  the  Internet  and  to  establish  our  GABRIEL  Connection
Technology™ as the industry standard security platform. Key elements of our strategy are to:

•

•

•
•
•

•

Actively recruit partners in various vertical markets, including healthcare, finance, legal, government to help us rapidly expand our enterprise
customer base.
Continue to grow our technology licensing program to commercialize our intellectual property, including our GABRIEL Connection
Technology™.
Promote our Gabriel Secure Communication Platform™ as a solution for delivering ZTNA.
Grow our GABRIEL Gateway product offering to secure enterprise applications, services, and infrastructure.
Grow registration of GABRIEL Secure Domains as the network segmentation component of our ZTNA solution. Establish VirnetX as the
exclusive, universal registry of secure domain names and enable our customers to act as registrars for their users and broker secure communication
between devices.
Promote Gabriel Collaboration Suite™ products in the general market for sale to end-user enterprises, directly and with partners, with targeted
promotions and other marketing programs. Expand GABRIEL Collaboration Suite™ to include video conferencing to assist remote workers and
offer an industry leading secure meeting solution.

GABRIEL Secure Communication Platform™ delivers ZTNA allowing enterprises to secure their information, control access and gain visibility into how
information is being used, who is accessing it and where it is going.  Our patented technology allows enterprises to license our technology for integration
into  their  products  and  services,  easily  deploy  our  technology  through  our  GABRIEL  Gateway  product  for  endpoint  security  or  securing  their
communications with our GABRIEL Collaboration Suite™ application.

We believe GABRIEL Gateway will support enterprises in securing their networks as their applications, services, virtualized resources, and data moves to
the  cloud.  GABRIEL  Gateway  secures  applications,  services  and  infrastructure  using  ZTNA.    Enterprises  can  quickly  deploy  GABRIEL  Gateway  to
protect  legacy  applications,  secure  new  cloud-based  services  and  remove  application  visibility  from  the  public  Internet.    Enterprises  can  move  towards
more granular network access control to protect their network at the edge and away from legacy VPN technologies.  GABRIEL Gateway enables remote
employees to securely communication with on-premise and cloud-based applications, regardless of their location. GABRIEL Gateway is included with the
GABRIEL Collaboration Suite™ and offered as a separate licensing program for enterprises that need a Gateway only solution.  Enterprises can also use
GABRIEL Gateway to secure open-source applications powering communications, data and analytics, infrastructure, and business services with a focus on
making those applications easier to secure, access and manage.

GABRIEL Secure Domains provide two fundamental capabilities for enterprises to manage device security and access control.

•

•

Unique, certificate-based device identities, tied to a user, that are used to authenticate and authorize device access (e.g., GABRIEL Connection
Technology™), based on a set of policies.
Flexible, software-based network segmentation that enterprises can deploy on-demand, without requiring additional hardware infrastructure.

Enterprise  customers  understand  the  complexity  of  device  certificate  management  at  scale,  the  operational  costs  and  security  ramifications,  if  not  done
properly. GABRIEL Secure Domains enable certificate-based identities and when used within the GABRIEL Secure Communication Platform™, provides
a cloud-based service that automates the process of issuing, renewing, and revoking device certificates across the enterprise at scale.   With GABRIEL
Secure Domains, enterprises have a solution for managing device security and access control driven by the rapid growth of IoT and remote work.

Each GABRIEL Secure Domain creates a network microsegment or secure enclave that includes a set of resources (e.g., applications, services, or data) and
a set of users and devices an enterprise can assign to access those resources. Used within the GABRIEL Secure Communication Platform™, enterprises can
scale and adapt their network architecture, on-demand, based on business and workforce needs. Enterprises see the power of GABRIEL Secure Domains as
a way to flexibility segment their networks, enforce access policies, audit compliance, isolate and limit lateral network movement, secure and limit access
for remote workers and gain access control and visibility into their network.

5

Index

We believe GABRIEL Collaboration Suite™ provides the foundation for real-time, secure communications and collaboration applications for the enterprise
remote workforce.  We bundle multiple applications together within the GABRIEL Collaboration Suite™, including Secure Chat, Secure Share, Secure
Video/Voice, Secure Mail, Secure Backup/Sync and GABRIEL Gateway. We are exploring unbundling the applications within GABRIEL Collaboration
Suite™ and offering à la carte product options.  This approach allows us to offer more flexible licensing options to solve specific customer use-cases, align
with partner product offerings and create upsell opportunities.

Competitive Strengths

We believe the following competitive strengths will enable our success in the marketplace:

•

•

Unique  patented  technology.  We  are  focused  on  developing  innovative  technology  for  securing  real-time  communications  over  the  Internet  and
establishing the exclusive secure domain name registry in the United States and other key markets around the world. Our unique solutions combine
industry  standard  encryption  methods  and  communication  protocols  with  our  patented  techniques  for  automated  DNS  lookup  mechanisms.  Our
technology  and  patented  approach  enable  users  to  create  a  secure  communication  link  by  generating  secure  domain  names.  We  currently  own
approximately 194 total patents and pending applications, including 70 U.S. patents/patent applications and 124 foreign patents/validations/pending
applications. Our portfolio includes patents and pending patent applications in the United States and other key markets that support our secure domain
name registry service for the Internet.

Scalable licensing business model. We are actively engaged in pursuing additional licensing agreements with OEMs, service providers and system
integrators within the IP-telephony, mobility, mobile-to-mobile communications, fixed-mobile convergence, and unified communications end-markets.

• Highly experienced research and development team. Our research and development team is comprised of nationally recognized network security
and encryption technology scientists and experts that have worked together as a team for over ten years. During their careers, this team has developed
several cutting-edge technologies for U.S. national defense, intelligence, and civilian agencies, many of which remain critical to our national security
today. Prior to joining VirnetX, our team worked for Leidos, during which time they invented the technology that is the foundation of our technology,
and software. Based on the collective knowledge and experience of our development team, we believe that we have one of the most experienced and
sophisticated groups of security experts researching vulnerability and threats to real-time communication over the Internet and developing solutions to
mitigate these problems.

License and Service Offerings

We offer a diversified portfolio of license and service offerings focused on securing real-time communications over the Internet, including:

•

VirnetX technology licensing. Customers who want to develop their own implementation of the VirnetX code module for supporting secure domain
names, or who want to use their own techniques that are covered by our patent portfolio for establishing secure communication links, could purchase a
technology license. We anticipate that these licenses would typically include an initial license fee, as well as an ongoing royalty. We expect that these
licenses will include a one-time delivery of GABRIEL software development kit including object libraries, sample code, testing and quality assurance
tools and the supporting documentation necessary for a customer to implement of the techniques we have developed.

• GABRIEL  Connection  Technology™  Software  Development  Kit  or  SDK.  OEM  customers  who  want  to  adopt  the  GABRIEL  Connection
Technology™ as their solution for establishing secure connections using secure domain names within their products could purchase an SDK license.
The software development kit consists of object libraries, sample code, testing and quality assurance tools and the supporting documentation necessary
for a customer to implement our technology. These tools are comprised of software for a secure domain name connection test server, a relay test server,
and  a  registration  test  server.  We  expect  that  customers  would  pay  an  up-front  license  fee  to  purchase  an  SDK  license  and  a  royalty  fee  for  every
product shipped with the embedded VirnetX code module.

•

Secure domain name registrar service. Customers, including service providers, telecommunication companies, ISPs, system integrators and OEMs
could  purchase  a  license  to  our  secure  domain  name  registrar  service.  We  would  provide  the  software  suite  and  technology  support  to  enable  such
customers  to  provision  devices  with  secure  domain  names  and  facilitate  secure  connections  between  registered  devices.  This  suite  includes  the
following server software modules:

6

Index

•

•

•

•

•

Registrar server software. We anticipate that our registrar server software would enable customers to operate as a secure domain name registrar that
provisions  devices  with  secure  domain  names.  The  registrar  server  software  is  designed  to  provide  an  interface  for  our  customers  to  register  new
virtual private domains and sub-domain names. This server module must be enrolled with the VirnetX secure domain name master registry to obtain its
credentials before functioning as an authorized registrar.

Connection server software. We  anticipate  that  our  connection  server  software  would  allow  customers  to  provide connection  services  to  enrolled
devices. The connection services include registration of presence information for authenticated users and devices, presence information query request
services, enforcement of policies and support for communication with peers behind firewalls.

Relay server software. We anticipate that our relay server software would allow customers to dynamically maintain connections  and  relay  data  to
private IP addresses for network devices that reside behind firewalls.

Secure domain name master registry and connection service. As part of enabling the secure domain name registrar service, we expect that we will
maintain  and  manage  the  secure  domain  name  master  registry.  This  service  is  expected  to  enroll  all  secure  domain  name  registrar  customers  and
generate the credentials required to function as an authorized registrar. It also is expected to provide connection services and universal name resolution,
presence information and secure connections between authorized devices with secure domain names. Secure domain name registrar service customers
will enter into a technology licensing and revenue sharing agreement with VirnetX whereby we will typically receive an up-front licensing fee for the
secure domain name registrar technology, as well as ongoing annual royalties for each secure domain name issued by the customer.

Technical support services. We intend to provide high-quality technical support services to licensees and customers for the rapid customization and
deployment of GABRIEL Connection Technology™ in an individual customer’s products and services.

Customers

Our  GABRIEL  Collaboration  Suite™  is  available  for  download  and  free  trial,  for  Android,  iOS,  Windows,  Linux,  and  Mac  OS  X  platforms,  at
http://www.gabrielsecure.com/.  We  continue  to  enhance  our  products  and  add  new  functionality  to  our  products.  We  will  provide  updates  to  new  and
existing customers as they are released publicly. Over 80 small and medium businesses have installed our GABRIEL Secure Communication Platform™
and GABRIEL Collaboration Suite™ products in their corporate networks. We continue to rapidly expand our customer base with targeted promotions and
direct sales initiatives.

We have signed Patent License Agreements with Aastra USA, Inc. Avaya, Inc., Microsoft Corporation, Mitel Networks Corporation, NEC Corporation and
NEC Corporation of America, Siemens Enterprise Communications GmbH & Co. KG, and Siemens Enterprise Communications Inc. to license certain of
our patents, for a one-time payment and an ongoing royalty for all future sales through the expiration of the licensed patents with respect to certain current
and future IP-encrypted products.

We  are  seeking  further  licensing  of  our  technology,  including  our  GABRIEL  Connection  Technology™  to  developers  and  original  equipment
manufacturers, or OEMs, of chips, servers, smart phones, tablets, e-Readers, laptops, net books, and other devices, within the IP-telephony, mobility, fixed-
mobile  convergence,  and  unified  communications  markets  including  4G/LTE.  We  have  published  our  royalty  rates  and  guidelines  on  our  website.  All
forward moving licenses have adhered to these guidelines and have met or exceeded these rates and we will use these rates and guidelines in all future
license negotiations.

Marketing and Sales

We employ a leveraged, partner-oriented, marketing strategy for our technology licenses and software product offerings. We successfully signed a number
of  Resellers  &  Managed  Service  Provider  in  various  market  segments,  including,  healthcare,  finance,  legal,  government,  etc.,  to  assist  us  in  selling  our
software products to their customers. A list of our partners can be found on our website at https://virnetx.com/partners. We plan to continue working on a
number of sales and marketing promotions, in the U.S. and Japan, to recruit more resellers and partners along with direct sales programs as we seek to
extend out our customer base internationally.

7

Index

We plan to directly market our Gabriel Secure Communication Platform™ and Gabriel Collaboration Suite™ products, domain name registry services to
our  service  provider  and  system  integrator  customers.  We  market  our  Gabriel  line  of  products  directly  to  small  and  medium  businesses  using  online
marketing programs and tools.

We  expect  to  leverage  our  relationship  with  Leidos,  to  extend  our  offering  to  departments  and  agencies  within  the  federal  government.  Leidos  is  a
FORTUNE 500® scientific, engineering and technology applications company that uses its deep domain knowledge to solve problems of vital importance
to the nation and the world, in national security, energy and the environment, critical infrastructure, and health. We intend to leverage our sales team for
managing current accounts and pursuing sales opportunities with new customers.

In January 2021, we added a Chief Operating Officer (COO) to our Japanese team to further our technology licensing efforts in Japan. We have signed a
non-exclusive Distribution and Service Agreement with IP Dream, a Japanese based strategic technology developer and service provider, to sell VirnetX’s
Gabriel Collaboration Suite as well as VirnetX’s Secure Domain Name technology to its clients in Japan and greater Asia. Jointly with IP Dream, we are
currently pursuing a number of OEM opportunities with some of the largest services providers in Japan. Along with our efforts with IP dream, we continue
to  explore  alternative  strategies  to  pursue  opportunities  to  work  with  other  third  parties  in  Japan,  and  elsewhere,  using  an  approach  that  will  seek  to
capitalize on these opportunities in part by placing more emphasis on the use of our own employees.

Our  GABRIEL  Collaboration  Suite™  is  available  for  download  and  free  trial,  for  Android,  iOS,  Windows,  Linux,  and  Mac  OS  X  platforms,
at https://virnetx.com.  We  continue  to  enhance  our  products  and  add  new  functionality  to  our  products.  We  will  provide  updates  to  new  and  existing
customers as they are released publicly. We continue to rapidly expand our customer base with targeted promotions and direct sales initiatives.

We intend to continue to license our patent portfolio, technology, and software, including our secure domain name registry service, to domain infrastructure
providers, communication service providers as well as to system integrators. We intend to seek further license of our technology, including our GABRIEL
Connection Technology™ to enterprise customers, developers and original equipment manufacturers, or OEMs, of chips, servers, smart phones, tablets, e-
Readers,  laptops,  net  books,  and  other  devices,  within  the  IP-telephony,  mobility,  fixed-mobile  convergence,  and  unified  communications  markets
including 5G and 4G/LTE. We have published our royalty rates and guidelines on our website at https://virnetx.com/licensing. All forward moving licenses
have adhered to these guidelines and have met or exceeded these rates and we will use these rates and guidelines in all future license negotiations.

8

Index

Intellectual Property and Patent Rights

Our intellectual property is primarily comprised of trade secrets, patented know-how, issued and pending patents, copyrights and technological innovation.

We  currently  own  approximately  194  total  patents  and  pending  applications,  including  70  U.S.  patents/patent  applications  and  124  foreign
patents/validations/pending  applications.  Our  portfolio  includes  a  number  of  patents  that  describe  unique  systems  and  methods  for  securing  real-time
communications over the Internet, as well as related services such as the establishment and maintenance of a secure domain name registry. Our software
and technology solutions also may have additional applications relating to operating systems and network security. A complete list of our U.S. patents is
available on our website located at www.virnetx.com. Each patent is publicly accessible on the Internet website of the U.S. Patent and Trademark Office at
www.uspto.gov. The term of each of our issued U.S. and foreign patents will expire during the period from 2020 to 2024.

Notwithstanding anything to the contrary set forth in any of our filings under the Securities Act of 1933 or the Securities Exchange Act of 1934 that might
incorporate future filings, the information set forth on the United States Patent and Trademark Office, or the USPTO Website, shall not be deemed to be a
part  of  or  incorporated  by  reference  into  any  such  filings.  The  Company  does  not  warrant  the  accuracy,  or  completeness  or  adequacy  of  the  USPTO
Website, and expressly disclaims liability for errors or omissions on such website.

Assignment of Patents

Some of our issued patents and pending patent applications were acquired by our principal operating subsidiary, VirnetX, Inc., from Leidos, pursuant to an
Assignment Agreement dated December 21, 2006, and a Patent License and Assignment Agreement dated August 12, 2005, as amended on November 2,
2006, including documents prepared pursuant to the November amendment, and as further amended on March 12, 2008. We recorded the assignment from
Leidos, with the U.S. Patent Office on December 21, 2006.
Key terms of these agreements are as follows:

•

•

•

Patent Assignment. Leidos, unconditionally and irrevocably conveyed, transferred, assigned, and quitclaimed all its right, title, and interest in and
to the patents and patent applications, as specifically set forth on Exhibit A to the assignment document recorded with the U.S. Patent Office,
including, without limitation, the right to sue for past infringement.

License to Leidos, Outside the Field of Use. Effective March 12, 2008, we granted to Leidos, a non-exclusive, royalty free, fully paid, perpetual,
worldwide, irrevocable, sub licensable and transferable right and license permitting Leidos, and its assignees to make, have made, import, use,
offer  for  sale,  and  sell  products  and  services  covered  by,  and  to  make  improvements  to,  the  patents  and  patent  applications  we  acquired  from
Leidos, solely outside our field of use.

Compensation Obligations. As consideration for the assignment of the patents and for the rights we obtained from Leidos, as amended, we are
required to make payments to Leidos, based on cash or certain other values generated from those patents. The amount of such payments depends
upon the type of value generated, and certain categories are subject to maximums and other limitations. In 2010, we met our maximum royalty
payment  requirement;  however,  Leidos  is  also  entitled  under  certain  circumstances  to  receive  a  portion  of  the  proceeds  paid  to  us  for  certain
acquisitions of VirnetX and the settlement of certain patent infringement claims of ours.

Government Regulation

The  laws  governing  online  secure  communications  remain  largely  unsettled,  even  in  areas  where  there  has  been  legislative  action.  It  may  take  years  to
determine whether and how existing laws governing intellectual property, privacy, data protection and libel apply to online communications and media.
Such legislation may interfere with the growth in use of online secure communications and decrease the acceptance of online secure communications as a
viable solution, which could adversely affect our business.

Due to the Internet’s popularity and increasing use, new laws regulating secure communications may be adopted. These laws and regulations may cover,
among other things, issues relating to privacy, data protection, pricing, taxation, telecommunications over the Internet, content, copyrights, distribution and
quality of products and services. We intend to comply with all new laws and regulations as they are adopted.

The U.S. government has controlled the authoritative domain name system, or DNS, root server since the inception of the Internet. On July 1, 1997, the
President of the United States directed the U.S. Secretary of Commerce to privatize the management of the domain name system in a manner that increases
competition and facilitates international participation in its management.

9

Index

On  September  29,  2006,  the  U.S.  Department  of  Commerce  extended  its  delegation  of  authority  by  entering  into  a  new  agreement  with  the  Internet
Corporation for Assigned Names and Numbers, or ICANN, a California non-profit corporation headquartered in Marina Del Rey, California. ICANN is
responsible for managing the accreditation of registry providers and registrars that manage the assignment of top-level domain names associated with the
authoritative DNS root directory. Although it is possible to create and manage other DNS root directories privately without accreditation from ICANN, the
possibility of conflicting name and number assignments makes it less likely that users would widely adopt a top-level domain name associated with an
alternative DNS root directory provided by a non-ICANN-accredited registry service.

Employees

On December 31, 2020, the Company had 21 full and part time employees, most of whom work remotely from our corporate offices.  The Company has
had an at-home work force since its inception.  The emphasis of our employees is on our technology research and product development with 11 employees
focused  on  this  effort.  The  team  has  been  working  on  enhancing  our  products  and  adding  new  functionality  along  with  successfully  filing  several  new
patent applications in  2021.  We also continue building our sales and marketing teams to expand our product-lines and customer base. In 2021 we added a
Chief Operating Officer for our subsidiary in Japan who will be focused on growing our market and products in that region.

In  addition  to  our  regular  employees,  we  also  engage  with  important  consultants  on  a  regular  basis.    These  consultants  can  be  involved  in  our  product
development, customer relations, legal, and/or regulatory compliance and reporting.  The Company has experienced low employee turnover rates over the
years with both employees and some consultants participating in our incentive stock option/RSU plans.

Available Information

We file or furnish various reports, such as registration statements, periodic and current reports, proxy statements and other materials with the SEC. Our
Internet website address is www.virnetx.com. You may obtain, free of charge on our Internet website, copies of our annual report on Form 10-K, quarterly
reports on Form 10-Q, current reports on Form 8-K, and amendments to those reports filed or furnished pursuant to Section 13(a) or 15(d) of the Exchange
Act, as soon as reasonably practicable after we electronically file such material with, or furnish it to, the SEC. The information we post is intended for
reference purposes only; none of the information posted on our website is part of this report or incorporated by reference herein.

The SEC also maintains an Internet site that contains reports, proxy and other information statements, and other information regarding issuers, including us,
that file electronically with the SEC. The Internet address of the SEC’s Internet site is http://www.sec.gov.

Item 1A.          Risk Factors

Our  operations  and  financial  results  are  subject  to  various  risks  and  uncertainties,  including  those  described  below,  which  could  adversely  affect  our
business, financial condition, results of operations, cash flows, and the trading price of our common and capital stock. You should carefully consider the
risks  and  uncertainties  described  below  in  addition  to  the  other  information  set  forth  in  this  Annual  Report  on  Form  10-K,  including  the  section  titled
“Management’s Discussion and Analysis of Financial Condition and Results of Operations” and our consolidated financial statements and related notes,
before  making  any  investment  in  our  common  stock.  The  risks  and  uncertainties  described  below  are  not  the  only  ones  we  face.  Additional  risks  and
uncertainties not presently known to us or that we currently believe to be immaterial may also adversely affect our business. If any of these risk factors
occur, you could lose substantial value or your entire investment in our shares.

Risks Related to Our Business and Our Financial Reporting

We are involved and will continue to be involved in litigation defending our patent portfolio, which can be time-consuming and costly, and we cannot
anticipate the results.

We spend a significant amount of our financial and management resources to pursue our current litigation. We believe that this litigation and others that we
may pursue in the future could continue for years and consume significant financial and management resources. The counterparties to our litigation include
large, well-financed companies with substantially greater resources than us. Patent litigation is risky, and the outcome is uncertain, and we cannot assure
you that any of our current or future litigation matters will result in a favorable outcome for us. In addition, even if we obtain favorable interim rulings or
verdicts, they may be inconsistent with the ultimate resolution of the dispute. Also, we cannot assure you that we will not be exposed to claims or sanctions
against us which may be costly or impossible for us to defend. Unfavorable or adverse outcomes may result in losses, exhaustion of financial resources or
other adverse effects, which could encumber our ability to develop and commercialize our products.

10

Index

We may not be able to capitalize on market opportunities related to our licensing strategy or our patent portfolio.

Our business strategy includes licensing our patents and technology to other companies in order to reach a larger end-user base than we could reach through
direct  sales  and  marketing  efforts;  as  such,  our  business  strategy  and  revenues  may  depend  on  intellectual  property  licensing  fees  and  royalties  for  the
majority of our revenues. We currently derive minimal revenue from licensing activities, and royalties, and we cannot assure you that we will successfully
capitalize on our market opportunities or that our current business strategy will succeed.

Although to date we have entered into a limited number of settlement and license agreements, we may not be successful in entering into further licensing
relationships,  or  if  we  are  successful  in  entering  into  such  relationships,  the  acquisition  of  them  may  be  expensive,  and  they,  as  well  as  our  existing
settlement and our existing and pending license agreements may not generate the financial results, we expect.

Factors that may affect our ability to execute our current business strategy include, but are not limited to, the following:

•

•

•

Third parties may challenge the validity of our patents;

The pendency of our various litigations may cause potential licensees not to do business with us;

Our patents may expire before we can make our business strategy successful;

• We  face,  and  we  expect  to  continue  to  face,  intense  competition  from  new  and  established  competitors  who  may  have  superior  products  and

services or better marketing, financial or other capacities than we do; and

•

It  is  possible  that  one  or  more  of  our  potential  customers  or  licensees  develops  or  otherwise  sources  products  or  technologies  similar  to,
competitive with or superior to ours.

If we are not able to adequately protect our patent rights, our business would be negatively impacted.

We believe our patents are valid, enforceable, and valuable. Notwithstanding this belief, third parties may make claims of infringement or invalidity claims
with respect to our patents and such claims could give rise to material cost for defense or settlement or both, jeopardize or substantially delay a successful
outcome of litigation we are or may become involved in, divert resources away from our other activities, limit or cease our revenues related to such patents,
or  otherwise  materially  and  adversely  affect  our  business.  Similar  challenges  could  also  prevent  us  from  obtaining  additional  patents  in  the  future.
Additionally, several of our patents are currently, and other patents may in the future be, subject to United States Patent and Trademark Office (“USPTO”)
post-grant inter partes review proceedings (“IPR”) which may result in all or part of these patents being invalidated, or the claims of our patents being
limited. Unfavorable or adverse outcomes in our litigation or IPRs may result in losses, exhaustion of financial resources, reduction in our ability to enforce
our  intellectual  property  rights,  or  other  adverse  effects,  which  could  encumber  our  ability  to  develop  and  commercialize  our  products.  Even  if  we  are
successful  in  enforcing  our  intellectual  property  rights,  our  patents  may  not  ultimately  provide  us  with  any  competitive  advantages  and  may  be  less
valuable than we currently expect. These risks may be heightened in countries other than the United States where laws regarding patent protection are less
developed, and may be negatively affected by the fact that legal standards in the United States and elsewhere for protection of intellectual property rights in
Internet-related  businesses  are  uncertain  and  still  evolving.  In  addition,  there  are  a  significant  number  of  United  States  and  foreign  patents  and  patent
applications in our areas of interest, and we expect that significant litigation in these areas will continue and will add uncertainty to the value of certain
patents and other intellectual property rights in our areas of interest. If we are unable to protect our intellectual property rights or otherwise realize value
from them, our business would be negatively affected.

11

Index

We can provide no assurances that the licensing of our essential security patents under FRAND will be successful.

At the request of the European Telecommunications Standards Institute (“ETSI”), and the Alliance for Telecommunications Industry Solutions (“ATIS”),
we agreed to update our licensing declaration to ETSI and ATIS under their respective Intellectual Property Rights policies. This was in response to our
Statement of Patent Holder identifying a group of our patents and patent applications that we believe are or may become essential to certain developing
specifications in the 3rd Generation Partnership Project Long Term Evolution (“LTE”), Systems Architecture Evolution project. We will make available a
non-exclusive patent license under FRAND (fair, reasonable and non-discriminatory terms, and conditions, with compensation) for the patents identified by
us  that  are  or  become  essential  to  applicants  desiring  to  implement  the  Technical  Specifications  identified  by  us,  as  set  forth  in  the  updated  licensing
declaration under the ATIS and ETSI Intellectual Property Rights policies. Our licensing declarations under the ATIS and ETSI Intellectual Property Rights
policies may limit our flexibility in determining royalties and license terms for certain of our patents. Consequently, we cannot assure you that the licensing
of the essential security patents will be successful or that third parties will be willing to enter into licenses with us on reasonable terms or at all, which
could have an adverse effect on our business and harm our competitive position.

Because  our  business  is  conducted  or  expected  to  be  conducted  in  an  environment  that  is  subject  to  rapid  change,  we  may  be  subject  to  various
developments in regulation, law, and consumer preferences to which we may not be able to adapt successfully.

The current regulatory environment for our products and services remains unclear. We can give no assurance that our planned product offerings will be in
compliance  with  laws  and  regulations  of  local,  state,  United  States  federal  or  foreign  authorities.  Further,  we  can  give  no  assurance  that  we  will  not
unintentionally violate such laws or regulations or that such laws or regulations will not be modified, or that new laws or regulations will be enacted in the
future which would cause us to be in violation of such laws or regulations. For example, Voice-Over-Internet Protocol (“VoIP”) services are not currently
subject to all the same regulations that apply to traditional telephony, but it is possible that similar regulations may be applied to VoIP in the future and that
these could result in substantial costs to us which could adversely affect the marketability of our products and planned products related to VoIP. For further
example, the use of the Internet and private Internet Protocol (“IP”) networks for communication is largely unregulated within the United States, but may
become  regulated  in  the  future;  additionally,  several  foreign  governments  have  enacted  measures  that  could  restrict  or  prohibit  voice  communications
services over the Internet or private IP networks.

Our  business  depends  on  the  growth  of  instant  messaging,  VoIP,  mobile  services,  streaming  video,  file  transfer  and  remote  desktop  and  other  next-
generation  Internet-based  applications.  A  decline  in  the  use  of  these  applications  due  to  complexity  or  cost  relative  to  alternate  traditional  or  newly
developed communications channels, or development of alternative technologies, could cause a material decline in the number of users in these areas.

More aggressive domestic or international regulation of the Internet in general, and Internet telephony providers and services specifically may materially
and adversely affect our business, financial condition, operating results, and future prospects.

Our exposure to outside influences beyond our control, including new legislation, court rulings or actions by the United States Patent and Trademark
Office, could adversely affect our licensing and enforcement activities and results of operations.

Our licensing and enforcement activities are subject to numerous risks from outside influences, including the following:

•

New legislation, regulations or rules related to obtaining patents or enforcing patents could significantly increase our operating costs and decrease
our revenue. For instance, the United States Supreme Court has modified some tests used by the USPTO in granting patents during the past 20
years which may decrease the likelihood that we will be able to obtain patents and increase the likelihood of challenge of any patents we obtain or
license.  In  addition,  in  2012  the  United  States  enacted  sweeping  changes  to  the  United  States  patent  system  under  the  Leahy-Smith  America
Invents Act, including changes that transition the United States from a “first-to-invent” system to a “first to file” system and alter the processes for
challenging issued patents;

• More patent applications are filed each year resulting in longer delays in getting patents issued by the USPTO;

12

Index

•

•

Federal courts are becoming more crowded, and as a result, patent enforcement litigation is taking longer; and

As patent enforcement becomes more prevalent, it may become more difficult for us to voluntarily license our patents.

New legislation, regulations or court rulings related to enforcing patents could harm our business and operating results.

Intellectual property is the subject of intense scrutiny by the courts, legislatures, and executive branches of governments around the world. Various patent
offices, governments or intergovernmental bodies may implement new legislation, regulations or rulings that impact the patent enforcement process, or the
rights of patent holders and such changes could negatively affect licensing efforts and/or litigations. For example, limitations on the ability to bring patent
enforcement claims, limitations on potential liability for patent infringement, lower evidentiary standards for invalidating patents, increases in the cost to
resolve patent disputes and other similar developments could negatively affect our ability to assert our patent or other intellectual property rights.

It is impossible to determine the extent of the impact of any new laws, regulations or initiatives that may be proposed, or whether any of the proposals will
become enacted as laws. Compliance with any new or existing laws or regulations could be difficult and expensive, affect the manner in which we conduct
our business and negatively impact our business, prospects, financial condition, and results of operations. We may need to raise additional capital to support
our business growth, and this capital will be dilutive, may cause our stock price to drop or may not be available on acceptable terms, if at all.

We may need to raise additional capital, which may not be available to us when needed or may not be available on terms acceptable to us, to support our
business growth or to respond to business opportunities, challenges, or unforeseen circumstances, including sales under our ATM or our universal shelf
registration statement. Our ability to obtain additional capital, if and when required, will depend on our business plans, investor demand, our operating
performance, the condition of the capital markets, the terms of our current contractual obligations and other factors. If we raise additional funds through the
issuance  of  equity,  equity-linked  or  debt  securities,  including  those  under  our  ATM  or  our  Universal  Shelf  Registration  Statement,  those  securities  may
have rights, preferences, or privileges senior to the rights of our common stock, and our existing stockholders may experience dilution. Additionally, we are
unable to predict the future success of our ATM or any other offering. Sales of a substantial number of shares of our common stock in the public market, or
the perception that these sales or other financings might occur, could depress the market price of our common stock, and could also impair our ability to
raise capital through the sale of additional equity securities. If we issue debt securities or incur indebtedness, we could experience increased future payment
obligations and a need to comply with restrictive covenants, such as limitations on our ability to incur additional debt, limitations on our ability to acquire,
sell or license intellectual property rights and other operating restrictions that could adversely impact our ability to conduct our business. If we are unable to
obtain additional capital or are unable to obtain additional capital on satisfactory terms, our ability to continue to support our business growth or to respond
to business opportunities, challenges, or other circumstances could be adversely affected, and our business may be harmed.

If we experience security breaches, we could be exposed to liability and our reputation and business could suffer.

We  expect  to  retain  certain  confidential  and  proprietary  customer  information  in  our  secure  data  centers  and  secure  domain  name  registry,  as  well  as
personal data and other confidential and proprietary information relating to our business. It will be critical to our business strategy that our facilities and
infrastructure remain secure and are perceived by the marketplace to be secure. Our secure domain name registry operations will also depend on our ability
to maintain our computer and telecommunications equipment in effective working order and to reasonably protect our systems against interruption, and
potentially depend on protection by other registrars in the shared registration system. The secure domain name servers that we will operate will be critical
hardware to our registry services operations. Therefore, we expect to have to expend significant time and money to maintain or increase the security of our
products, facilities, and infrastructure. Security technologies are constantly being tested by computer professionals, academics and “hackers.” Advances in
computer  capabilities  and  the  techniques  for  attacking  security  solutions,  new  discoveries  in  the  field  of  cryptography  or  other  events  or  developments
could result in compromises or breaches of our security measures and could make some or all our products obsolete or unmarketable. Likewise, if any of
our  products  are  found  to  have  significant  security  vulnerabilities,  then  we  may  need  to  dedicate  engineering  and  other  resources  to  eliminate  the
vulnerabilities and to repair or replace products already sold or licensed to our customers. Despite the security measures that we and our service providers
utilize, our infrastructure and that of our service providers may be vulnerable to physical break-ins, computer viruses, attacks by hackers, phishing attacks,
social  engineering,  or  similar  disruptive  problems.  It  is  possible  that  we  may  have  to  expend  additional  financial  and  other  resources  to  address  such
problems. The COVID-19 pandemic is increasing vulnerability to cyber-attacks, as more individuals and companies work online, which increases these
risks. As a provider of Internet security software and technology, we may be the target of dedicated efforts by hackers and other third parties to overcome
or defeat our security measures. Any physical or electronic break-in or other security breach or compromise of the information stored at our secure data
centers and domain name registration systems, including any compromise due to human error or employee or contractor malfeasance, may jeopardize the
security  of  information  stored  on  our  premises  or  in  the  computer  systems  and  networks  of  our  customers.  In  such  an  event,  we  could  face  significant
liability and current or potential customers could be reluctant to use our services. Additionally, any such data security incident, or the perception that one
has occurred could also result in adverse publicity, harm to our reputation and competitive position, and therefore adversely affect the market’s perception
of the security of electronic commerce and communications over IP networks as well as the security or reliability of our services.

13

Index

A security breach or other security incident could require a substantial level of financial resources to rectify and otherwise respond to, may be difficult to
identify or address in a timely manner, and could result in claims, investigations, and inquires by private parties or governmental entities that may divert
management’s attention and require the expenditure of significant time and resources, and which may cause us to incur substantial fines, penalties, or other
liability and related legal and other costs. Any actual or perceived security breach or other security incident may also harm our reputation and make it more
difficult or impossible for us to successfully market to others. Any of the foregoing matters could harm our operating results and financial condition.

Privacy  and  data  security  concerns,  and  data  collection  and  transfer  restrictions  and  related  domestic  or  foreign  regulations  may  limit  the  use  and
adoption of our solutions and adversely affect our business.

Personal privacy, information security, and data protection are significant issues in the United States, Europe, and many other jurisdictions where we have
operations or offer our products. The regulatory framework governing the collection, processing, storage and use of confidential and proprietary business
information  and  personal  data  is  rapidly  evolving.  The  United  States  federal  and  various  state  and  foreign  governments  have  adopted  or  proposed
requirements regarding the collection, distribution, use, security and storage of personally identifiable information and other data relating to individuals,
and federal and state consumer protection laws are being applied to enforce regulations related to the online collection, use and dissemination of data.

Further, many foreign countries and governmental bodies, including the European Union (“EU”), where we conduct business, have laws and regulations
concerning  the  collection  and  use  of  personal  data  obtained  from  their  residents  or  by  businesses  operating  within  their  jurisdiction.  These  laws  and
regulations  often  are  more  restrictive  than  those  in  the  United  States.  Laws  and  regulations  in  these  jurisdictions  apply  broadly  to  the  collection,  use,
storage,  disclosure,  and  security  of  data  that  identifies  or  may  be  used  to  identify  or  locate  an  individual,  such  as  names,  email  addresses  and,  in  some
jurisdictions, IP addresses.

We also expect that there will continue to be new proposed laws, regulations and industry standards concerning privacy, data protection and information
security in the United States, the EU, and other jurisdictions. For example, the European Commission adopted a General Data Protection Regulation (the
“GDPR”)  that  became  fully  effective  on  May  25,  2018,  superseding  prior  EU  data  protection  legislation,  imposing  more  stringent  EU  data  protection
requirements, and providing for greater penalties for noncompliance. The United Kingdom enacted a Data Protection Act that substantially implements the
GDPR.  We  are  evaluating  obligations  imposed  on  us  by  the  GDPR  and  we  may  be  required  to  incur  substantial  expense  in  order  to  make  significant
changes to our product and business operations in connection with obtaining and maintaining compliance with the GDPR and similar legislation, such as
the  UK  Data  Protection  Act,  all  of  which  may  adversely  affect  our  revenue  and  product  sales.  Additionally,  California  recently  enacted  legislation,  the
California Consumer Privacy Act (the “CCPA”) that, among other things, requires covered companies to provide new disclosures to California consumers,
and afford such consumers new abilities to opt-out of certain sales of personal information. We cannot fully predict the impact of the CCPA on our business
or operations, but it may require us to modify our data processing practices and policies and to incur substantial costs and expenses in an effort to comply.
Additionally, a new privacy law, the California Privacy Rights Act (“CPRA”), recently was certified by the California Secretary of State to appear on the
ballot for the November 3, 2020 election. If this initiative is approved by California voters, the CPRA would significantly modify the CCPA, potentially
resulting in further uncertainty and requiring us to incur additional costs. More generally, we cannot yet fully determine the impact these or future laws,
regulations and standards may have on our business. Privacy, data protection and information security laws and regulations are often subject to differing
interpretations, may be inconsistent among jurisdictions, and may be alleged to be inconsistent with our current or future practices. Additionally, we may be
bound by contractual requirements applicable to our collection, use, processing, and disclosure of various types of data, including personal data, and may
be bound by, or voluntarily comply with, self-regulatory or other industry standards relating to these matters. These and other requirements could reduce
demand  for  our  products,  increase  our  costs,  impair  our  ability  to  grow  our  business,  or  restrict  our  ability  to  store  and  process  data  or,  in  some  cases,
impact our ability to offer our service in some locations and may subject us to liability. Any failure or perceived failure to comply with applicable laws,
regulations, industry standards, and contractual obligations may adversely affect our business. Further, in view of new or modified federal, state, or foreign
laws and regulations, industry standards, contractual obligations and other legal obligations, or any changes in their interpretation, we may find it necessary
or desirable to fundamentally change our business activities and practices or to expend significant resources to modify our product and otherwise adapt to
these changes. We may be unable to make such changes and modifications in a commercially reasonable manner or at all, and our ability to develop new
products and features could be limited.

14

Index

The  costs  of  compliance  with  and  other  burdens  imposed  by  laws,  regulations  and  standards  may  limit  the  use  and  adoption  of  our  service  and  reduce
overall  demand  for  it,  or  lead  to  significant  fines,  penalties,  or  liabilities  for  any  noncompliance.  Privacy,  information  security,  and  data  protection
concerns, whether valid or not valid, may inhibit market adoption of our platform, particularly in certain industries and foreign countries.

We expect that we will experience long and unpredictable sales cycles, which may impact our operating results.

The sales cycle between initial customer contact and execution of a contract or license agreement with a customer or purchaser of our products can vary
widely. We expect that our sales cycles will be long and unpredictable due to several factors, including but not limited to:

•

•

•

•

•

•

•

The need to educate potential customers about our patent rights and our product and service capabilities;

The  impact  of  the  COVID-19  pandemic  on  our  potential  customers  and  their  business  operations,  including  their  budgetary  constraints  and
resources devoted to adopting new products.

Our customers’ willingness to invest potentially substantial resources and modify their network infrastructures to take advantage of our products;

Our customers’ budgetary constraints;

The timing of our customers’ budget cycles;

Delays caused by customers’ internal review processes; and

Long sales cycles that may increase the risk that our financial resources are exhausted before we are able to generate significant revenue.

In  addition,  potential  customers  of  our  products  include  local,  state,  federal  and  foreign  government  authorities.  Sales  to  government  authorities  can  be
extended  and  unpredictable.  Government  authorities  generally  have  complex  budgeting,  purchasing,  and  regulatory  processes  that  govern  their  capital
spending, and their spending is likely to be adversely impacted by economic conditions, including impacts from the COVID-19 pandemic. In addition, in
many  instances,  sales  to  government  authorities  may  require  field  trials  and  may  be  delayed  by  the  time  it  takes  for  government  officials  to  evaluate
multiple competing bids, negotiate terms, and award contracts.

For these reasons, the sales cycle associated with our products is subject to a number of significant risks that are beyond our control. Consequently, if our
forecasted customer orders are not realized or delayed, our revenues and results of operations could be materially and adversely affected.

If we are unable to expand our revenue sources or establish, sustain, grow, or replace relationships with a diversified customer base, our revenues may
be limited.

We  currently  generate  revenue  from  a  limited  number  of  customers  that  have  entered  settlement  and  license  agreements.  Our  GABRIEL  Collaboration
Suite™ is currently generating limited revenue, and it will take time for us to grow our installed user base and generate new customers. Additionally, there
is no guarantee that we will be able to derive revenue from new customers, sustain or increase revenue from existing customers or replace customers from
whom we currently generate revenue. As a result, our revenue may be limited or static.

15

Index

We have limited technical resources and are at an early stage in commercialization of our GABRIEL products.

Part of our business includes the internal development of commercial products we seek to monetize. This aspect of our business may require significant
capital, time and resources and we cannot guarantee that it will be successful or meet our expectations. As such, we have a small technical team, which may
limit our ability to rapidly adapt our product to customer requirements or add new product features to maintain our competitive edge and drive adoption.
Based on the scale of our technical resources, our limited historical financial data upon which to base our projected revenue or planned operating expenses
related to our GABRIEL Collaboration Suite™, we may not be able to effectively:

•

•

•

•

•

•

•

•

Generate revenues or profit from product sales;

Drive adoption of our products;

Attract and retain customers for our products;

Provide appropriate levels of customer training and support for our products;

Implement an effective marketing strategy to promote awareness of our products;

Focus our research and development efforts in areas that generate returns on our efforts;

Anticipate and adapt to changes in our market; or

Protect our products from any system failures or other breaches.

In addition, a high percentage of our expenses are and will continue to be fixed. Accordingly, if we do not generate revenue as and when anticipated, our
losses may be greater than expected and our operating results will suffer.

Our products are highly technical and may contain undetected errors, which could cause harm to our reputation and adversely affect our business.

Our products are highly technical and complex and, when deployed, may contain errors or defects. Despite testing, some errors in our products may only be
discovered after a product has been installed and used by customers. Any errors or defects discovered in our products after commercial release could result
in failure to achieve market acceptance, loss of revenue or delay in revenue recognition, loss of customers and increased service and warranty cost, any of
which could adversely affect our business, operating results, and financial condition. In addition, we could face claims for product liability, tort, or breach
of warranty, including claims relating to changes to our products made by our channel partners. The performance of our products could have unforeseen or
unknown adverse effects on the networks over which they are delivered as well as on third-party applications and services that utilize our services, which
could result in legal claims against us, harming our business. Furthermore, we expect to provide implementation, consulting, and other technical services in
connection with the implementation and ongoing maintenance of our products, which typically involves working with sophisticated software, computing
and communications systems. We expect that our contracts with customers will contain provisions relating to warranty disclaimers and liability limitations,
which may not be upheld. Defending a lawsuit, regardless of its merit, is costly and may divert management’s attention and adversely affect the market’s
perception  of  us  and  our  products.  In  addition,  if  our  business  liability  insurance  coverage  proves  inadequate  or  future  coverage  is  unavailable  on
acceptable terms or at all, our business, operating results, and financial condition could be adversely impacted.

Malfunctions of third-party communications infrastructure, hardware and software expose us to a variety of risks that we cannot control.

Our business will depend upon, among other things, the capacity, reliability, security, and unimpeded access of the infrastructure owned by third parties that
we will use to deploy our offerings. We have no control over the operation, quality, or maintenance of a significant portion of that infrastructure or whether
those third parties will upgrade or improve their equipment. We depend on these companies to maintain the operational integrity of our connections. If one
or more of these companies is unable or unwilling to supply or expand its levels of service to us in the future, our operations could be severely interrupted.
Also, to the extent that the number of users of networks utilizing our current or future products suddenly increases, the technology platform and secure
hosting services which will be required to accommodate a higher volume of traffic may result in slower response times or service interruptions. System
interruptions or increases in response time could result in a loss of potential or existing users and, if sustained or repeated, could reduce the appeal of the
networks to users. In addition, users depend on real-time communications; outages caused by increased traffic could result in delays and system failures.
These types of occurrences could cause users to perceive that our solution does not function properly and could therefore adversely affect our ability to
attract and retain licensees, strategic partners, and customers.

16

Index

System failure or interruption or our failure to meet increasing demands on our systems could harm our business.

The success of our license and service offerings will depend on the uninterrupted operation of various systems, secure data centers and other computer and
communication networks that we establish. To the extent, the number of users of networks utilizing our future products suddenly increases, the technology
platform and hosting services which will be required to accommodate a higher volume of traffic may result in slower response times, service interruptions
or delays or system failures. Our systems and operations will also be vulnerable to damage or interruption from, among other things:

•

•

•

•

Power loss, transmission cable cuts and other telecommunications failures;

Damage or interruption caused by fire, earthquake, and other natural disasters;

Computer viruses or software defects; and

Physical or electronic break-ins, sabotage, intentional acts of vandalism, terrorist attacks and other events beyond our control.

System interruptions or failures and increases or delays in response time could result in a loss of potential or existing users and, if sustained or repeated,
could reduce the appeal of the networks to users. These types of occurrences could cause users to perceive that our solution does not function properly and
could therefore adversely affect our ability to attract and retain licensees, strategic partners, and customers.

Any  significant  problem  with  our  systems  or  operations  could  result  in  lost  revenue,  customer  dissatisfaction  or  lawsuits  against  us.  A  failure  in  the
operation  of  our  secure  domain  name  registration  system  could  result  in  the  inability  of  one  or  more  registrars  to  register  and  maintain  secure  domain
names for a period of time. A failure in the operation or update of the master directory that we plan to maintain could result in deletion or discontinuation
of assigned secure domain names for a period of time. The inability of the registrar systems we establish, including our back-office billing and collections
infrastructure, and telecommunications systems to meet the demands of an increasing number of secure domain name requests could result in substantial
degradation in our customer support service and our ability to process registration requests in a timely manner.

Our ability to sell our solutions will be dependent on the quality of our technical support, and our failure to deliver high- quality technical support
services could have a material adverse effect on our sales and results of operations.

If  we  do  not  effectively  assist  our  customers  in  deploying  our  products,  succeed  in  helping  our  customers  quickly  resolve  post-  deployment  issues  and
provide  effective  ongoing  support,  or  if  potential  customers  perceive  that  we  may  not  be  able  achieve  to  the  foregoing,  our  ability  to  sell  our  products
would  be  adversely  affected,  and  our  reputation  with  current  and  potential  customers  could  be  harmed.  In  addition,  as  we  expand  our  operations
internationally, our technical support team will face additional challenges, including those associated with delivering support, training, and documentation
in  languages  other  than  English.  Our  failure  to  deliver  and  maintain  high-quality  technical  support  services  to  our  customers  could  result  in  customers
choosing to use our competitors’ products and support services instead of ours in the future.

Telephone  carriers  have  petitioned  governmental  agencies  to  enforce  regulatory  tariffs,  which,  if  granted,  would  increase  the  cost  of  online
communication, and such increase in cost may impede the growth of online communication and adversely affect our business.

17

Index

Use of the Internet has over-burdened existing telecommunications infrastructures, and many high traffic areas have begun to experience interruptions in
service. As a result, certain local telephone carriers have petitioned governmental agencies to enforce regulatory tariffs on IP telephony traffic that crosses
over  their  traditional  telephone  networks.  If  the  relief  sought  in  these  petitions  is  granted,  the  costs  of  communicating  via  online  could  increase
substantially,  potentially  adversely  affecting  the  growth  in  the  use  of  online  secure  communications.  Any  of  these  developments  could  have  an  adverse
effect on our business.

The departure of Kendall Larsen, our Chief Executive Officer and President, and/or other key personnel could compromise our ability to execute our
strategic plan and materially harm our business.

Our success largely depends on the skills, experience, and performance of our key personnel. Due to the specialized nature of our business and limited
staff, we are particularly dependent on Kendall Larsen, our Chief Executive Officer and President. We have no employment agreements with any of our key
executives  that  prevent  them  from  leaving  us  at  any  time.  In  addition,  we  do  not  maintain  key  person  life  insurance  for  any  of  our  officers  or  key
employees. The loss of Mr. Larsen, or our failure to retain other key personnel or adequately plan for the succession of key personnel, would jeopardize our
ability to execute our strategic plan and materially harm our business.

We will need to recruit and retain additional qualified personnel to successfully grow our business.

Our  future  success  will  depend,  in  part,  on  our  ability  to  attract  and  retain  qualified  engineering,  operations,  marketing,  sales  and  executive  personnel.
Inability to attract and retain such personnel could adversely affect our business. Competition for engineering, operations, marketing, sales, and executive
personnel  is  intense,  particularly  in  the  technology  and  Internet  sectors  and  in  the  regions  where  we  conduct  our  business.  We  may  need  to  invest
significant amounts of cash and equity to attract and retain employees and expend significant time and resources to identify, recruit, train and integrate such
employees, and we may never realize returns on these investments. Additionally, we can provide no assurance that we will attract or retain such personnel.

Our international expansion will subject us to additional costs and risks, and our plans may not be successful.

We  expect  to  expand  our  presence  internationally  in  Japan  and  elsewhere  through,  third  party  arrangements  such  as  international  partnerships,  joint
ventures and potentially establishing international subsidiaries and offices. Our international expansion may present challenges and risks, including those
inherent in international operations, to us and may require significant attention from management. For example, the COVID-19 pandemic could disrupt and
slow  our  international  expansion  and  partnership  efforts,  as  our  international  partners’  businesses  could  be  disrupted.  We  may  not  be  successful  in  our
international partnerships, expansion efforts, and we may incur significant operating expenses in our efforts to expand internationally.

We  have  incurred  and  will  continue  to  incur  significant  increased  costs  as  a  result  of  operating  as  a  public  company,  and  our  management  will  be
required to continue to devote substantial time to various compliance initiatives.

The Sarbanes-Oxley Act of 2002, the Dodd-Frank Wall Street Reform and Consumer Protection Act of 2010, as well as other rules implemented by the
SEC  and  the  New  York  Stock  Exchange  (“NYSE”),  impose  various  requirements  on  public  companies,  including  requiring  changes  in  corporate
governance practices. These and proposed corporate governance laws and regulations under consideration may further increase our compliance costs. If
compliance with these various legal and regulatory requirements diverts our management’s attention from other business concerns, it could have a material
adverse  effect  on  our  business,  financial  condition,  and  operating  results.  The  Sarbanes-Oxley  Act  requires,  among  other  things,  that  we  assess  the
effectiveness of our internal control over financial reporting annually and disclosure controls and procedures quarterly. If we are unable to assert in any
future reporting periods that our internal control over financial reporting is effective (or if our independent registered public accounting firm is unable to
express  an  opinion  on  the  effectiveness  of  our  internal  controls),  we  could  lose  investor  confidence  in  the  accuracy  and  completeness  of  our  financial
reports, which would have an adverse effect on our share price.

Although we believe that we currently maintain effective control over our disclosures and procedures and internal control over financial reporting, we may
in the future identify deficiencies regarding the design and effectiveness of our system of internal control over financial reporting. If we experience any
material weaknesses in our internal control over financial reporting in the future or are unable to provide unqualified management or attestation reports
about our internal controls, we may be unable to meet financial and other reporting deadlines and may incur costs associated with remediation, and any of
which could cause our share price to decline. Moreover, if we identify deficiencies in our internal control over financial reporting that are deemed to be
material weaknesses in future periods, the market price of our ordinary shares could decline, and we could be subject to potential delisting by the NYSE
and  review  by  the  NYSE,  the  SEC,  or  other  regulatory  authorities,  which  would  require  the  expenditure  by  us  of  additional  financial  and  management
resources.  As  a  result,  our  shareholders  could  lose  confidence  in  our  financial  reporting,  which  would  harm  our  business  and  the  market  price  of  our
ordinary shares.

18

Index

There are inherent uncertainties involved in estimates, judgments and assumptions used in the preparation of financial statements in accordance with
U.S.  GAAP.  Any  changes  in  estimates,  judgments  and  assumptions  could  have  a  material  adverse  effect  on  our  business,  financial  condition,  and
operating results.

The preparation of financial statements in accordance with U.S. GAAP involves making estimates, judgments and assumptions that affect reported amounts
of assets (including intangible assets), liabilities and related reserves, revenues, expenses, and income. Estimates, judgments and assumptions are inherently
subject to change in the future, and any such changes could result in corresponding changes to the amounts of assets, liabilities, revenues, expenses, and
income. Any such changes could have a material adverse effect on our business, financial condition, and operating results.

Our  results  of  operations  and  financial  condition  could  be  materially  affected  by  the  enactment  of  legislation  implementing  changes  in  the  U.S.  or
foreign taxation of international business activities or the adoption of other tax reform policies.

As we expand the scale of our international business activities, any changes in the U.S. or foreign taxation of such activities may increase our worldwide
effective tax rate and harm our business, results of operations, and financial condition. For example, in December 2017, the legislation commonly referred
to as the Tax Cuts and Jobs Act (the “Tax Act”) was enacted, which contained significant changes to U.S. tax law, including, but not limited to, a reduction
in the corporate tax rate and a transition to a new territorial system of taxation. The impact of future changes to U.S. and foreign tax law on our business is
uncertain and could be adverse, and we will continue to monitor and assess the impact of any such changes.

War,  terrorism,  other  acts  of  violence,  or  natural  or  manmade  disasters  may  affect  the  markets  in  which  we  operates,  our  clients  and  our  service
delivery.

Our business may be adversely affected by instability, disruption, or destruction in a geographic region in which we operates, regardless of cause, including
war,  terrorism,  riot,  civil  insurrection,  or  social  unrest,  and  natural  or  manmade  disasters,  including  famine,  flood,  fire,  earthquake,  storm,  or  pandemic
events and spread of disease, such as the COVID-19 pandemic. Such events may cause our customers to delay their decisions on spending for the services
we provide and give rise to sudden significant changes in regional and global economic conditions and cycles. These events may also pose risks to our
personnel and to physical facilities and operations, which could adversely affect our financial results.

The global COVID-19 pandemic may harm our business, financial condition, and results of operations.

In December 2019, a novel coronavirus, COVID-19 was reported in China and in March 2020, the World Health Organization declared it a pandemic. This
contagious disease outbreak has continued to spread across the globe and is impacting worldwide economic activity and financial markets. In light of the
uncertain and rapidly evolving situation relating to the spread of COVID-19, we have taken precautionary measures intended to minimize the risk of the
virus  to  our  employees,  our  customers,  and  other  third  parties  with  whom  we  interact.  We  are  requiring  all  employees  to  work  remotely  and  have  also
suspended all non-essential travel worldwide for our employees. While we have a distributed workforce and our employees are accustomed to working
remotely or working with other remote employees, our workforce is not fully remote. Our employees and consultants travel frequently to establish and
maintain relationships with one another, our customers and prospective customers, partners, and investors. Although we continue to monitor the situation
and may adjust our current policies as more information and public health guidance becomes available, temporarily suspending travel and restricting the
ability to do business in person could negatively affect our customer success efforts, sales and marketing efforts, challenge our ability to enter into customer
contracts in a timely manner, slow down our recruiting efforts, or create operational or other challenges, any of which could harm our business, financial
condition  and  results  of  operations.  Furthermore,  if  a  natural  disaster,  power  outage,  connectivity  issue,  or  other  event  occurred  that  impacted  our
employees’ ability to work remotely, it may be difficult or, in certain cases, not possible, for us to continue our business for a substantial period of time.
The increase in remote working may also result in consumer privacy, IT security and fraud concerns as well as increase our exposure to potential wage and
hour issues. In addition, the COVID-19 pandemic may disrupt the operations of our customers, partners, suppliers, and other third-party providers for an
indefinite period of time, including as a result of travel restrictions, adverse effects on budget planning processes, and/or business shutdowns, all of which
could negatively impact our business, financial condition, and results of operations. More generally, the COVID-19 pandemic could continue to adversely
affect economies and financial markets globally, potentially leading to an economic downturn, which could decrease technology spending and adversely
affect our business.

19

Index

Risks Related to Our Common Stock

Trading in our common stock is limited and the price of our common shares may be subject to substantial volatility.

Our common stock is currently listed on the NYSE and was previously listed on the NYSE American LLC (formerly the NYSE MKT LLC). Over the past
years, the market price of our common stock has experienced significant fluctuations. Between January 1, 2020, and December 31, 2020, the reported last
adjusted closing price on the NYSE American LLC, and now NYSE,  for our common stock ranged between $3.20 and $7.54 per share. The price of our
common stock may continue to be volatile as a result of several factors, some of which are beyond our control. These factors include, but not limited to, the
following:

•

•

•

•

•

•

Developments or lack thereof in any then-outstanding litigation;

Quarterly variations in our operating results;

Large purchases or sales of common stock or derivative transactions related to our stock;

Actual or anticipated announcements of new products or services by us or competitors;

General conditions in the markets in which we compete; and

General social, political, economic, and financial conditions, including the significant volatility in the global financial markets, and impacts from
the COVID-19 pandemic.

In addition, we believe there has been and may continue to be substantial trading in derivatives of our stock, including short selling activity or related
similar activities, which are beyond our control and which may be beyond the full control of the SEC and Financial Institutions Regulatory Authority
or “FINRA”. While the SEC and FINRA rules prohibit some forms of short selling and other activities that may result in stock price manipulation,
such activity may nonetheless occur without detection or enforcement. We have held conversations with regulators concerning trading activity in our
stock; however, there can be no assurance that should there be any illegal manipulation in the trading of our stock, it will be detected, prosecuted, or
successfully eradicated. Significant short selling market manipulation could cause our stock trading price to decline, to become more volatile, or both.

The market price of our common stock has been and may continue to be volatile, and you could lose all or part of your investment.

The trading price of our common stock has been volatile since our initial public offering and is likely to continue to be volatile. Factors that could cause
fluctuations in the market price of our common stock include, but are not limited to the following:

•

•

•

•

Price  and  volume  fluctuations  in  the  overall  stock  market  from  time  to  time,  including  fluctuations  due  to  general  economic  uncertainty  or
negative market sentiment, in particular related to the COVID-19 pandemic;

Volatility in the market prices and trading volumes of companies in our industry or companies that investors consider comparable;

Changes in operating performance and stock market valuations of other companies generally, or those in our industry;

Sales of shares of our common stock by us or our stockholders;

20

Index

•

•

•

•

•

•

•

•

•

•

•

•

•

Failure of securities analysts to maintain coverage of us, changes in financial estimates by securities analysts who follow us, or our failure to meet
these estimates or the expectations of investors;

The financial projections we may provide to the public, any changes in those projections or our failure to meet those projections;

Announcements by us or our competitors of new products or services;

The public’s reaction to our press releases, other public announcements, and filings with the SEC;

Rumors and market speculation involving us or other companies in our industry;

Actual or anticipated changes in our results of operations;

Actual or anticipated developments in our business, our competitors’ businesses, or the competitive landscape generally;

Litigation involving us, our industry or both, or investigations by regulators into our operations or those of our competitors;

Announced or completed acquisitions of businesses or technologies by us or our competitors;

New laws or regulations or new interpretations of existing laws or regulations applicable to our business;

Changes in accounting standards, policies, guidelines, interpretations, or principles;

Any significant change in our management; and

General economic conditions and slow or negative growth of our markets, including any economic downturn from the COVID-19 pandemic;

Further,  in  recent  years  the  stock  markets  have  experienced  extreme  price  and  volume  fluctuations  that  have  affected  and  continue  to  affect  the  market
prices  of  equity  securities  of  many  companies.  These  fluctuations  often  have  been  unrelated  or  disproportionate  to  the  operating  performance  of  those
companies. In addition, the stock prices of many technology companies have experienced wide fluctuations that have often been unrelated to the operating
performance  of  those  companies.  These  broad  market  and  industry  fluctuations,  as  well  as  general  economic,  political  and  market  conditions  such  as
recessions, government shutdowns, global pandemics (such as the COVID-19 pandemic), interest rate changes the stability of the EU and the exit of the
United  Kingdom  or  international  currency  fluctuations,  may  cause  the  market  price  of  our  common  stock  to  decline.  In  the  past,  following  periods  of
volatility in the overall market and the market price of a particular company’s securities, securities class action litigation has often been instituted against
these companies.

We have broad discretion in how we apply our funds, and we may not use these funds effectively, which could affect our results of operations and cause
our stock price to decline.

Our management will have broad discretion in the application of our existing cash, cash equivalents and marketable securities and could spend these funds
in ways that do not improve our results of operations or enhance the value of our common stock. Pending their use, we may invest our available funds in a
manner that does not produce income or that loses value. The failure by our management to apply our available funds effectively could result in financial
losses that could cause the price of our common stock to decline and delay the development of our products.

In  addition,  an  entity  that,  among  other  things,  is  or  holds  itself  out  as  being  engaged  primarily,  or  proposes  to  engage  primarily,  in  the  business  of
investing, reinvesting, owning, trading, or holding certain types of securities would be deemed an Investment Company under the Investment Company Act
of 1940 (the “1940 Act”). If we do not manage our investments and business in a manner that meets the requirements for an exemption under the 1940 Act,
we may be deemed to be an investment company under the 1940 Act and subject to additional limitations on operating our business including limitations
on the issuance of securities, which may make it difficult for us to raise capital.

21

Index

We do not regularly pay dividends on our common stock and thus stockholders must look to appreciation of our common stock to realize a gain on their
investments.

Our dividend policy is within the discretion of our Board of Directors and will depend upon various factors, including our business, financial condition,
results of operations, capital requirements, and investment opportunities. We therefore cannot make assurances that our Board of Directors will determine
to pay regular or special dividends in the future. Accordingly, unless our Board of Directors determines to pay dividends, stockholders will be required to
look to appreciation of our common stock to realize a gain on their investment. This appreciation may not occur.

The exercise of our outstanding stock options, warrants and RSUs and issuance of new shares would result in a dilution of our current stockholders’
voting power and an increase in the number of shares eligible for future resale in the public market which may negatively impact the market price of
our stock.

The  exercise  of  our  outstanding  vested  stock  options,  warrants  and  RSUs  would  dilute  the  ownership  interests  of  our  existing  stockholders.  As  of
December  31,  2020,  we  had  outstanding  options,  warrants  and  RSUs  to  purchase  an  aggregate  of  6,341,844  shares  of  common  stock  representing
approximately 9% of our total shares outstanding of which 4,426,250 were vested and therefore exercisable. To the extent outstanding stock options are
exercised,  additional  shares  of  common  stock  will  be  issued,  existing  stockholders’  percentage  voting  interests  will  decline  and  the  number  of  shares
eligible for resale in the public market will increase. Such increase may have a negative effect on the value or market trading price of our common stock.

The market price of our common stock may decline because our operating results may not be consistent and may be difficult to predict.

Our reported net income has fluctuated in the past due to several factors. We expect that our future operating results may also fluctuate due to the same or
similar factors. While we had net income of $280.4 million for the year ended December 31, 2020, we had net losses of $19.2 million for 2019 and $25.4
million for 2018, and as of December 31, 2020, we had accumulated deficits of $8.0 million. The following include some of the factors that may cause our
operating results to fluctuate:

•

•

•

•

•

•

•

The  outcome  of  actions  to  enforce  our  intellectual  property  rights  currently  in  progress  or  that  we  may  undertake  in  the  future,  and  the  timing
thereof;

The impact of the COVID-19 pandemic on our sales cycle and results;

The amount and timing of receipt of license fees from potential infringers, licensees, or customers;

The rate of adoption of our patented technologies;

The number of new license arrangements we may execute, or that may expire, within a particular period and the scope of those licenses, including
the number of our patents which are licensed, the extent of prior infringement of our patent rights, royalty rates, timing of payment obligations,
expiration date etc.;

The success of a licensee in selling products that use our patented technologies; and

The  amount  and  timing  of  expenses  related  to  our  patent  filings  and  enforcement  proceedings,  including  litigation,  related  to  our  intellectual
property rights.

These fluctuations may make our business particularly difficult to manage, adversely affect our business and operating results, make our operating results
difficult for investors to predict and, further, cause our results to fall below investor’s expectations and adversely affect the market price of our common
stock.

Because ownership of our common stock is concentrated, investors may have limited influence on stockholder decisions.

As of December 31, 2020, our executive officers and directors beneficially owned approximately 13% of our outstanding common stock. In addition, a
group of stockholders that, as of December 31, 2007, held 4,766,666 shares, or approximately 7% of our outstanding common stock, have entered into a
voting  agreement  with  us  that  requires  them  to  vote  all  of  their  shares  of  our  voting  stock  in  favor  of  the  director  nominees  approved  by  our  Board  of
Directors at each director election going forward, and in a manner that is proportional to the votes cast by all other voting shares as to any other matters
submitted to the stockholders for a vote. However, we cannot be certain how many shares of our common stock this group of stockholders currently owns.
Because of their beneficial ownership interest, our officers and directors could significantly influence stockholder actions of which you disapprove or that
are contrary to your interests. This ability to exercise significant influence could prevent or significantly delay another company from acquiring or merging
with us.

22

Index

Our protective provisions in our amended and restated certificate of incorporation and bylaws could make it difficult for a third party to successfully
acquire us even if you would like to sell your stock to them.

We have a number of protective provisions in our amended and restated certificate of incorporation and bylaws that could delay, discourage, or prevent a
third party from acquiring control of us without the approval of our Board of Directors. These protective provisions include:

•

•

•

•

•

•

A  staggered  Board  of  Directors:  This  means  that  only  one  or  two  directors  (since  we  have  a  five-person  Board  of  Directors)  will  be  up  for
election at any given annual meeting. This has the effect of delaying the ability of stockholders to affect a change in control of us because it would
take two annual meetings to effectively replace a majority of the Board of Directors.

Blank  check  preferred  stock:  Our  Board  of  Directors  has  the  authority  to  establish  the  rights,  preferences,  and  privileges  of  our  10,000,000
authorized, but unissued, shares of preferred stock. Therefore, this stock may be issued at the discretion of our Board of Directors with preferences
over your shares of our common stock in a manner that is materially dilutive to you. In addition, blank check preferred stock can be used to create
a “poison pill” which is designed to deter a hostile bidder from buying a controlling interest in our stock without the approval of our Board of
Directors. We have not adopted such a “poison pill;” but our Board of Directors has the ability to do so in the future, very rapidly and without
stockholder approval.

Advance  notice  requirements  for  director  nominations  and  for  new  business  to  be  brought  up  at  stockholder  meetings:  Stockholders
wishing to submit director nominations or raise matters to a vote of the stockholders must provide notice to us within very specific date windows
and in very specific form in order to have the matter voted on at a stockholder meeting. This has the effect of giving our Board of Directors and
management  more  time  to  react  to  stockholder  proposals  generally  and  could  also  have  the  effect  of  disregarding  a  stockholder  proposal  or
deferring it to a subsequent meeting to the extent such proposal is not raised properly.

No stockholder actions by written consent: No stockholder or group of stockholders may take actions rapidly and without prior notice to our
Board of Directors and management or to the minority stockholders. Along with the advance notice requirements described above, this provision
also gives our Board of Directors and management more time to react to proposed stockholder actions.

Super majority requirement for stockholder amendments to the bylaws: Stockholder proposals to alter or amend our bylaws or to adopt new
bylaws can only be approved by the affirmative vote of at least 66 2/3% of the outstanding shares of our common stock.

No ability of stockholders to call a special meeting of the stockholders: Only the Board of Directors or management can call special meetings
of the stockholders. This could mean that stockholders, even those who represent a significant percentage of our shares of common stock, may
need to wait for the annual meeting before nominating directors or raising other business proposals to be voted on by the stockholders.

In  addition,  the  provisions  of  Section  203  of  the  Delaware  General  Corporation  Law  govern  us.  These  provisions  may  prohibit  large  stockholders,
particularly those owning 15% or more of our outstanding voting stock, from merging or combining with us for a certain period of time.

These  and  other  provisions  in  our  amended  and  restated  certificate  of  incorporation,  our  bylaws  and  under  Delaware  law  could  discourage  potential
takeover attempts, reduce the price that investors might be willing to pay for shares of our common stock in the future and result in the market price being
lower than it would be without these provisions.

23

Index

Our amended and restated bylaws designate a state or federal court located within the State of Delaware as the exclusive forum for substantially all
disputes between us and our stockholders, which could limit our stockholders’ ability to choose the judicial forum for disputes with us or our directors,
officers, or employees.

Our amended and restated bylaws provide that, unless we consent in writing to the selection of an alternative forum, the sole and exclusive forum for (1)
any derivative action or proceeding brought on our behalf, (2) any action asserting a claim of breach of a fiduciary duty owed by any of our directors,
stockholders, officers, or other employees to us or our stockholders, (3) any action arising pursuant to any provision of the Delaware General Corporation
Law, or our amended and restated certificate of incorporation or amended and restated bylaws or (4) any other action asserting a claim that is governed by
the internal affairs doctrine shall be the Court of Chancery of the State of Delaware (or, if the Court of Chancery does not have jurisdiction, another State
court in Delaware or the federal district court for the District of Delaware), in all cases subject to the court having jurisdiction over indispensable parties
named as defendants.

However,  notwithstanding  the  exclusive  forum  provisions,  our  amended  and  restated  bylaws  explicitly  state  that  they  would  not  preclude  the  filing  of
claims brought to enforce any liability or duty created under federal securities laws, including the Securities Act of 1933 or the Securities Exchange Act of
1934.

Any  person  or  entity  purchasing  or  otherwise  acquiring  any  interest  in  any  of  our  securities  shall  be  deemed  to  have  notice  of  and  consented  to  this
provision. This exclusive-forum provision may limit a stockholder’s ability to bring a claim in a judicial forum of its choosing for disputes with us or our
directors, officers, or other employees, which may discourage lawsuits against us and our directors, officers, and other employees. If a court were to find
this  exclusive-forum  provision  in  our  amended  and  restated  bylaws  to  be  inapplicable  or  unenforceable  in  an  action,  we  may  incur  additional  costs
associated with resolving the dispute in other jurisdictions, which could harm our results of operations.

Item 1B.

Unresolved Staff Comments.

None.

Item 2.

Properties

Our  principal  executive  offices  are  located  at  308  Dorla  Court,  Suite  206,  Zephyr  Cove,  Nevada,  89448.  We  lease  this  property,  which  comprises
approximately 2,090 square feet of office space, from a third party for a term that ends in October 2021. We have no other properties and believe that our
office facility is suitable and appropriately supports our current business needs.

Item 3.

Legal Proceedings (See “Litigation” in Item 7 - Management’s Discussion and Analysis of Financial Condition and Results of
Operations)

Item 4.

Mine Safety Disclosure

Not applicable.

24

 
 
 
 
 
 
 
Index

PART II

Item 5.

Market for the Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities

Market Information

Our common stock currently trades under the symbol “VHC” on the NYSE.

Holders of Record

As of March 11, 2021, we had 53 stockholders of record. Because many of our shares of common stock are held of record by brokers and other institutions
on behalf of stockholders, we are unable to estimate the total number of beneficial stockholders represented by such record holders.

Dividend Policy

(See "Dividend" in Note -8, in Notes to Consolidated Financial Statements).

Securities Authorized for Issuance under Equity Compensation Plan

See  Item  12,  Security  Ownership  of  Certain  Beneficial  Owners  and  Management  and  Related  Stockholder  Matters  for  information  regarding  securities
authorized for issuance.

Recent Sales of Unregistered Securities

During the year ended December 31, 2020, we had no sales of unregistered securities and no repurchases of stock.

Item 6.

Not applicable

Item 7.

Management’s Discussion and Analysis of Financial Condition and Results of Operations

The Company
We are an Internet security software and technology company with patented technology for various types of secure network communications, including 5G
and  4G  LTE  network  security.  Our  patented  Secure  Domain  Name  Registry  and  GABRIEL  Connection  Technology™,  are  the  foundation  for  our
GABRIEL Secure Communication Platform™ that protects communications using Zero Trust Network Access (ZTNA). Our technology generates secure
connections on a “zero-click” or “single-click” basis, significantly simplifying the deployment of secure real-time communication solutions by eliminating
the need for end-users to enter any encryption information. Our portfolio of intellectual property is the foundation of our business model. We currently own
approximately  194  total  patents  and  pending  applications,  including  70  U.S.  patents/patent  applications  and  124  foreign  patents/validations/pending
applications. Our patent portfolio is primarily focused on securing real-time communications over the Internet, and related services, and is used in all our
technology and products, some of which were acquired by our principal operating subsidiary; VirnetX, Inc., from Leidos, Inc., or Leidos, (f/k/a Science
Applications International Corporation, or SAIC) in 2006.

Our  product  portfolio  includes  sophisticated  technologies,  products  and  services  that  are  available  for  sale  worldwide.  Our  GABRIEL  Secure
Communication Platform™ includes a set of software libraries with application interfaces available for securing third-party applications seamlessly across
multiple operating systems. It enables individuals and organizations to maintain complete ownership and control over their personal and confidential data,
secured within their own private network, while enabling authorized secure encrypted access from anywhere at any time.

25

 
 
 
 
 
 
 
 
 
 
 
Index

Our GABRIEL Gateway product extends our Secure Communication Platform™ by allowing existing networked devices and services to seamlessly join
the “GABRIEL SECURED” network without requiring any modifications. All these devices or services, including on-premise or cloud-based services, can
now be assigned a VirnetX Secure Domain Name and use fully authenticated, secure communication channels for its communications.

Our  GABRIEL  Collaboration  Suite™  is  a  set  of  communication  applications  and  tools  that  use  our  GABRIEL  Secure  Communication  Platform™.  It
enables  seamless  and  secure  cross-platform  communications  between  devices  that  are  enrolled  in  our  “GABRIEL  SECURED”  network  and  have  our
software  installed.  Our  GABRIEL  Collaboration  Suite™  is  available  for  download  and  free  trial,  for  Android,  iOS,  Windows,  Linux,  and  Mac  OS  X
platforms, at https://virnetx.com.

We continue to enhance our products and add new functionality. We will provide updates to new and existing customers as they are released to the public.
Many small and medium businesses have installed our GABRIEL Secure Communication Platform™ and GABRIEL Collaboration Suite™ products in
their corporate networks. We intend to continue to expand our customer base with targeted promotions and direct sales initiatives.

We have an ongoing GABRIEL Licensing Program under which we offer licenses to a portion of our patent portfolio, technology, and software, including
our  secure  domain  name  registry  service,  to  domain  infrastructure  providers,  communication  service  providers  as  well  as  to  system  integrators.  Our
GABRIEL Connection Technology™ License is offered to OEM customers who want to adopt the GABRIEL Connection Technology™ as their solution
for establishing secure connections using secure domain names within their products. We have developed GABRIEL Connection Technology™ Software
Development Kit (SDK) to assist with rapid integration of these techniques into existing software implementations. Customers who want to develop their
own implementation of the VirnetX patented techniques for supporting secure domain names, or other techniques that are covered by our patent portfolio
for establishing secure communication links, can purchase a patent license. The number of patents licensed, and therefore the cost of the patent license to
the customer, will depend upon which of the patents are used in a particular product or service. These licenses will typically include an initial license fee, as
well as an ongoing royalty.

Our employees include the core development team behind our patent portfolio, technology, and software. Some members of this team have worked together
for  over  twenty  years  and  were  on  same  team  that  invented  and  developed  this  technology  while  working  at  Leidos,  Inc.  (“Leidos”).  The  team  has
continued its research and development work and expanded the set of patents we acquired in 2006 from Leidos, into a larger patent portfolio. This portfolio
now serves as the foundation of our products, services, and our licensing business. It is expected to generate most of our future revenue in license fees and
royalties. We intend to continue our efforts to develop new products and technologies and further strengthen and expand our patent portfolio. We intend to
continue using an outsourced and leveraged model to maintain efficiency and manage costs as we grow our licensing business by, for example, offering
incentives to early licensing targets or asserting our rights for use of our patents.

26

Index

Litigation (all dollar amounts in this section are expressed in thousands except for rates per device)

We have several intellectual property infringement lawsuits pending in the United States District Court for the Eastern District of Texas, Tyler Division
(“USDC”), and United States Court of Appeals for the Federal Circuit (“USCAFC”) and the Supreme Court of the United States (“SCOTUS”).

VirnetX Inc. v. Cisco Systems, Inc. et al. (Case 6:10-CV-00417-LED) (“Apple I”)

On August 11, 2010, we filed a complaint against Aastra USA. Inc. (“Aastra”), Apple Inc. (“Apple”), Cisco Systems, Inc. (“Cisco”), and NEC Corporation
(“NEC”)  the  USDC  in  which  we  alleged  that  these  parties  infringe  on  certain  of  our  patents  (U.S.  Patent  Nos.  6,502,135,  7,418,504,  7,921,211  and
7,490,151). We sought damages and injunctive relief. The cases against each defendant were separated by the judge. Aastra and NEC agreed to sign license
agreements with us, and we dropped all accusations of infringement against them. A jury in USDC decided that our patents were not invalid and rendered a
verdict of non-infringement by Cisco on March 4, 2013. Our motion for a new Cisco trial was denied and the case against Cisco was closed.

On November 6, 2012, a jury in the USDC awarded us over $368,000 for Apple’s infringement of four of our patents, plus daily interest up to the final
judgment.

Apple filed an appeal of the judgment to the USCAFC. On September 16, 2014, USCAFC affirmed the USDC jury’s finding that all four of our patents at
issue are valid and confirmed the USDC jury’s finding of infringement of VPN on Demand under many of the asserted claims of our ‘135 and ‘151 patents,
and the USDC’s decision to allow evidence about our license and royalty rates regarding the determination of damages. However, the USCAFC vacated the
USDC jury’s damages award and some of the USDC’s claim construction with respect to parts of our ‘504 and ‘211 patents and remanded the damages
award and determination of infringement with respect to FaceTime back to the USDC for further proceedings.

On September 30, 2016, pursuant to the 2014 remand from the USCAFC, a jury in the USDC awarded us $302,400 for Apple’s infringement of four of our
patents. On September 29, 2017, the USDC entered its final judgment, denied all of Apple’s post-trial motions, granted all our post-trial motions, including
our  motion  for  willful  infringement  and  enhanced  the  royalty  rate  during  the  willfulness  period  from  $1.20  to  $1.80  per  device,  and  awarded  us  costs,
certain  attorneys’  fees,  and  prejudgment  interest.  The  total  amount  in  the  final  judgment  was  $439,700,  including  $302,400  (jury  verdict),  $41,300
(enhanced damages) and $96,000 (costs, fees, and interest).

On October 27, 2017 Apple appealed the final judgment entered on September 29, 2017 to the USCAFC. Oral arguments in this case were held on January
8, 2019. On January 15, 2019, the Court issued a Rule 36 order affirming the district court’s final judgment. Apple filed a petition for panel rehearing and
rehearing en-banc in this matter on February 21, 2019. On October 1, 2019, USCAFC issued an order denying Apple’s petition. Apple filed a petition for a
writ  of  certiorari  with  the  SCOTUS,  which  was  denied  on  February  24,  2020.  Prior  to  the  SCOTUS  decision  denying  Apple’s  petition  for  a  writ  of
certiorari,  on  February  20,  2020,  Apple  filed  a  Rule  60(b)  motion  for  relief  from  judgment  with  the  USDC,  seeking  relief  from  the  district  court’s
September 29, 2017 final judgment. VirnetX filed a responsive brief in opposition on March 5, 2020.

27

Index

On March 13, 2020, the Company received payment of $454,034 from Apple, representing the previously announced final judgment with interest in this
case. Apple sought payment relief by filing a motion under Rule 60(b). On September 1, 2020 USDC issued an order denying Apple’s motion for relief of
judgement. This case is now closed.

VirnetX Inc. v. Apple, Inc. (Case 6:12-CV-00855-LED) (“Apple II”)

This case began on November 6, 2012, when we had filed a complaint against Apple in USDC in which we alleged that Apple infringed on certain of our
patents,  (U.S.  Patent  Nos.  6,502,135,  7,418,504,  7,921,211  and  7,490,151).  We  sought  damages  and  injunctive  relief.  The  accused  products  include  the
iPhone 5, iPod Touch 5th Generation, iPad 4th Generation, iPad mini, and the latest Macintosh computers; these products were not included in the Apple I
case because they were released after the Apple I case was initiated. Post-trial motions hearing was held on July 18, 2018. On August 31, 2018, the USDC
entered  a  Final  Judgment  and  issued  its  Memorandum  Opinion  and  Order  regarding  post-trial  motions,  affirming  the  jury’s  verdict  of  $502,600  and
granting  VirnetX  motions  for  supplemental  damages,  a  sunset  royalty,  and  the  royalty  rate  of  $1.20  per  infringing  iPhone,  iPad  and  Mac  products,  pre-
judgment and post-judgment interest and costs. Apple filed a notice of appeal with the USCAFC in the Apple II case.

On October 9, 2018, USCAFC docketed the appeal as Case No. 19-1050 - VirnetX Inc. v. Apple Inc . On January 24, 2019 Apple filed its opening brief.
We  filed  our  response  brief  on  March  1,  2019.  Apple  filed  its  reply  brief  on  April  5,  2019.  The  oral  arguments  were  heard  on  October  4,  2019.  On
November  22,  2019,  the  USCAFC  issued  an  opinion  affirming  the  district  court’s  findings  that  Apple  is  precluded  from  making  certain  invalidity
arguments and that Apple infringed the ’135 and ’151 patents; reversing the USDC’s finding that Apple infringed the ’504 and ’211 patents; and remanding
the case for proceedings on damages. Apple sought panel and en banc rehearing, which the USCAFC denied on February 10, 2020.

On February 22, 2020, the USDC issued a scheduling order for the parties to brief the court about the need for a new trial for recalculating the damages.
We filed our motion for entry of judgment on February 28, 2020. The arguments on this matter were heard on April 14, 2020. In its order, unsealed on May
1,  2020,  the  USDC  denied  VirnetX’s  motion  for  entry  of  a  new  judgment  based  on  the  prior  jury  verdict  and  ordered  a  new  jury  trial  on  damages.  On
August  10,  2020,  the  USDC  granted  Apple’s  motion  for  continuance  and  reset  the  date  to  October  26,  2020.  On  October  30,  2020,  a  jury  returned  a
$502,800 verdict in favor of VirnetX based on Apple’s infringement of two network security patents: VirnetX US Patents No. 6,502,135 and No. 7,490,151.
The  jury  verdict  called  for  damages  of  $0.84  per  accused  device  since  the  2013  launch  of  Apple’s  iOS  7  operating  system  and  represents  598,629,580
infringing units from US sales only. On January 15, 2021, the district court denied Apple’s motion for judgment as a matter of law, and on February 4,
2021, Apple filed a notice of appeal to the USCAFC.

VirnetX Inc. v. Mangrove Partners Master Fund, Ltd., Apple Inc. (USCAFC Case 20-2271) and VirnetX Inc. v. Mangrove Partners Master Fund,
Ltd., Apple Inc., and Black Swamp, LLC (USAFC Case 20-2272)

On September 15, 2020, we filed with the USCAFC an appeal of the invalidity findings by the PTAB in inter-partes review proceedings IPR2015-01046
and  IPR2016-00062  involving  our  U.S.  Patent  No.  6,502,135,  and  an  appeal  of  the  invalidity  findings  by  the  PTAB  in  inter  partes  review  proceedings
IPR2015-1047,  IPR2016-  00063,  and  IPR2016-00167  involving  our  U.S.  Patent  No.  7,490,151.  On  September  25,  2020,  the  USCAFC  issued  an  order
consolidating the two appeals. On December 15, 2020, we filed a motion to vacate the PTAB decisions below and to remand these appeals to the PTAB,
which remains pending.  In view of our motion to remand, our deadline to file an initial brief is currently stayed.

Iancu v. Luoma (SCOTUS Case 20-74)

On July 23, 2020, the United States and the USPTO (collectively, “the United States”) filed a petition for a writ of certiorari from several decisions by the
USAFC, including decisions in VirnetX Inc. v. Cisco Systems, Inc., Nos. 2019-1671, and VirnetX Inc. v. Iancu, Nos. 2017-2593, -2594.  In those cases, the
USAFC granted VirnetX’s motions to vacate the underlying decisions of the PTAB on the basis of Arthrex, Inc. v. Smith & Nephew, Inc., 941 F.3d 1320
(Fed. Cir. 2019), and remanded for further proceedings.  The United States requested that the SCOTUS hold its certiorari petition pending the disposition of
the United States’ separate petition in United States v. Arthrex, Inc., No. 19-1434 (filed June 25, 2020).  On August 26, 2020, VirnetX filed a response,
agreeing that the United States’ certiorari petition should be held pending the disposition of the petition for a writ of certiorari in No. 19-1434 (and related
petitions filed by private parties in Nos. 19-1452 and 19-1458), and any further SCOTUS proceedings.

28

Index

On  October  13,  2020,  SCOTUS  granted  the  United  States’  petition  for  a  writ  of  certiorari  in  No.  19-1434  as  to  USAFC  Case  No.  2018-2140,  and  the
petitions for writs of certiorari in Nos. 19-1452 and 19-1458, all limited to Questions 1 and 2 as set forth in the July 22, 2020 Memorandum for the United
States filed in No. 19-1434. The consolidated petition is seeking review of decisions by the USCAFC holding that administrative patent judges (“APJ”) of
the Patent Trial and Appeal Board of the U.S. Patent and Trademark Office must be appointed by the President and confirmed by the Senate; and, whether
the  remedy  imposed  by  USCAFC  that  federal  laws  that  place  restrictions  on  when  officials  can  be  removed  from  office  cannot  apply  to  APJ,  was  the
appropriate one. SCOTUS heard oral argument in these consolidated cases on March 1, 2021.

McKool Smith P.C. v. VirnetX, Inc., AAA Case No. 01-20-0003-7975

On March 23, 2020, the law firm of McKool Smith, P.C. (“McKool”) filed a Demand for Arbitration against VirnetX, Inc. with the American Arbitration
Association (“AAA”). In its demand, McKool claims that a retention agreement it entered into in 2010 with VirnetX entitles it to a contingency fee arising
from the recent 2020 payment made by Apple. McKool claims it is owed approximately $36,300 (or 8% of the Apple I payment). We have filed a general
response with the AAA denying McKool’s claim and are contesting the matter vigorously. An evidentiary hearing was held on the matter during the week
of February 22, 2021 and the parties will be submitting additional briefing.  A ruling is expected sometime thereafter.

Neal Hurwitz v. Kendall Larsen et al. (Case 2020-0425-JRS)

On June 2, 2020, stockholder Neal Hurwitz filed a verified derivative complaint in the Delaware Court of Chancery against Kendall Larsen, Robert D.
Short  Ill,  Gary  Feiner,  Michael  F.  Angelo,  and  Thomas  M.  O’Brien  and  naming  the  Company  as  nominal  defendant.  The  lawsuit  alleges  breaches  of
fiduciary duty, corporate waste, and unjust enrichment arising out of a series of previously-disclosed transactions and compensation awards and seeks an
award  of  monetary  damages  and  equitable  relief.  On  July  1,  2020,  the  defendants  filed  a  motion  to  dismiss  the  complaint  based  on  a  failure  to  plead
demand futility and a failure to state a claim on which relief can be granted and, on August 19, 2020, the defendants filed an opening brief in support of
their motion to dismiss. On October 16, 2020, plaintiff amended his complaint rather than respond to the arguments in the defendants’ opening brief. On
October 23, 2020, the defendants filed a renewed motion to dismiss plaintiff’s amended complaint based on a failure to plead demand futility and a failure
to state a claim on which relief can be granted. On January 12, 2021, Hurwitz voluntarily dismissed his suit without prejudice.

Other Legal Matters

One  or  more  potential  intellectual  property  infringement  claims  may  also  be  available  to  us  against  certain  other  companies  who  have  the  resources  to
defend against any such claims. Although we believe these potential claims are likely valid, commencing a lawsuit can be expensive and time-consuming,
and  there  is  no  assurance  that  we  could  prevail  on  such  potential  claims  if  we  made  them.  In  addition,  bringing  a  lawsuit  may  lead  to  potential
counterclaims  which  may  distract  our  management  and  our  other  resources,  including  capital  resources,  from  efforts  to  successfully  commercialize  our
products.

Currently, we are not a party to any other pending legal proceedings and are not aware of any proceeding threatened or contemplated against us.

Commitments and Related Party Transactions

We lease our offices under an operating lease with a third party expiring in October 2021. We recognize rent expense on a straight-line basis over the term
of the lease.

We entered into a service agreement for the use of an aircraft from K2 Investment Fund LLC (“LLC”) for business travel for employees of the Company.
We  incurred  approximately  $324,  and  $1,790  in  rental  fees  and  reimbursements  to  the  LLC  during  the  years  ended  December  31,  2020,  and  2019,
respectively. We pay for the Company’s business usage of the aircraft and have no right to purchase. Our Chief Executive Officer and Chief Administrative
Officer are the managing partners of the LLC and control the equity interests of the LLC. We entered into a 12-month non-exclusive agreement with the
LLC for use of the plane at a rate of $8 per flight hour, with no minimum usage requirement. The agreement contains other terms and conditions normal in
such transactions and can be cancelled by either us or the LLC with 30 days’ notice. The agreement renews on an annual basis unless terminated by either
party. Neither party has exercised their termination rights.

29

 
 
Index

Critical Accounting Policies

The preparation of financial statements in conformity with accounting principles generally accepted in the United States (“GAAP”) requires us to make
estimates  and  assumptions  that  affect  the  reported  amounts  of  assets  and  liabilities  and  disclosure  of  contingent  assets  and  liabilities  at  the  date  of  the
financial  statements  and  the  reported  amounts  of  revenues  and  expenses  during  the  reported  period.  The  critical  accounting  policies  we  employ  in  the
preparation  of  our  consolidated  financial  statements  are  those  which  involve  impairment  of  long-lived  assets,  income  taxes,  fair  value  of  financial
instruments and stock-based compensation.

Basis of Consolidation

The consolidated financial statements include the accounts of VirnetX Holding Corporation and our wholly-owned subsidiaries. All intercompany balances
and transactions have been eliminated.

Use of Estimates

We prepare our consolidated financial statements in accordance with U.S. GAAP. In doing so, we must make estimates and assumptions that affect our
reported amounts of assets, liabilities, revenues, and expenses, as well as related disclosure of contingent assets and liabilities. In some cases, we could
reasonably  have  used  different  accounting  policies  and  estimates.  In  some  cases,  changes  in  our  accounting  estimates  are  reasonably  likely  to  occur.
Accordingly, actual results could differ materially from our estimates. To the extent that there are material differences between these estimates and actual
results, our financial condition or results of operations will be affected. We base our estimates on experience and other assumptions that we believe are
reasonable under the circumstances, at the time they are made, and we evaluate these estimates on an ongoing basis. We refer to accounting estimates of
this type as critical accounting policies and estimates, which we discuss further below.

Leases

The Company determines if an arrangement, giving the Company a right-of-use (“ROU”) asset, is a lease at inception. Operating lease ROU assets are
included in other assets on the Condensed Consolidated Balance Sheet. ROU assets represent the Company’s right to use an underlying asset for the lease
term and lease liabilities represent the Company’s obligation to make lease payments arising from the lease. ROU assets and lease liabilities are recognized
at the commencement date of the arrangement based on the present value of lease payments over the lease term. Other assets at December 31, 2020, include
a ROU asset related to a facility lease for corporate promotional and marketing purposes. The facility lease was paid in full at inception and the ROU is
being amortized over the term of the lease. Other assets also include an ROU related to our office operating lease which expires in October 2021 (See Note
13 - Leases).

Revenue Recognition

The Company derives revenue from licensing and royalty fees from contracts with customers which often span several years. We account for this revenue
in  accordance  with  Accounting  Standards  Codification  (“ASC”)  Topic  606,  Revenue  from  Contracts  with  Customers.  A  performance  obligation  is  a
promise in a contract to transfer a distinct good or service to the customer. A contract’s transaction price is allocated to each distinct performance obligation
and recognized as revenue when, or as, the performance obligation is satisfied. Our revenue arrangements may consist of multiple-element arrangements,
with revenue for each unit of accounting recognized as the product or service is delivered to the customer.

With  the  licensing  of  our  patents,  performance  obligations  are  generally  satisfied  at  a  point  in  time  as  work  is  complete  when  our  patent  rights  are
transferred to our customers. We generally have no further obligation to our customers regarding our technology.

Certain  contracts  may  require  our  customers  to  enter  into  a  hosting  arrangement  with  us  and  for  these  arrangements,  revenue  is  recognized  over  time,
generally over the life of the servicing contract.

The  Company  actively  monitors  and  enforces  its  intellectual  property  (“IP”)  rights,  including  seeking  appropriate  compensation  from  third  parties  that
utilize the Company’s IP without a license. As a result, the Company may, from time to time, receive payments as part of a settlement or compensation for
a patent infringement dispute. Proceeds received are allocated to each element identified in the settlement or compensation, based on the fair value of each
element. Generally, settlements and compensation may include the following elements: the value of a license or royalty agreement, cost reimbursement,
damages, and interest. Elements identified related to licensing and royalty are recognized as revenue. Elements identified as reimbursed costs are generally
recorded  as  a  reduction  to  the  reported  expenses.  Elements  identified  as  damages  or  interest  are  generally  recorded  in  other  income  in  the  condensed
consolidated statement of operations.

30

 
 
 
 
 
 
 
 
Index

Licensing Costs

Licensing costs are incurred pursuant to favorable court decisions relating to patent infringement cases and are included in operating expenses in the
Company’s consolidated statement of operations.

Contingent Gains

ASC Topic 450-30-25, Contingent Gains, prohibits recognition of contingent gains until realized. Accordingly, we do not record contingent gains ahead of
such realization. Management generally considers any such gains as realized only upon the collection of cash.

Earnings (Loss) Per Share

Basic earnings (loss) per share are computed by dividing earnings (loss) available to common stockholders by the weighted average number of outstanding
common shares during the period. Diluted earnings per share are computed by dividing net income by the weighted average number of shares outstanding
during  the  period  increased  to  include  the  number  of  additional  shares  of  common  stock  that  would  have  been  outstanding  if  the  potentially  dilutive
securities had been issued.

Concentration of Credit Risk and Other Risks and Uncertainties

Our cash and cash equivalents are primarily maintained at two major financial institutions in the United States. A portion of those balances are insured by
the Federal Deposit Insurance Corporation. During the year ended December 31, 2020, we had funds which were uninsured. We do not believe that we are
subject to any unusual financial risk beyond the normal risk associated with commercial banking relationships with major financial institutions. We have
not experienced any losses on our deposits of cash and cash equivalents.

Impairment of Long-Lived Assets

We  identify  and  record  impairment  losses  on  long-lived  assets  used  in  operations  when  events  and  changes  in  circumstances  indicate  that  the  carrying
amount  of  an  asset  might  not  be  recoverable,  but  not  less  than  annually.  Recoverability  is  measured  by  comparison  of  the  anticipated  future  net
undiscounted cash flows to the related assets’ carrying value. If such assets are considered to be impaired, the impairment to be recognized is measured by
the amount by which the carrying amount of the assets exceeds the projected discounted future net cash flows arising from the asset.

Income Taxes

We account for income taxes using the asset and liability method. The asset and liability method require the recognition of deferred tax assets and liabilities
for  expected  future  tax  consequences  of  temporary  differences  that  currently  exist  between  the  tax  basis  and  financial  reporting  basis  of  our  assets  and
liabilities. We calculate current and deferred tax provisions based on estimates and assumptions that could differ from actual results reflected on the income
tax returns filed during the following years. Adjustments based on filed returns are recorded when identified in the subsequent years. The effect on deferred
taxes for a change in tax rates is recognized in income in the period that the tax rate change is enacted. In assessing our deferred tax assets, we consider
whether it is more likely than not that all or some portion of the deferred tax assets will not be realized.

A valuation allowance is provided for deferred income tax assets when, in our judgment, based upon currently available information and other factors, it is
more likely than not that all or a portion of such deferred income tax assets will not be realized. The determination of the need for a valuation allowance is
based on an on-going evaluation of current information including, among other things, historical operating results, estimates of future earnings in different
taxing  jurisdictions  and  the  expected  timing  of  the  reversals  of  temporary  differences.  We  believe  the  determination  to  record  a  valuation  allowance  to
reduce a deferred income tax asset is a significant accounting estimate because it is based, among other things, on an estimate of future taxable income in
the United States and certain other jurisdictions, which is susceptible to change and may or may not occur, and because the impact of adjusting a valuation
allowance may be material. In determining when to release the valuation allowance established against our net deferred income tax assets, we consider all
available evidence, both positive and negative. Due to the 2020 income, we have released the valuation allowance against federal net deferred tax assets,
and we maintain a partial valuation allowance against the state net operating loss and credit carryovers due to lack of income in California. We continually
assess our ability to generate sufficient taxable income during future periods in which our deferred tax assets may be realized. If and when we believe it is
more likely than not that we will recover our deferred tax assets, we will reverse the valuation allowance as an income tax benefit in our statements of
operations.

31

 
 
 
 
Index

We account for our uncertain tax positions in accordance with U.S. GAAP. The U.S. GAAP method of accounting for uncertain tax positions utilizes a two-
step approach to evaluate tax positions. Step one, recognition, requires evaluation of the tax position to determine if based solely on technical merits it is
more likely than not to be sustained upon examination. Step two, measurement, is addressed only if a position is more likely than not to be sustained. In
step two, the tax benefit is measured as the largest amount of benefit, determined on a cumulative probability basis, which is more likely than not to be
realized upon ultimate settlement with tax authorities. If a position does not meet the more likely than not threshold for recognition in step one, no benefit
is recorded until the first subsequent period in which the more likely than not standard is met, the issue is resolved with the taxing authority, or the statute
of limitations expires. Positions previously recognized are derecognized when we subsequently determine the position no longer is more likely than not to
be  sustained.  Evaluation  of  tax  positions,  their  technical  merits,  and  measurements  using  cumulative  probability  are  highly  subjective  management
estimates. Actual results could differ materially from these estimates.

Stock-based Compensation

We account for stock-based compensation using the fair value recognition method. We recognize these compensation costs on a straight-line basis over the
requisite service period of the award, which is generally based on the option vesting term of 4 years.

In addition, we record stock-based compensation expense for awards granted to non-employees at fair value of the consideration received or the fair value
of the equity investments issued generally as they vest over the performance period.

Fair Value

We apply fair value accounting to all financial assets and liabilities and non-financial assets and liabilities that are recognized or disclosed at fair value in
the financial statements on a recurring basis. Fair value is estimated by applying the following hierarchy, which prioritizes the inputs used to measure fair
value into three levels and bases the categorization within the hierarchy upon the lowest level of input that is available and significant to the fair value
measurement:

Level 1 – Quoted prices in active markets for identical assets or liabilities.

Level 2 – Observable inputs other than quoted prices in active markets for identical assets and liabilities, quoted prices for identical or similar assets or
liabilities in inactive markets, or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the
assets or liabilities.

Level  3  –  Inputs  that  are  generally  unobservable  and  typically  reflect  management’s  estimate  of  assumptions  that  market  participants  would  use  in
pricing the asset or liability.

Our financial instruments are stated at amounts that equal, or are intended to approximate, fair value. When we approximate fair value, we utilize market
data or assumptions that we believe market participants would use in pricing the financial instrument, including assumptions about risk and inputs to the
valuation  technique.  We  use  quoted  valuation  techniques,  primarily  the  income  and  market  approach  that  maximize  the  use  of  observable  inputs  and
minimize the use of unobservable inputs for recurring fair value measurements.

New Accounting Pronouncements

In  December  2019,  the  Financial  Accounting  Standards  Board  (“FASB”) issued  Accounting  Standards  Update  (“ASU”)  2019-12  Income  Taxes  (Topic
740). The amendments in this ASU simplify the accounting for income taxes by removing certain exceptions to the general principles in Topic 740. The
amendments also improve consistent application of and simplify U.S. GAAP for other areas of Topic 740 by clarifying and amending existing guidance.
The  amendments  in  this  ASU  are  effective  for  fiscal  years,  and  interim  periods  within  those  fiscal  years,  beginning  after  December  15,  2020.  We  are
currently evaluating the impact, if any this ASU will have on our consolidated financial statements and related disclosures.

32

 
 
 
 
 
 
 
 
 
 
 
Index

In June 2016, the FASB issued ASU 2016-13, Measurement of Credit Losses on Financial Instruments, and issued subsequent amendments to the initial
guidance within ASU 2019-04 and ASU 2019-05 (collectively, “ASU 2016-13”). The amendments in ASU 2016-13 replace the incurred loss impairment
methodology with the current expected credit loss model, which requires consideration of a broader range of reasonable and supportable information to
estimate  credit  losses.  The  Company  adopted  this  ASU  effective  January  1,  2020  and  the  adoption  did  not  have  a  material  impact  on  the  Company’s
financial position, results of operations or cash flows.

Results of Operations (all amounts in this section are expressed in thousands)

Revenue

Revenue

2020

2019

  $

302,636    $

85 

Revenue generated for the year ended December 31, 2020 was $302,636 compared to revenue for the year ended December 31, 2019 of $85.  During the
year  ended  December  31,  2020,  the  Company  collected  a  lump  sum  payment  of  $454,034  from  Apple,  Inc.  (see  “Legal  Proceedings”),  as  a  result  of  a
favorable court decision relating to a patent infringement case. The one-time payment includes past royalties, damages for willful infringement, interest,
court  costs  and  attorneys’  fees.  (See  “Revenue  Recognition”  in  Note  2  -  Summary  of  Significant  Accounting  Policies,  in  the  Notes  to  Consolidated
Financial Statements.)

We recognized royalty revenue as part of license agreements entered into with customers during the patent infringement actions (see “Litigation”). These
revenues relate to payment for use of our patented technology prior to the signing of a license agreement, and royalty payments after the execution of the
license agreements.

Licensing Costs

Included  in  operating  expenses  for  the  year  ended  December  31,  2020,  were  $90,101  in  licensing  costs  we  incurred  in  conjunction  with  the  proceeds
received from Apple Inc., pursuant to a favorable court decision relating to a patent infringement case.

Research and Development Expenses

Research and Development

2020

2019

  $

8,830    $

3,845 

Research and development costs include expenses paid to outside development consultants and compensation-related expenses for our engineering staff.
Research and development costs are expensed as incurred.

Our research and development expenses for the year ended December 31, 2020 were $8,830 compared to December 31, 2019 of $3,845. The increase in
2020 compared to 2019 was primarily due to increased compensation expense.

Selling, General and Administrative Expenses

Selling, General and Administrative

2020

2019

  $

45,812    $

15,905 

Selling, general and administrative expenses include compensation expense for management and administrative personnel, as well as expenses for outside
legal, accounting, and consulting services.

Our selling, general and administrative expenses for the year ended December 31, 2020 were $45,812 compared to December 31, 2019 of $15,905. The
volatility within selling, general and administrative expenses was primarily due to legal fees related to cases involving the defense of our patents. Legal
fees were $30,699 and $5,898 in 2020 and 2019, respectively and represent approximately 67% of selling, general and administrative expenses for 2020
compared to 37% for 2019.

Gain on Settlement

For the year ended December 31, 2020, we recorded a gain of $41,271 pursuant to a favorable court ruling in the case regarding Apple, Inc. discussed
above. (See “Revenue Recognition” in Note 2 - Summary of Significant Accounting Policies, in the Notes to Consolidated Financial Statements.)

Interest and Other Income, net

Interest and Other Income

2020

2019

  $

108,288    $

92 

33

 
 
 
 
   
 
 
 
 
 
 
 
 
 
   
 
 
 
 
 
 
 
   
 
 
 
 
 
 
 
 
 
   
 
Index

Interest and other income for the year ended December 31, 2020 was $108,288 compared to December 31, 2019 of $92.  During 2020 we received interest
of  $108,221  pursuant  to  a  favorable  court  ruling  in  the  case  with  Apple,  Inc.  discussed  above.  (See  “Revenue  Recognition”  in  Note  2  -  Summary  of
Significant Accounting Policies, in the Notes to Consolidated Financial Statements.)

Effective Income Tax Rate

A reconciliation of the United States federal statutory income tax rate to our effective income tax rate is as follows:

United States federal statutory rate
State taxes, net of federal benefit
Valuation allowance
Stock based compensation
R&D Credit
Other
Effective income tax rate

Year Ended
December 31, 2020

Year Ended
December 31, 2019

21.00  %  
0.17  %  
(12.22) %  
(0.01) %  
(0.21) %  
0.06  %  
8.79  %  

21.00  %  
1.99  %  
(21.96) %  
— 

1.34  %  
(0.38) %  
1.99  %  

The Company’s effective tax rate for both 2020 and 2019 was lower than the statutory Federal income tax rate primarily due to the change in valuation
allowance.  In 2020 we had pre-tax income of $307,452 and in 2019 we had pre-tax losses of $19,573.  At December 31, 2020, we had state net operating
loss carryforwards of $107,989.  All of the Federal net operating loss (NOL) carryforwards have been utilized to offset the taxable income in 2020. The
state NOL carryforwards begin expiring in 2029.

Liquidity and Capital Resources

For the year ended December 31, 2020, our cash and cash equivalents totaled $192,908 and our short-term investments totaled $28,348 compared to $3,135
and $2,394, respectively, for the year ended December 31, 2019.

We expect that our cash and cash equivalents and short-term investments as of December 31, 2020, will be sufficient to fund our current level of selling,
general and administration costs, including legal expenses and provide related working capital for the foreseeable future. Over the longer term, we expect
to derive the majority of our future revenue from license fees and royalties associated with our patent portfolio, technology, software and secure domain
name registry in the United States and other markets around the world.

Universal Shelf Registration and ATM Offering

On July 30, 2018 we filed a $100,000 universal shelf registration statement on SEC Form S-3 which was declared effective by the SEC on August 16,
2018. We also entered an at-the-market equity offering sales agreement (“ATM”) with Cowen & Company, LLC on August 31, 2018, under which we can
offer and sell shares of our common stock having an aggregate value of up to $50,000.

We use the ATM proceeds for GABRIEL product development, marketing, and general corporate purposes, which may include working capital, capital
expenditures, other corporate expenses and acquisitions of complementary products, technologies, or businesses. As of December 31, 2020, common stock
with an aggregate value of up to $21,964 remained available for offer and sale under the ATM agreement.

During  the  year  ended  December  31,  2020,  we  sold  1,049,382  shares  under  the  ATM.  The  average  sales  price  per  common  share  was  $4.41  and  the
aggregate proceeds from the sales totaled $4,627 during the period. Sales commissions, fees and other costs associated with the ATM totaled $139.

Item 7A.

Quantitative and Qualitative Disclosures about Market Risk

Consistent with the rules applicable to “smaller reporting companies,” we have omitted the information required by Item 7A.

34

 
 
 
 
 
 
 
  
 
  
 
  
 
  
 
 
  
 
  
 
  
 
 
 
 
 
 
 
 
 
 
Index

Item 8.          Financial Statements and Supplementary Data

FINANCIAL STATEMENTS

Financial Statements Index

Report of Farber Hass Hurley LLP, Independent Registered Public Accounting Firm
Consolidated Balance Sheets of VirnetX Holding Corporation as of December 31, 2020 and December 31, 2019
Consolidated Statements of Operations of VirnetX Holding Corporation for the years ended December 31, 2020 and, December 31, 2019
Consolidated Statements of Comprehensive Income (Loss) of VirnetX Holding Corporation for the years ended December 31, 2020 and December

31, 2019

Consolidated Statements of Stockholders’ Equity of VirnetX Holding Corporation for the years ended December 31, 2020 and, December 31, 2019
Consolidated Statements of Cash Flows of VirnetX Holding Corporation for the years ended December 31, 2020, and December 31, 2019
Notes to Consolidated Financial Statements of VirnetX Holding Corporation

Page

36
38
39

39
40
41
42

35

 
 
 
 
Index

REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

To the Board of Directors and
Stockholders of VirnetX Holding Corporation

Opinion on the Financial Statements

We have audited the accompanying consolidated balance sheets of VirnetX Holding Corporation (the “Company”) as of December 31, 2020 and  2019, and
the related consolidated statements of operations, comprehensive income (loss), stockholders’ equity, and cash flows for each of the years in the two-year
period ended December 31, 2020, and the related notes (collectively referred to as the financial statements). In our opinion, the financial statements present
fairly, in all material respects, the financial position of the Company as of December 31, 2020, and 2019, and the results of its operations and its cash flows
for each of the years in the two-year period ended December 31, 2020, in conformity with accounting principles generally accepted in the United States of
America.

We also have audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (“PCAOB”), the Company’s
internal control over financial reporting as of December 31, 2020, based on criteria established in Internal Control—Integrated Framework (2013) issued
by the Committee of Sponsoring Organizations of the Treadway Commission (“COSO”), and our report dated March 16, 2021, expressed an unqualified
opinion.

Basis for Opinion

These financial statements are the responsibility of the Company’s management. Our responsibility is to express an opinion on the Company’s financial
statements  based  on  our  audits.  We  are  a  public  accounting  firm  registered  with  the  PCAOB  and  are  required  to  be  independent  with  respect  to  the
Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the
PCAOB.

We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable
assurance  about  whether  the  financial  statements  are  free  of  material  misstatement,  whether  due  to  error  or  fraud.  Our  audits  included  performing
procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to
those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audits
also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the
financial statements. We believe that our audits provide a reasonable basis for our opinion.

Critical Audit Matters

The  critical  audit  matters  communicated  below  are  matters  arising  from  the  current  period  audit  of  the  financial  statements  that  were  communicated  or
required  to  be  communicated  to  the  audit  committee  and  that:  (1)  relate  to  accounts  or  disclosures  that  are  material  to  the  financial  statements  and  (2)
involved our especially challenging, subjective, or complex judgments. The communication of critical audit matters does not alter in any way our opinion
on the financial statements, taken as a whole, and we are not, by communicating the critical audit matters below, providing separate opinions on the critical
audit matters or on the accounts or disclosures to which they relate.

36

 
 
Index

Description of the Matter

Revenue Recognition

As  discussed  in  Notes  2  and  12  to  the  financial  statements,  during  the  year  ended  December  31,  2020  the
Company  collected  a  lump  sum  payment  in  the  amount  of  $454  million  from  Apple  Inc.  on  a  judgement  as  a
result of a favorable verdict relating to a patent infringement lawsuit. As disclosed by management, the process
for  determining  the  value  of  revenue  from  the  basis  of  the  award  was  identified  in  the  Final  Judgement  which
included,  fixed  royalty  rate  per  device,  damages  for  willful  infringement,  interest,  and  reimbursement  for  court
costs and attorney’s fees.

Our determination that revenue recognition pertaining to the Final Judgement is a critical audit matter results from
the significant judgment exercised by management in determining the classification. Processes involving higher
amounts  of  management  judgment  include  the  interpretation  of  the  provisions  of  the  Final  Judgement  to
determine  the  amount  of  revenue  to  recognize  and  whether  or  not  the  Company  is  acting  as  a  principal  in  the
fulfillment of the identified performance obligations.

Audit Procedures

Our principal audit procedures related to the Company’s revenue recognition for the Final Judgement included the
following:

Description of the Matter

-          We evaluated the Company’s internal controls related to the identification of distinct performance

obligations and the determination of the timing of revenue recognition.

-          We evaluated management’s significant accounting policies related to the Final Judgement.
-          We obtained and read the Final Judgement and evaluated and tested management’s identification of the
significant terms for completeness. From the terms in the Final Judgement, we evaluated the appropriateness of
management’s application of their accounting principles, in their determination of revenue recognition
conclusions.

-          We tested the mathematical accuracy of management’s calculations of the classification of the Final

Judgement as well as the associated timing of revenue recognized in the financial statements.

Deferred Taxes

As discussed in Notes 2 and 10 to the financial statements, the Company recorded a deferred tax asset, net of a
valuation  allowance  as  of  December  31,  2020.  In  assessing  the  ability  to  realize  the  deferred  tax  assets,
management considers whether it is more likely than not that some portion or all of the deferred tax assets will not
be realized. The valuation allowance is based on management’s estimates of future taxable income and application
of relevant income tax law.

Our determination that valuation of deferred taxes is a critical audit matter results from the significant judgment
by management when assessing the ability to realize the deferred tax assets, particularly as it relates to estimates
of  future  taxable  income.  This  in  turn  led  to  a  high  degree  of  auditor  judgment,  subjectivity,  and  effort  in
performing procedures relating to management’s assessment of the realizability of deferred tax assets, as it relates
to estimates of future taxable income and application of income tax law.

Audit Procedures

Our principal audit procedures related to the Company’s deferred taxes included the following:

-          We evaluated management’s assessment of the realizability of deferred tax assets on a jurisdictional

basis. This included evaluating estimates of future taxable income, evaluating management's application of
income tax law, and testing the completeness and accuracy of underlying data used in management’s assessment.
-          We evaluated management’s estimates of future taxable income which involved evaluating whether the
estimates used by management were reasonable considering the current and past performance of the respective
entity and whether the estimates were consistent with evidence obtained in other areas of the audit.

/s/ Farber Hass Hurley LLP

We have served as the Company’s auditor since 2008.

Chatsworth, California
March 16, 2021

37

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
VIRNETX HOLDING CORPORATION
CONSOLIDATED BALANCE SHEETS
(in thousands, except share amounts)

ASSETS

Index

Current assets:

Cash and cash equivalents
Investments available for sale
Accounts receivables
Prepaid income tax
Prepaid expenses and other current assets

Total current assets

Prepaid expenses and other assets
Property and equipment, net
Long term, deferred tax asset
Total assets

LIABILITIES AND STOCKHOLDERS’ EQUITY

Current liabilities:

Accounts payable and accrued liabilities
Accrued payroll and related expenses
Accrued licensing costs
Other liabilities, current

Total current liabilities

Other liabilities

Total liabilities

Commitments and contingencies (Note 4)

Stockholders’ equity:

As of
December 31, 2020   

As of
December 31, 2019 

  $

  $

  $

192,908    $
28,348     
8     
2,905     
263     
224,432     
1,301     
11     
9,049     
234,793    $

654    $
220     
9,438     
44     
10,356     

—     
10,356     

3,135 
2,394 
5 
— 
237 
5,771 
1,711 
16 
— 
7,498 

1,346 
287 
— 
193 
1,826 

44 
1,870 

Preferred  stock,  par  value  $0.0001  per  share  Authorized:  10,000,000  shares  at  December  31,  2020  and

December 31, 2019, Issued and outstanding: 0 shares at December 31, 2020 and December 31, 2019

—     

— 

Common stock, par value $0.0001 per share
Authorized:  100,000,000  shares  at  December  31,  2020  and  December  31,  2019,  Issued  and  outstanding:
71,058,570 shares and 69,586,764 shares, at December 31, 2020 and December 31, 2019, respectively

Additional paid-in capital
Accumulated deficit
Accumulated other comprehensive loss

Total stockholders’ equity

Total liabilities and stockholders’ equity

See accompanying notes to consolidated financial statements.

38

7     
232,457     
(8,014)    
(13)    
224,437     
234,793    $

7 
223,237 
(217,602)
(14)
5,628 
7,498 

  $

 
   
     
 
   
     
 
   
   
   
   
   
   
   
   
   
      
  
   
      
  
   
   
   
   
 
   
      
  
   
   
   
     
 
 
   
      
  
   
      
  
   
   
      
  
   
   
   
   
   
Index

Revenue
Operating expense:
Licensing costs
Research and development
Selling, general and administrative expenses

Total operating expense

Income (loss) from operations
Gain on settlement
Interest and other income, net
Income (loss) before taxes
Income tax (expense) benefit
Net income (loss)

Basic earnings (loss) per share
Diluted earnings (loss) per share
Weighted average shares outstanding basic

Weighted average shares outstanding diluted

VIRNETX HOLDING CORPORATION
CONSOLIDATED STATEMENTS OF OPERATIONS
(in thousands, except share and per share amounts)

Year Ended
December 31, 2020   

  $

  $
  $
  $

Year Ended
December 31, 2019 
85 

302,636    $

90,101     
8,830     
45,812     
144,743     
157,893     
41,271     
108,288     
307,452     
(27,023)    
280,429    $
3.96    $
3.92    $
70,850,311     

71,615,843     

— 
3,845 
15,905 
19,750 
(19,665)
— 
92 
(19,573)
393 
(19,180)
(0.28)
(0.28)
68,564,321 

68,564,321 

VIRNETX HOLDING CORPORATION
CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)
(in thousands)

Year Ended
December 31, 2020   

Net income (loss)
Other comprehensive (loss), net of tax:

Change in unrealized gain (loss) on investments
Change in foreign currency translation

Total other comprehensive gain (loss), net of tax
Comprehensive income (loss)

See accompanying notes to consolidated financial statements.

39

  $

  $

Year Ended
December 31, 2019 
(19,180)

280,429    $

—     
1     
1     
280,430    $

3 
(3)
— 
(19,180)

 
   
      
  
   
   
   
   
   
   
   
   
   
   
   
 
   
      
  
   
   
   
Index

VirnetX Holding Corporation
CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY
(in thousands, except share amounts)

Common Stock

    Additional

Balance at December 31, 2018

Stock issued for cash at $4.00 -$6.49 per

share, net

Stock issued for options and RSUs, net
Stock-based compensation
Comprehensive loss:

Net loss
Change  in  foreign  currency  translation,

net of tax

Change in unrealized gains, net of tax

Comprehensive loss
Balance at December 31, 2019

Stock issued for cash at $4.00 -$4.96 per

share, net

Stock issued for options and RSUs, net
Stock-based compensation
Warrants issued for services
Dividends declared and paid, $1.00 per

share

Comprehensive income:

Net income
Change  in  foreign  currency  translation,

net of tax

Comprehensive income
Balance at December 31, 2020

Shares
66,879,847    $

Amount

1,860,483     
846,434     

Paid-in
Capital

Accumulated
Deficit

Accumulated
Other
Comprehensive
Loss

Total
Stockholders’  

Equity

7    $

208,317    $

(198,422)   $

(14)   $

9,888 

10,539     
670     
3,711     

(19,180)    

(3)    
3     

69,586,764    $

7    $

223,237    $

(217,602)   $

(14)   $

1,049,382     
422,424     

4,488     
690     
3,938     
104     

(70,841)    

280,429     

1     

71,058,570    $

7    $

232,457    $

(8,014)   $

(13)   $

10,539 
670 
3,711 

(19,180)

(3)
3 
(19,180)
5,628 

4,488 
690 
3,938 
104 

(70,841)

280,429 

1 
280,430 
224,437 

See accompanying notes to consolidated financial statements.

40

 
     
   
   
 
 
   
   
   
   
   
 
   
 
   
      
      
      
      
      
  
   
      
      
      
   
      
      
      
   
      
      
      
      
   
      
      
      
      
      
  
   
      
      
      
      
   
      
      
      
      
   
      
      
      
      
   
      
      
      
      
      
   
 
   
      
      
      
      
      
  
   
      
      
      
   
      
      
      
   
      
      
      
      
   
      
      
      
      
   
      
      
      
      
   
      
      
      
      
      
  
   
      
      
      
      
   
      
      
      
      
   
      
      
      
      
      
   
Index

VIRNETX HOLDING CORPORATION
CONSOLIDATED STATEMENTS OF CASH FLOWS
(in thousands)

Cash flows from operating activities:
Net income (loss)

Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:

Year Ended
December 31, 2020   

Year Ended
December 31, 2019 

  $

280,429    $

(19,180)

Depreciation
Stock-based compensation
Amortization of warrant issuance costs
Deferred income taxes
Changes in assets and liabilities:

Prepaid expenses and other assets
Accounts payable and accrued liabilities
Other liabilities
Accrued payroll and related expenses
Accrued licensing costs
Accounts receivable
Prepaid income taxes

Net cash provided by (used in) operating activities
Cash flows from investing activities:
Purchase of property and equipment
Purchase of investments
Proceeds from sale or maturity of investments

Net cash used in investing activities
Cash flows from financing activities:
Proceeds from exercise of options
Proceeds from sale of common stock
Payment of dividends on common stock
Payments on payroll taxes on cashless vesting of RSUs

Net cash (used in) provided by financing activities
Net increase (decrease) in cash and cash equivalents
Cash and cash equivalents, beginning of period
Cash and cash equivalents, end of period

Cash paid for income taxes

See accompanying notes to consolidated financial statements.

5     
3,938     
69     
(9,049)    

419     
(692)    
(193)    
(67)    
9,438     
(3)    
(2,905)    
281,389     

—     
(33,065)    
7,112     
(25,953)    

1,046     
4,488     
(70,841)    
(356)    
(65,663)    
189,773     
3,135     
192,908    $

38,977    $

7 
3,711 
— 
— 

374 
296 
97 
10 
— 
1 
(396)
(15,080)

(14)
(5,784)
5,192 
(606)

816 
10,539 
— 
(145)
11,210 
(4,476)
7,611 
3,135 

4 

  $

  $

41

 
   
     
 
   
      
  
   
   
   
   
   
      
  
   
   
   
   
   
   
   
   
   
      
  
   
   
   
   
   
      
  
   
   
   
   
   
   
   
Index

VirnetX Holding Corporation
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(in thousands except share, per share and per device amounts)

Note 1 − Formation and Business of the Company

VirnetX  Holding  Corporation,  which  we  refer  to  as”  we”,  “us”,  “our”,  “the  Company”  or  “VirnetX”,  is  engaged  in  the  business  of  commercializing  a
portfolio of patents. We seek to license our technology, including GABRIEL Connection Technology™, to various original equipment manufacturers, or
OEMs, that use our technologies in the development and manufacturing of their own products within the IP-telephony, mobility, fixed-mobile convergence,
and  unified  communications  markets.  Prior  to  2012  our  revenue  was  limited  to  an  insignificant  amount  of  software  royalties  pursuant  to  the  terms  of  a
single  license  agreement.  During  2012,  2013  and  2020  we  had  revenues  from  settlements  of  patent  infringement  disputes  whereby  we  received
consideration for past sales of licensees that utilized our technology, where there was no prior patent license agreement (see “Revenue Recognition”).

Our portfolio of intellectual property is the foundation of our business model. We currently own approximately 194 total patents and pending applications,
including  70  U.S.  patents/patent  applications  and  124  foreign  patents/validations/pending  applications.  Our  patent  portfolio  is  primarily  focused  on
securing  real-time  communications  over  the  Internet,  as  well  as  related  services  such  as  the  establishment  and  maintenance  of  a  secure  domain  name
registry.  Our  patented  methods  also  have  additional  applications  in  the  key  areas  of  device  operating  systems  and  network  security  for  Cloud  services,
M2M communications in areas of Smart City, Connected Car and Connected Home. The subject matter of all our U.S and foreign patents and pending
applications relates generally to securing communications over the Internet and such covers all our technology and other products. Our issued U.S. and
foreign patents expire at various times during the period from 2020 to 2024. Some of our issued patents and pending patent applications were acquired by
our principal operating subsidiary; VirnetX, Inc., from Leidos, (f/k/a Science Applications International Corporation or SAIC) in 2006 and we are required
to make payments to Leidos, based on cash or certain other values generated from those patents. The amount of such payments depends upon the type of
value generated, and certain categories are subject to maximums and other limitations.

Note 2 − Summary of Significant Accounting Policies

The preparation of financial statements in conformity with accounting principles generally accepted in the United States requires us to make estimates and
assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements
and  the  reported  amounts  of  revenues  and  expenses  during  the  reported  period.  The  critical  accounting  policies  we  employ  in  the  preparation  of  our
consolidated financial statements are those which involve impairment of long-lived assets, income taxes, fair value of financial instruments and stock-based
compensation.

Use of Estimates

We prepare our consolidated financial statements in accordance with accounting principles generally accepted in the U.S. (“U.S. GAAP”). In doing so, we
have  to  make  estimates  and  assumptions  that  affect  our  reported  amounts  of  assets,  liabilities,  revenues,  and  expenses,  as  well  as  related  disclosure  of
contingent assets and liabilities. In some cases, we could reasonably have used different accounting policies and estimates. In some cases, changes in the
accounting estimates are reasonably likely to occur from period to period. Accordingly, actual results could differ materially from our estimates. To the
extent that there are material differences between these estimates and actual results, our financial condition or results of operations will be affected. We
base our estimates on past experience and other assumptions that we believe are reasonable under the circumstances, and we evaluate these estimates on an
ongoing  basis.  We  refer  to  accounting  estimates  of  this  type  as  critical  accounting  policies  and  estimates,  which  we  discuss  further  below.  We  have
reviewed our critical accounting policies and estimates with the audit committee of our board of directors.

Basis of Consolidation

The consolidated financial statements include the accounts of VirnetX Holding Corporation and our wholly owned subsidiaries. All intercompany balances
and transactions have been eliminated.

42

Index

Leases

The Company determines if an arrangement is a lease at inception in accordance with Accounting Standards Codification (“ASC”) Topic 842. Operating
lease  right-of-use  (“ROU”)  assets  are  included  in  Prepaid  expense,  and  other  assets  on  the  Consolidated  Balance  Sheet.  ROU  assets  represent  the
Company’s right to use an underlying asset for the lease term and lease liabilities represent the Company’s obligation to make lease payments arising from
the lease. ROU assets and lease liabilities are recognized at the commencement date based on the present value of lease payments over the lease term (see
Note 13 – Leases).

Revenue Recognition

The Company derives revenue from licensing and royalty fees from contracts with customers which often span several years. We account for this revenue
in accordance with Accounting Standards Codification Topic 606, Revenue from Contracts with Customers. A performance obligation is a promise in a
contract  to  transfer  a  distinct  good  or  service  to  the  customer.  A  contract’s  transaction  price  is  allocated  to  each  distinct  performance  obligation  and
recognized as revenue when, or as, the performance obligation is satisfied. Our revenue arrangements may consist of multiple-element arrangements, with
revenue for each unit of accounting recognized as the product or service is delivered to the customer.

With  the  licensing  of  our  patents,  performance  obligations  are  generally  satisfied  at  a  point  in  time  as  work  is  complete  when  our  patent  rights  are
transferred to our customers. We generally have no further obligation to our customers regarding our technology.

Certain  contracts  may  require  our  customers  to  enter  into  a  hosting  arrangement  with  us  and  for  these  arrangements,  revenue  is  recognized  over  time,
generally over the life of the servicing contract.

The  Company  actively  monitors  and  enforces  its  intellectual  property  (“IP”)  rights,  including  seeking  appropriate  compensation  from  third  parties  that
utilize the Company’s IP without a license. As a result, the Company may, from time to time, receive payments as part of a settlement or compensation for
a patent infringement dispute. Proceeds received are allocated to each element identified in the settlement or compensation, based on the fair value of each
element. Generally, settlements and compensation may include the following elements: the value of a license or royalty agreement, cost reimbursement,
damages, and interest. Elements identified related to licensing and royalty are recognized as revenue. Elements identified as reimbursed costs are generally
recorded  as  a  reduction  to  the  reported  expenses.  Elements  identified  as  damages  or  interest  are  generally  recorded  in  other  income  in  the  condensed
consolidated statement of operations. During the year ended December 31, 2020, the Company collected a lump sum payment of $454,034 from Apple,
Inc., because of a favorable court decision relating to a patent infringement case. The court decision identified the following as the basis of the award:
$302,428 for past royalties, $41,271 in damages for willful infringement, $108,221 for interest, and $2,114 in reimbursement for court costs and attorney’s
fees (see Note 12 - Litigation). Elements of the payment were recognized in the Company’s condensed consolidated statement of operations as follows:

Classification of Payment Received in the Company’s Condensed Consolidated Statement of Operations
Year Ended:

Revenue (royalties)
Operating expenses: selling, general and administrative (reimbursed litigation costs)
Other income: gain (willful infringement)
Other income: interest income (pre- and post-judgment interest)
Total cash received

Licensing Costs

  December 31, 2020 
302,428 
  $
2,114 
41,271 
108,221 
454,034 

  $

Included in operating expenses for the year ended December 31, 2020, is $90,101 in licensing costs we incurred in conjunction with the proceeds received
from Apple Inc., pursuant to a favorable court decision relating to a patent infringement case.

Contingent Gains

We recognize gain contingencies in accordance with ASC 450-30-25 which prohibits recognition of contingent gains until realized. Accordingly, we do not
record contingent gains ahead of such realization. Management generally considers any such gains as realized only upon the collection of cash.

43

 
 
   
   
   
Index

Cash and Cash Equivalents

We consider all highly liquid investments purchased with original maturities of three months or less at the date of purchase to be cash equivalents. Our cash
and cash equivalents are not subject to significant interest rate risk due to the short maturities of these investments.

Investments

Investments  are  classified  as  available-for-sale  and  are  recorded  at  fair  market  value.  Unrealized  gains  and  losses  are  reported  as  other  comprehensive
income. Realized gains and losses are recorded in income in the period they are realized using specific identification of each security’s cost basis. We invest
our excess cash primarily in highly liquid debt instruments including corporate, government and federal agency securities, with contractual maturities less
than two years. By policy, we limit the amount of credit exposure to any one issuer.

Property and Equipment

Property and equipment are stated at historical cost, less accumulated depreciation, and amortization. Depreciation and amortization are computed using the
accelerated and straight-line methods over the estimated useful lives of the assets, which range from five to seven years. Repair and maintenance costs are
charged to expense as incurred.

Concentration of Credit Risk and Other Risks and Uncertainties

Our  cash  and  cash  equivalents  are  primarily  maintained  at  two  major  financial  institutions  in  the  United  States.  Deposits  held  with  these  financial
institutions  may  exceed  the  amount  of  insurance  provided  on  such  deposits.  A  portion  of  those  balances  are  insured  by  the  Federal  Deposit  Insurance
Corporation, or FDIC. During the year ended December 31, 2020 and 2019, we had, at times, funds that were uninsured. We do not believe that we are
subject to any unusual financial risk beyond the normal risk associated with commercial banking relationships. We have not experienced any losses on our
deposits of cash and cash equivalents.

Fair Value

The carrying amounts of our financial instruments, including cash equivalents, accounts payable, and accrued liabilities, approximate fair value because of
their generally short maturities.

Intangible Assets

We record intangible assets at cost, less accumulated amortization. Amortization of intangible assets is provided over their estimated useful lives, which
can range from 3 to 15 years, on either a straight-line basis or as revenue is generated by the assets.

Impairment of Long-Lived Assets

We  identify  and  record  impairment  losses  on  long-lived  assets  used  in  operations  when  events  and  changes  in  circumstances  indicate  that  the  carrying
amount  of  an  asset  might  not  be  recoverable,  but  not  less  than  annually.  Recoverability  is  measured  by  comparison  of  the  anticipated  future  net
undiscounted cash flows to the related assets’ carrying value. If such assets are considered to be impaired, the impairment to be recognized is measured by
the amount by which the carrying amount of the assets exceeds the projected discounted future net cash flows arising from the asset.

Research and Development

Research and development costs include expenses paid to outside development consultants and compensation related expenses for our engineering staff.
Research and development costs are expensed as incurred.

Income Taxes

We  account  for  income  taxes  using  the  asset  and  liability  method.  The  asset  and  liability  method  requires  the  recognition  of  deferred  tax  assets  and
liabilities for expected future tax consequences of temporary differences that currently exist between the tax basis and financial reporting basis of our assets
and liabilities. We calculate current and deferred tax provisions based on estimates and assumptions that could differ from actual results reflected on the
income tax returns filed during the following years. Adjustments based on filed returns are recorded when identified in the subsequent years. The effect on
deferred taxes for a change in tax rates is recognized in income in the period that the tax rate change is enacted. In assessing our deferred tax assets, we
consider whether it is more likely than not that all or some portion of the deferred tax assets will not be realized.

44

Index

A valuation allowance is provided for deferred income tax assets when, in our judgment, based upon currently available information and other factors, it is
more likely than not that all or a portion of such deferred income tax assets will not be realized. The determination of the need for a valuation allowance is
based on an on-going evaluation of current information including, among other things, historical operating results, estimates of future earnings in different
taxing  jurisdictions  and  the  expected  timing  of  the  reversals  of  temporary  differences.  We  believe  the  determination  to  record  a  valuation  allowance  to
reduce a deferred income tax asset is a significant accounting estimate because it is based, among other things, on an estimate of future taxable income in
the United States and certain other jurisdictions, which is susceptible to change and may or may not occur, and because the impact of adjusting a valuation
allowance may be material. In determining when to release the valuation allowance established against our net deferred income tax assets, we consider all
available evidence, both positive and negative. Due to the 2020 income, we have released the valuation allowance against federal net deferred tax assets,
and we maintain a partial valuation allowance against the state net operating loss and credit carryovers due to lack of income in California. We continually
assess our ability to generate sufficient taxable income during future periods in which our deferred tax assets may be realized. If and when we believe it is
more likely than not that we will recover our deferred tax assets, we will reverse the valuation allowance as an income tax benefit in our statements of
operations.

We account for our uncertain tax positions in accordance with U.S. GAAP. The U.S. GAAP method of accounting for uncertain tax positions utilizes a two-
step approach to evaluate tax positions. Step one, recognition, requires evaluation of the tax position to determine if based solely on technical merits it is
more likely than not to be sustained upon examination. Step two, measurement, is addressed only if a position is more likely than not to be sustained. In
step two, the tax benefit is measured as the largest amount of benefit, determined on a cumulative probability basis, which is more likely than not to be
realized upon ultimate settlement with tax authorities. If a position does not meet the more likely than not threshold for recognition in step one, no benefit
is recorded until the first subsequent period in which the more likely than not standard is met, the issue is resolved with the taxing authority, or the statute
of limitations expires. Positions previously recognized are derecognized when we subsequently determine the position no longer is more likely than not to
be  sustained.  Evaluation  of  tax  positions,  their  technical  merits,  and  measurements  using  cumulative  probability  are  highly  subjective  management
estimates. Actual results could differ materially from these estimates.

Stock-Based Compensation

We account for stock-based compensation using the fair value recognition method in accordance with U.S. GAAP. We recognize these compensation costs
on a straight-line basis over the requisite service period of the award, which is generally the vesting term of 4 years. We do not estimate the forfeiture rate
and recognize forfeitures, if any, when they occur. See Note 6 - Stock-Based Compensation below for additional information concerning our share-based
compensation awards.

In addition, as required we record stock-based compensation expense for awards granted to non-employees at fair value of the consideration received or the
fair value of the equity instruments issued as they vest over the performance period.

Earnings per Share

Basic earnings per share are computed by dividing earnings available to common stockholders by the weighted average number of outstanding common
shares during the period. Diluted earnings per share is computed by dividing net income by the weighted average number of shares outstanding during the
period increased to include the number of additional shares of common stock that would have been outstanding if the potentially dilutive securities had
been issued. During 2019 we incurred losses; therefore, the effect of any common stock equivalent would be anti-dilutive during the year.

New Accounting Pronouncements

In  December  2019,  the  Financial  Accounting  Standards  Board  (“FASB”)  issued  Accounting  Standards  Update  (“ASU”)  2019-12  Income  Taxes  (Topic
740). The amendments in this ASU simplify the accounting for income taxes by removing certain exceptions to the general principles in Topic 740. The
amendments also improve consistent application of and simplify U.S. GAAP for other areas of Topic 740 by clarifying and amending existing guidance.
The  amendments  in  this  ASU  are  effective  for  fiscal  years,  and  interim  periods  within  those  fiscal  years,  beginning  after  December  15,  2020.  We  are
currently evaluating the impact, if any this ASU will have on our consolidated financial statements and related disclosures.

45

Index

In June 2016, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2016-13, Measurement of Credit Losses
on  Financial  Instruments,  and  issued  subsequent  amendments  to  the  initial  guidance  within  ASU  2019-04  and  ASU  2019-05  (collectively,  “ASU  2016-
13”).  The  amendments  in  ASU  2016-13  replace  the  incurred  loss  impairment  methodology  with  the  current  expected  credit  loss  model,  which  requires
consideration of a broader range of reasonable and supportable information to estimate credit losses. The Company adopted this ASU effective January 1,
2020 and the adoption did not have a material impact on the Company’s financial position, results of operations or cash flows.

Note 3 − Property and Equipment

Our major classes of property and equipment were as follows:

Office furniture
Computer equipment
Total
Less accumulated depreciation
Total property and equipment, net

December 31

2020

2019

79    $
81     
160     
(149)    
11    $

79 
81 
160 
(144)
16 

  $

  $

Depreciation expense for the years ended December 31, 2020 and 2019 was $5, and $7, respectively.

Note 4 − Commitments, Contingencies and Related Party Transactions

We lease our offices under an operating lease with a third party expiring in October 2021. We recognize rent expense on a straight-line basis over the term
of the lease. Rent expense was $56, for each of the years ended December 31, 2020, and 2019. Future minimum rents due under the lease total $46 in 2021,
when the lease expires.

We entered into a service agreement for the use of an aircraft from K2 Investment Fund LLC (“LLC”) for business travel for employees of the Company.
We  incurred  approximately  $324  and  $1,790  in  rental  fees  and  reimbursements  to  the  LLC  during  the  years  ended  December  31,  2020  and  2019,
respectively. We pay for the Company’s usage of the aircraft and have no rights to purchase. Our Chief Executive Officer and Chief Administrative Officer
are the managing partners of the LLC and control the equity interests of the LLC. We entered into a 12-month non-exclusive agreement with the LLC for
use of the plane at a rate of $8 per flight hour, with no minimum usage requirement. The agreement contains other terms and conditions normal in such
transactions and can be cancelled by either us or the LLC with 30 days’ notice. The agreement renews on an annual basis unless terminated by either party.
Neither party has exercised their termination rights.

Note 5 − Stock Plan

We have a stock incentive plan for employees and others called the VirnetX Holding Corporation 2013 Equity Incentive Plan (the “2013 Plan”), which has
been approved by our stockholders. To the extent that any award should expire, become un-exercisable or is otherwise forfeited, the shares subject to such
award will again become available for issuance under the 2013 Plan. The 2013 Plan provides for the granting of stock options and restricted stock units
purchase rights (“RSUs”) to our employees and consultants. Stock options granted under the 2013 Plan may be incentive stock options or nonqualified
stock  options.  Incentive  stock  options  (“ISOs”)  may  only  be  granted  to  our  employees  (including  officers  and  directors).  Nonqualified  stock  options
(“NSOs”) and stock purchase rights may be granted to our employees and consultants.

The 2013 Plan will expire in 2023. Options may be granted under the 2013 Plan with an exercise price determined by our Board of Directors, or a duly
appointed committee thereof, provided, however, that the exercise price of an option granted to any employee shall be not less than 100% of the fair market
value at the date of grant in the case of ISOs or 85% of the fair market value at the date of grant in the case of an NSO. The exercise price of an ISO or
NSO granted to one of our Named Executive Officers shall not be less than 100% fair market value of the shares at the date of grant and the exercise price
of an ISO granted to a 10% shareholder shall not be less than 110% of the fair market value of the shares on the date of grant. Stock options granted under
the 2013 Plan typically vest over four years and have a 10-year term. All RSUs are considered to be granted at the fair value of our stock on the date of
grant because they have no exercise price. RSUs typically vest over four years. At December 31, 2020, there were 545,210 shares available for grant under
the 2013 Plan.

46

 
 
 
 
 
   
 
   
   
   
Index

Note 6 − Stock-Based Compensation

The following tables summarize information about stock options and RSUs outstanding at December 31, 2020:

Options Outstanding

Range of
Exercise Prices

$ 2.35 -  6.95 
$ 14.52 - 35.25 

Number

Outstanding    

4,558,896     
1,253,625     
5,812,521     

Weighted
Average
Remaining
Contractual
Life (Years)    

Weighted
Average
Exercise
Price

Options Vested and Exercisable
Weighted
Average
Remaining
Contractual
Life (Years)    

Weighted
Average
Exercise
Price

Number

Exercisable    

7.04    $
1.71    $
5.89    $

4.53     
23.16     
8.62     

3,147,625     
1,253,625     
4,401,250     

6.47    $
1.71    $
5.11    $

4.26 
23.16 
9.64 

The following tables summarize activity under the Plan for the indicated periods:

Outstanding at December 31, 2018
Options granted
Options exercised
Options cancelled
Outstanding at December 31, 2019
Options granted
Options exercised
Options cancelled
Outstanding at December 31, 2020
Options exercisable at December 31, 2020

Outstanding at December 31, 2018
RSUs granted
RSUs vested
RSUs cancelled
Outstanding at December 31, 2019
RSUs granted
RSUs vested
Outstanding at December 31, 2020

Number of
Shares

5,998,837    $
345,000     
(663,816)    
(50,000)    
5,630,021    $
747,500     
(262,031)    
(302,969)    
5,812,521    $
4,401,250    $

Options

Weighted
Average
Exercise
Price

Weighted
Average
Remaining
Contractual
Life (Years)    

Aggregate
Intrinsic
Value

7.72     
6.06     
1.23     
4.95     
8.49     
6.07     
3.99     
5.30     
8.55     
9.64     

—    $
—     
—     
—     
6.11    $
—     
—     
—     
5.89    $
5.11    $

— 
— 
— 
— 
516 
— 
— 
— 
3,650 
2,927 

RSUs
Weighted
Average
Grant Date
Fair Value    

Aggregate
Intrinsic
Value

3.83    $
6.06     
4.07     
4.65     
4.71    $
6.89     
4.63     
5.69    $

— 
— 
— 

86 
— 
— 
230 

Number of
RSUs

504,994    $
229,996     
(207,334)    
(29,167)    
498,489    $
218,329     
(212,495)    
504,323    $

Intrinsic value is calculated as the difference between the per-share market price of our common stock on the last trading day of 2020, which was $5.04 and
the  exercise  price  of  the  options.  For  options  exercised,  the  intrinsic  value  is  the  difference  between  market  price  and  the  exercise  price  on  the  date  of
exercise. We received cash proceeds of $1,046 and $816 from stock options exercised in 2020 and 2019, respectively. The total intrinsic value of options
exercised was $151 and $2,473 during the years ended December 31, 2020 and 2019, respectively.

Stock-based compensation expense is included in operating expense for each period as follows:

Stock-Based Compensation by Type of Award
Stock options
RSUs
Total stock-based compensation expense

Year Ended
December 31, 2020   

Year Ended
December 31, 2019 
2,756 
955 
3,711 

2,872    $
1,066     
3,938    $

  $

  $

47

   
 
 
   
 
   
   
 
   
 
 
 
 
   
   
 
   
   
   
   
   
   
   
   
   
   
 
 
 
 
   
 
   
   
   
   
  
   
   
   
   
 
   
Index

As of December 31, 2020, there was $5,249 of unrecognized stock-based compensation expense related to unvested employee stock options and $2,215 of
unrecognized stock-based compensation expense related to unvested RSUs. These costs are expected to be recognized over a weighted-average period of
2.24 and 2.33 years, respectively.

The fair value of each option grant was estimated on the date of grant using the Black-Scholes option pricing model using the following weighted average
assumptions:

Expected stock price volatility
Risk-free interest rate
Expected life term
Expected dividends

Year Ended
December 31, 2020 

Year Ended
December 31, 2019 

93.45%   
0.63%   

92.34%
2.09%

6.21 years 

6.14 years 

0%   

0%

Based on the Black-Scholes option pricing model, the weighted average estimated fair value of employee stock options granted was $4.62 and $4.63 per
share during the years ended December 31, 2020 and 2019, respectively.

The expected life was determined using the simplified method outlined in ASC 718, “Compensation - Stock Compensation”. Expected volatility of the
stock options was based upon historical data and other relevant factors. We have not provided an estimate for forfeitures because we have had nominal
forfeited options and RSUs and believed that all outstanding options and RSUs at December 31, 2020, would vest.

Note 7 − Earnings Per Share

Basic  earnings  per  share  are  based  on  the  weighted  average  number  of  shares  outstanding  for  a  period.  Diluted  earnings  per  share  are  based  upon  the
weighted average number of shares and potentially dilutive common shares outstanding. Potential common shares outstanding principally include stock
options and RSUs under our stock plan and warrants. During 2019, we incurred losses; therefore, the effect of any common stock equivalent would be anti-
dilutive during the year.

The table below sets forth the basic and diluted loss per share calculations:

Net income (loss)

Basic weighted average number of shares outstanding
Effect of dilutive securities
Diluted weighted average number of shares outstanding

Basic earnings (loss) per share
Diluted earnings (loss) per share

Note 8 − Common Stock

2020

2019

  $

280,429    $

(19,180)

70,850     
766     
71,616     

  $
  $

3.96    $
3.92    $

68,564 
— 
68,564 

(0.28)
(0.28)

Each share of common stock has the right to one vote. The holders of common stock are entitled to receive dividends whenever funds are legally available
and when declared by our Board of Directors, subject to the prior rights of holders of all classes of stock outstanding having priority rights as to dividends.
Our restated articles of incorporation authorize us to issue up to 100,000,000 shares of $0.0001 par value common stock.

On  July  30,  2018  we  filed  a  $100,000  universal  shelf  registration  statement  on  SEC  Form  S-3.  This  replacement  registration  statement  was  declared
effective by the SEC on August 16, 2018. We also entered a new ATM with Cowen on August 31, 2018, under which we could offer and sell shares of our
common stock having an aggregate value of up to $50,000.

We use the ATM proceeds for GABRIEL product development and marketing, and general corporate purposes, which may include working capital, capital
expenditures, other corporate expenses and acquisitions of complementary products, technologies, or businesses. As of December 31, 2020, common stock
with an aggregate value of up to $21,964 remained available for offer and sale under the ATM agreement.

48

 
 
   
   
 
 
   
 
   
 
 
   
      
  
   
   
   
 
   
      
  
Index

We sold 1,049,382 and 1,860,483 shares of common stock under the ATM program during the years ended December 31, 2020 and 2019, respectively. The
average sales price per common share sold during the year ended December 31, 2020 was $4.41 and the aggregate proceeds from the sales totaled $4,627
during  the  period.  Sales  commissions,  fees  and  other  costs  associated  with  the  ATM  transactions  totaled  $139  for  2020.  The  average  sales  price  per
common share sold during the year ended December 31, 2019 was $5.84 and the aggregate proceeds from the sales totaled $10,866 during the period. Sales
commissions, fees and other costs associated with the ATM transactions totaled $326 for 2019.

Dividends

On May 8, 2020, we declared a one-time cash dividend to shareholders of record as of the close of business on May 18, 2020 of $1 per share of common
stock, payable on May 26, 2020. The timing and amounts of future dividends, if any, will depend on market conditions, corporate business and financial
considerations and regulatory requirements.

Warrants

In 2020, we issued warrants for the purchase of 25,000 shares of common stock at an exercise price of $5.75 per share, exercisable on the date of grant
expiring in April 2025. The weighted average fair value at the grant date was $4.16 per warrant. The fair value at the grant date was estimated utilizing the
Black-Scholes valuation model with the following weighted average assumptions (i) dividend yield on our common stock of 0 percent (ii) expected stock
price volatility of 97 percent (iii) a risk-free interest rate of 0.27 percent and (iv) and expected option term of 5 years.

Warrants
Issued

Exercise
 Price

25,000
25,000

$7.00
$5.75
—

Outstanding and
Exercisable
December 31, 2019
25,000
—
25,000

Issued

Exercised

—
25,000
25,000

Terminated /
Cancelled

—
—
—

(25,000)
—
(25,000)

Outstanding and
Exercisable
December 31, 2020
—
25,000
25,000

Expiration Date

April 30, 2020
April 30, 2025
—

Note 9 − Employee Benefit Plan

We sponsor a defined contribution 401k plan covering substantially all our employees. Our matching contribution to the plan was approximately $112 and
$101 in 2020 and 2019, respectively.

Note 10 − Income Taxes

The income tax provision (benefit) is comprised of the following:

Current:
Federal
State

Deferred:
Federal
State

Total income tax provision (benefit)

Year Ended
December 31, 2020   

Year Ended
December 31, 2019 

  $

  $

35,122    $
950     
36,072     

(8,816)    
(233)    
(9,049)    
27,023    $

— 
(393)
(393)

— 
— 
— 
(393)

A reconciliation of the United States federal statutory income tax rate to our effective income tax rate is as follows:

United States federal statutory rate
State taxes, net of federal benefit
Valuation allowance
Stock based compensation
R&D Credit
Other
Effective income tax rate

Year Ended
December 31, 2020 

Year Ended
December 31, 2019 

21.00%    
0.17%    
(12.22)%   
(0.01)%   
(0.21)%   
0.06%    
8.79%    

21.00%
1.99%
(21.96)%
— 
1.34%
(0.38)%
1.99%

The Company’s effective tax rate for both 2020 and 2019 was lower than the statutory federal income tax rate primarily due to the change of valuation
allowance.  Due to the income in 2020, our valuation allowance against federal net deferred tax assets was fully released in 2020.  We continue to provide
partial valuation allowance against California net operating loss and research credit carryovers due to the fact that we have no income in California.

49

 
 
   
     
 
   
 
   
   
      
  
   
   
 
   
 
 
 
   
   
   
   
   
   
   
Index

Deferred tax assets (liabilities) consist of the following:

Deferred tax assets:
Reserves and accruals
Research and development credits and other credits
Net operating loss carry forward
Stock based compensation
Other
Total deferred tax assets

Valuation allowance
Deferred tax assets after valuation allowance

Total deferred tax liability

Net deferred tax assets

As of
December 31, 2020   

As of
December 31, 2019 

  $

  $

48    $
13     
598     
8,998     
3     
9,660    $

(611)    
9,049     

—     

  $

9,049    $

62 
1,730 
27,907 
8,402 
11 
38,112 

(38,112)
— 

— 

— 

In 2020 and 2019, we had pre-tax income of $307,452 and pre-tax losses of $19,573, respectively. At December 31, 2020, we had federal and state net
operating loss carryforwards of approximately $0 and $107,989, respectively. All of the federal net operating loss carryforwards has been utilized to offset
taxable income in 2020.  The state net operating loss carryforward will be expiring beginning in 2029.

A valuation allowance is provided for deferred tax assets when, in our judgment, based upon currently available information and other factors, it is more
likely than not that all or a portion of such deferred income tax assets will not be realized. The determination of the need for a valuation allowance is based
on an on-going evaluation of current information including, among other things, historical operating results, estimates of future earnings in different taxing
jurisdictions and the expected timing of the reversals of temporary differences. We believe the determination to record, or reduce, a valuation allowance
associated with a deferred income tax asset is a significant accounting estimate because it is based, among other things, on an estimate of future taxable
income in the United States and certain other jurisdictions, which is susceptible to change and may or may not occur, and because the impact of adjusting a
valuation allowance may be material. In determining when to release the valuation allowance established against our net deferred income tax assets, we
consider all available evidence, both positive and negative.

Internal Revenue Code Section 382 places a limitation on the amount of net operating loss carryforwards that can be used to offset taxable income after a
change in control (generally greater than 50% change in ownership) of a loss corporation. California, the state in which our headquarters was once located,
has similar rules. Since the Company did not have a greater than 50% change of control as defined under the Internal Revenue Code, no limitation applies
to the Company’s Net Operating Losses.

We are required to recognize the financial statement effects of a tax position when it is more likely than not, based on the technical merits, that the position
will  be  sustained  upon  examination.  In  2019,  we  released  all  ASC  740-10  uncertain  tax  positions  due  to  the  expiring  of  the  statute  of  limitation.  At
December 31, 2020, we have no uncertain tax positions.

Our tax years for 2005 and forward are subject to examination by the U.S. tax authority and various state tax authorities. These years are open due to NOLs
and tax credits generated in these years were utilized in 2020. The statute of limitation for these years shall expire three years after the date of filing 2020
income tax returns.

Our  policy  is  to  recognize  interest  and  penalties,  if  any,  accrued  on  any  unrecognized  tax  benefits,  as  a  component  of  income  tax  expense.  We  had  no
interest or penalties accrued for the year ended December 31, 2020 or 2019.

50

 
   
     
 
   
   
   
   
 
   
      
  
   
   
 
   
      
  
   
 
   
      
  
Index

Reconciliation of provision for uncertain tax position discussed above:

Balance at the beginning of the year
Additions based on tax positions related to the current year
Additions for tax positions of prior years
Settlements
Lapse of applicable statute of limitations
Balance at the end of the year

Note 11 − Fair Value Measurement

Year Ended
December 31, 2020   

Year Ended
December 31, 2019 
316 
— 
— 
— 
(316)
— 

—    $
—     
—     
—     
—     
—    $

  $

  $

We apply fair value accounting for all financial assets and liabilities and non-financial assets and liabilities that are recognized or disclosed at fair value in
the financial statements on a recurring basis. Fair value is estimated by applying the following hierarchy, which prioritizes the inputs used to measure fair
value into three levels and bases the categorization within the hierarchy upon the lowest level of input that is available and significant to the fair value
measurement:

Level 1 – Quoted prices in active markets for identical assets or liabilities.

Level 2 – Observable inputs other than quoted prices in active markets for identical assets and liabilities, quoted prices for identical or similar assets
or liabilities in inactive markets, or other inputs that are observable or can be corroborated by observable market data for substantially the full term
of the assets or liabilities.

Level 3 – Inputs that are generally unobservable and typically reflect management’s estimate of assumptions that market participants would use in
pricing the asset or liability.

The carrying amounts for cash and cash equivalents, investments in certificates of deposit, accounts payable and accrued expenses approximate their fair
values due to the short period of time until maturity.

Mutual funds: Valued at the quoted net asset value (NAV) of shares held.

U.S. agency and treasury securities: Fair value measured at the closing price reported on the active market on which the individual securities are
traded.

The following table shows the adjusted cost, gross unrealized gains, gross unrealized losses, and fair value of our financial assets as of December 31, 2020
and 2019 (in thousands):

Adjusted
Cost

Unrealized
Gains

Unrealized
Losses

Fair
Value

Cash
and Cash

Equivalents    

Investments
Available
for Sale

December 31, 2020

Cash
Level 1:
Mutual funds
U.S. agency securities
U.S. treasury securities

Total

  $

  $

121,785    $

70,996     
13,767     
14,707     
99,470     
221,255    $

—    $

—     
2     
—     
2     
2    $

—    $

121,785    $

121,785    $

— 

—     
—     
(1)    
(1)    
(1)   $

70,996     
13,769     
14,706     
99,471     
221,256    $

70,996     
127     
—     
71,123     
192,908    $

— 
13,642 
14,706 
28,348 
28,348 

Cash
Level 1:
Mutual funds
U.S. agency securities

Total

  $

Adjusted
Cost

Unrealized
Gains

Unrealized
Losses

Fair
Value

Cash
and Cash

Equivalents    

Investments
Available
for Sale

December 31, 2019

  $

2,076    $

613     
2,837     
3,450     
5,526    $

—    $

—     
3     
3     
3    $

—    $

2,076    $

2,076    $

— 

—     
—     
—     
—    $

613     
2,840     
3,453     
5,529    $

613     
446     
1,059     
3,135    $

— 
2,394 
2,394 
2,394 

The maturities of our marketable securities generally range from within one to two years. Actual maturities could differ from contractual maturities due to
call or prepayment provisions.

51

 
   
   
   
   
 
 
 
 
   
   
   
   
 
   
      
      
      
      
      
  
   
   
   
 
   
 
 
 
 
   
   
   
   
 
   
      
      
      
      
      
  
   
   
 
   
Index

Note 12 – Litigation (all dollar amounts in this section are expressed in thousands except for rates per device)

We have several intellectual property infringement lawsuits pending in the United States District Court for the Eastern District of Texas, Tyler Division
(“USDC”), and United States Court of Appeals for the Federal Circuit (“USCAFC”) and the Supreme Court of the United States (“SCOTUS”).

VirnetX Inc. v. Cisco Systems, Inc. et al. (Case 6:10-CV-00417-LED) (“Apple I”)

On August 11, 2010, we filed a complaint against Aastra USA. Inc. (“Aastra”), Apple Inc. (“Apple”), Cisco Systems, Inc. (“Cisco”), and NEC Corporation
(“NEC”)  the  USDC  in  which  we  alleged  that  these  parties  infringe  on  certain  of  our  patents  (U.S.  Patent  Nos.  6,502,135,  7,418,504,  7,921,211  and
7,490,151). We sought damages and injunctive relief. The cases against each defendant were separated by the judge. Aastra and NEC agreed to sign license
agreements with us, and we dropped all accusations of infringement against them. A jury in USDC decided that our patents were not invalid and rendered a
verdict of non-infringement by Cisco on March 4, 2013. Our motion for a new Cisco trial was denied and the case against Cisco was closed.

On November 6, 2012, a jury in the USDC awarded us over $368,000 for Apple’s infringement of four of our patents, plus daily interest up to the final
judgment.

Apple filed an appeal of the judgment to the USCAFC. On September 16, 2014, USCAFC affirmed the USDC jury’s finding that all four of our patents at
issue are valid and confirmed the USDC jury’s finding of infringement of VPN on Demand under many of the asserted claims of our ‘135 and ‘151 patents,
and the USDC’s decision to allow evidence about our license and royalty rates regarding the determination of damages. However, the USCAFC vacated the
USDC jury’s damages award and some of the USDC’s claim construction with respect to parts of our ‘504 and ‘211 patents and remanded the damages
award and determination of infringement with respect to FaceTime back to the USDC for further proceedings.

On September 30, 2016, pursuant to the 2014 remand from the USCAFC, a jury in the USDC awarded us $302,400 for Apple’s infringement of four of our
patents. On September 29, 2017, the USDC entered its final judgment, denied all of Apple’s post-trial motions, granted all our post-trial motions, including
our  motion  for  willful  infringement  and  enhanced  the  royalty  rate  during  the  willfulness  period  from  $1.20  to  $1.80  per  device,  and  awarded  us  costs,
certain  attorneys’  fees,  and  prejudgment  interest.  The  total  amount  in  the  final  judgment  was  $439,700,  including  $302,400  (jury  verdict),  $41,300
(enhanced damages) and $96,000 (costs, fees and interest).

On October 27, 2017 Apple appealed the final judgment entered on September 29, 2017 to the USCAFC. Oral arguments in this case were held on January
8, 2019. On January 15, 2019, the Court issued a Rule 36 order affirming the district court’s final judgment. Apple filed a petition for panel rehearing and
rehearing en-banc in this matter on February 21, 2019. On October 1, 2019, USCAFC issued an order denying Apple’s petition. Apple filed a petition for a
writ  of  certiorari  with  the  SCOTUS,  which  was  denied  on  February  24,  2020.  Prior  to  the  SCOTUS  decision  denying  Apple’s  petition  for  a  writ  of
certiorari,  on  February  20,  2020,  Apple  filed  a  Rule  60(b)  motion  for  relief  from  judgment  with  the  USDC,  seeking  relief  from  the  district  court’s
September 29, 2017 final judgment. VirnetX filed a responsive brief in opposition on March 5, 2020.

On March 13, 2020, the Company received payment of $454,034 from Apple, representing the previously announced final judgment with interest in this
case. Apple sought payment relief by filing a motion under rule 60(b). On September 1, 2020 USDC issued an order denying Apple’s motion for relief of
judgement. This case is now closed.

VirnetX Inc. v. Apple, Inc. (Case 6:12-CV-00855-LED) (“Apple II”)

This case began on November 6, 2012, when we had filed a complaint against Apple in USDC in which we alleged that Apple infringed on certain of our
patents,  (U.S.  Patent  Nos.  6,502,135,  7,418,504,  7,921,211  and  7,490,151).  We  sought  damages  and  injunctive  relief.  The  accused  products  include  the
iPhone 5, iPod Touch 5th Generation, iPad 4th Generation, iPad mini, and the latest Macintosh computers; these products were not included in the Apple I
case because they were released after the Apple I case was initiated. Post-trial motions hearing was held on July 18, 2018. On August 31, 2018, the USDC
entered  a  Final  Judgment  and  issued  its  Memorandum  Opinion  and  Order  regarding  post-trial  motions,  affirming  the  jury’s  verdict  of  $502,600  and
granting  VirnetX  motions  for  supplemental  damages,  a  sunset  royalty  and  the  royalty  rate  of  $1.20  per  infringing  iPhone,  iPad  and  Mac  products,  pre-
judgment and post-judgment interest and costs. Apple filed a notice of appeal with the USCAFC in the Apple II case.

52

Index

On October 9, 2018, USCAFC docketed the appeal as Case No. 19-1050 - VirnetX Inc. v. Apple Inc . On January 24, 2019 Apple filed its opening brief.
We  filed  our  response  brief  on  March  1,  2019.  Apple  filed  its  reply  brief  on  April  5,  2019.  The  oral  arguments  were  heard  on  October  4,  2019.  On
November  22,  2019,  the  USCAFC  issued  an  opinion  affirming  the  district  court’s  findings  that  Apple  is  precluded  from  making  certain  invalidity
arguments and that Apple infringed the ’135 and ’151 patents; reversing the USDC’s finding that Apple infringed the ’504 and ’211 patents; and remanding
the case for proceedings on damages. Apple sought panel and en banc rehearing, which the USCAFC denied on February 10, 2020.

On February 22, 2020, the USDC issued a scheduling order for the parties to brief the court about the need for a new trial for recalculating the damages.
We filed our motion for entry of judgment on February 28, 2020. The arguments on this matter were heard on April 14, 2020. In its order, unsealed on May
1, 2020,  the  USDC  denied  VirnetX’s  motion  for  entry  of  a  new  judgment  based  on  the  prior  jury  verdict  and  ordered  a  new  jury  trial  on  damages.  On
August  10,  2020,  the  USDC  granted  Apple’s  motion  for  continuance  and  reset  the  date  to  October  26,  2020.  On  October  30,  2020,  a  jury  returned  a
$502,800  verdict  in  favor  of  VirnetX  based  on  Apple’s  infringement  of  two  network  security  patents:  VirnetX  US  Patents  No.  6,502,135  and  No.
7,490,151.  The  jury  verdict  called  for  damages  of  $0.84  per  accused  device  since  the  2013  launch  of  Apple’s  iOS  7  operating  system  and  represents
598,629,580 infringing units from US sales only. On January 15, 2021, the district court denied Apple’s motion for judgment as a matter of law, and on
February 4, 2021, Apple filed a notice of appeal to the USCAFC.

VirnetX Inc. v. Mangrove Partners Master Fund, Ltd., Apple Inc. (USCAFC Case 20-2271) and VirnetX Inc. v. Mangrove Partners Master Fund,
Ltd., Apple Inc., and Black Swamp, LLC (USAFC Case 20-2272)

On September 15, 2020, we filed with the USCAFC an appeal of the invalidity findings by the PTAB in inter-partes review proceedings IPR2015-01046
and IPR2016-00062  involving  our  U.S.  Patent  No. 6,502,135,  and  an  appeal  of  the  invalidity  findings  by  the  PTAB  in  inter  partes  review  proceedings
IPR2015-1047, IPR2016- 00063,  and  IPR2016-00167  involving  our  U.S.  Patent  No. 7,490,151.  On  September  25,  2020,  the  USCAFC  issued  an  order
consolidating the two appeals. On December 15, 2020, we filed a motion to vacate the PTAB decisions below and to remand these appeals to the PTAB,
which remains pending.  In view of our motion to remand, our deadline to file an initial brief is currently stayed.

Iancu v. Luoma (SCOTUS Case 20-74)

On July 23, 2020, the United States and the USPTO (collectively, “the United States”) filed a petition for a writ of certiorari from several decisions by the
USAFC, including decisions in VirnetX Inc. v. Cisco Systems, Inc., Nos. 2019-1671, and VirnetX Inc. v. Iancu, Nos. 2017-2593, -2594.  In those cases, the
USAFC granted VirnetX’s motions to vacate the underlying decisions of the PTAB on the basis of Arthrex, Inc. v. Smith & Nephew, Inc., 941 F.3d 1320
(Fed. Cir. 2019), and remanded for further proceedings.  The United States requested that the SCOTUS hold its certiorari petition pending the disposition of
the United States’ separate petition in United States v. Arthrex, Inc., No. 19-1434 (filed June 25, 2020).  On August 26, 2020,  VirnetX  filed  a  response,
agreeing that the United States’ certiorari petition should be held pending the disposition of the petition for a writ of certiorari in No. 19-1434 (and related
petitions filed by private parties in Nos. 19-1452 and 19-1458), and any further SCOTUS proceedings.

On October  13,  2020,  SCOTUS  granted  the  United  States’  petition  for  a  writ  of  certiorari  in  No. 19-1434  as  to  USAFC  Case  No. 2018-2140,  and  the
petitions for writs of certiorari in Nos. 19-1452 and 19-1458, all limited to Questions 1 and 2 as set forth in the July 22, 2020 Memorandum for the United
States filed in No. 19-1434. The consolidated petition is seeking review of decisions by the USCAFC holding that administrative patent judges (“APJ”) of
the Patent Trial and Appeal Board of the U.S. Patent and Trademark Office must be appointed by the President and confirmed by the Senate; and, whether
the  remedy  imposed  by  USCAFC  that  federal  laws  that  place  restrictions  on  when  officials  can  be  removed  from  office  cannot  apply  to  APJ,  was  the
appropriate one. SCOTUS heard oral argument in these consolidated cases on March 1, 2021.

McKool Smith P.C. v. VirnetX, Inc., AAA Case No. 01-20-0003-7975

On March 23, 2020, the law firm of McKool Smith, P.C. (“McKool”) filed a Demand for Arbitration against VirnetX, Inc. with the American Arbitration
Association (“AAA”). In its demand, McKool claims that a retention agreement it entered into in 2010 with VirnetX entitles it to a contingency fee arising
from the recent 2020 payment made by Apple. McKool claims it is owed approximately $36,300 (or 8% of the Apple I payment). We have filed a general
response with the AAA denying McKool’s claim and are contesting the matter vigorously. An evidentiary hearing was held on the matter during the week
of February 22, 2021 and the parties will be submitting additional briefing.  A ruling is expected sometime thereafter.

53

Index

Neal Hurwitz v. Kendall Larsen et al. (Case 2020-0425-JRS)

On June 2, 2020,  stockholder  Neal  Hurwitz  filed  a  verified  derivative  complaint  in  the  Delaware  Court  of  Chancery  against  Kendall  Larsen,  Robert  D.
Short  Ill,  Gary  Feiner,  Michael  F.  Angelo,  and  Thomas  M.  O’Brien  and  naming  the  Company  as  nominal  defendant.  The  lawsuit  alleges  breaches  of
fiduciary duty, corporate waste, and unjust enrichment arising out of a series of previously-disclosed transactions and compensation awards and seeks an
award  of  monetary  damages  and  equitable  relief.  On  July  1,  2020,  the  defendants  filed  a  motion  to  dismiss  the  complaint  based  on  a  failure  to  plead
demand futility and a failure to state a claim on which relief can be granted and, on August 19, 2020, the defendants filed an opening brief in support of
their motion to dismiss. On October 16, 2020, plaintiff amended his complaint rather than respond to the arguments in the defendants’ opening brief. On
October 23, 2020, the defendants filed a renewed motion to dismiss plaintiff’s amended complaint based on a failure to plead demand futility and a failure
to state a claim on which relief can be granted. On January 12, 2021, Hurwitz voluntarily dismissed his suit without prejudice.

Other Legal Matters

One  or  more  potential  intellectual  property  infringement  claims  may  also  be  available  to  us  against  certain  other  companies  who  have  the  resources  to
defend against any such claims. Although we believe these potential claims are likely valid, commencing a lawsuit can be expensive and time-consuming,
and  there  is  no  assurance  that  we  could  prevail  on  such  potential  claims  if  we  made  them.  In  addition,  bringing  a  lawsuit  may  lead  to  potential
counterclaims  which  may  distract  our  management  and  our  other  resources,  including  capital  resources,  from  efforts  to  successfully  commercialize  our
products.

Currently, we are not a party to any other pending legal proceedings and are not aware of any proceeding threatened or contemplated against us.

Note 13 – Leases

We lease office space under an operating lease which expires on October 31, 2021. At December 31, 2020, the underlying ROU asset and lease liability
totaled $44.  At December 31, 2019, the underlying ROU asset and lease liability totaled $97.  Lease expense totaled $56 in both 2020 and 2019.

We also lease a facility for corporate promotional and marketing purposes which was prepaid at inception and originally expired in 2024.  In September
2020, the lease was extended for one year to 2025, due to COVID use-restrictions in 2020.  No other terms of the original agreement were affected and
there was no impact on cash flow.  At December 31, 2020 and 2019, the ROU asset totaled $1,248 and $1,604, respectively; lease expense totaled $356 and
$385, during 2020 and 2019, respectively.

54

Index

REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

To the Board of Directors and
Stockholders of VirnetX Holding Corporation

Opinion on Internal Control over Financial Reporting

We  have  audited  VirnetX  Holding  Corporation’s  (the  Company’s)  internal  control  over  financial  reporting  as  of  December  31,  2020,  based  on  criteria
established  in  Internal  Control—Integrated  Framework  (2013)  issued  by  the  Committee  of  Sponsoring  Organizations  of  the  Treadway  Commission
(COSO).  In  our  opinion,  the  Company  maintained,  in  all  material  respects,  effective  internal  control  over  financial  reporting  as  of  December  31,  2020,
based on criteria established in Internal Control—Integrated Framework (2013) issued by COSO.

We also have audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (PCAOB), the consolidated
balance sheets and the related consolidated statements of operations, comprehensive income (loss), stockholders’ equity, and cash flows of the Company,
and our report dated March 16, 2021, expressed an unqualified opinion.

Basis for Opinion

The Company’s management is responsible for maintaining effective internal control over financial reporting, and for its assessment of the effectiveness of
internal  control  over  financial  reporting,  included  in  the  accompanying  Management’s  Report  on  Internal  Control  Over  Financial  Reporting.  Our
responsibility  is  to  express  an  opinion  on  the  Company’s  internal  control  over  financial  reporting  based  on  our  audit.  We  are  a  public  accounting  firm
registered with the PCAOB and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the
applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.

We conducted our audit in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable
assurance  about  whether  effective  internal  control  over  financial  reporting  was  maintained  in  all  material  respects.  Our  audit  of  internal  control  over
financial reporting included obtaining an understanding of internal control over financial reporting, assessing the risk that a material weakness exists, and
testing and evaluating the design and operating effectiveness of internal control based on the assessed risk. Our audit also included performing such other
procedures as we considered necessary in the circumstances. We believe that our audit provides a reasonable basis for our opinion.

Definition and Limitations of Internal Control over Financial Reporting

A company’s internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting
and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. A company’s internal control
over financial reporting includes those policies and procedures that (1) pertain to the maintenance of records that, in reasonable detail, accurately and fairly
reflect the transactions and dispositions of the assets of the company; (2) provide reasonable assurance that transactions are recorded as necessary to permit
preparation  of  financial  statements  in  accordance  with  generally  accepted  accounting  principles,  and  that  receipts  and  expenditures  of  the  company  are
being  made  only  in  accordance  with  authorizations  of  management  and  directors  of  the  company;  and  (3)  provide  reasonable  assurance  regarding
prevention or timely detection of unauthorized acquisition, use, or disposition of the company’s assets that could have a material effect on the financial
statements.

Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of
effectiveness  to  future  periods  are  subject  to  the  risk  that  controls  may  become  inadequate  because  of  changes  in  conditions,  or  that  the  degree  of
compliance with the policies or procedures may deteriorate.

/s/ Farber Hass Hurley LLP

Chatsworth, California
March 16, 2021

55

 
 
 
 
 
 
 
 
 
 
Index

Item 9.

None.

Changes in and Disagreements with Accountants on Accounting and Financial Disclosure

Item 9A.

Controls and Procedures

Evaluation of Disclosure Controls and Procedures

Under the supervision and with the participation of our management, including our Chief Executive Officer and Chief Financial Officer, we conducted an
evaluation of the effectiveness of the design and operation of our disclosure controls and procedures, as defined in Rules 13a-15(e) and 15d-15(e) under the
Securities Exchange Act of 1934, as amended, December 31, 2020.

The  purpose  of  this  evaluation  was  to  determine  whether  as  of  December  31,  2020  our  disclosure  controls  and  procedures  were  effective  to  provide
reasonable  assurance  that  the  information  we  are  required  to  disclose  in  our  filings  with  the  SEC,  (i)  is  recorded,  processed,  summarized  and  reported
within the time periods specified in the SEC’s rules and forms and (ii) accumulated and communicated to our management, including our Chief Executive
Officer and Chief Financial Officer, as appropriate to allow timely decisions regarding required disclosure.

Based on their evaluation, our Chief Executive Officer and Chief Financial Officer have concluded that as of December 31, 2020, our disclosure controls
and procedures were effective.

Changes in Internal Control Over Financial Reporting

There were no changes in our internal controls over financial reporting (as such term is defined in rules 13a-15(f) under the Securities Exchange Act of
1934, as amended) during the fiscal year ended December 31, 2020 that have materially affected, or are reasonably likely to materially affect, our internal
controls over financial reporting.

Management’s Report on Internal Control Over Financial Reporting

Our management is responsible for establishing and maintaining adequate internal control over financial reporting for the Company. Internal control over
financial reporting is a process to provide reasonable assurance regarding the reliability of our financial reporting for external purposes in accordance with
accounting  principles  generally  accepted  in  the  United  States  of  America.  Internal  control  over  financial  reporting  includes  maintaining  records  that  in
reasonable detail accurately and fairly reflect our transactions; providing reasonable assurance that transactions are recorded as necessary for preparation of
our  financial  statements;  providing  reasonable  assurance  that  receipts  and  expenditures  of  Company  assets  are  made  in  accordance  with  management
authorization; and providing reasonable assurance that unauthorized acquisition, use or disposition of Company assets that could have a material effect on
our financial statements would be prevented or detected on a timely basis. Because of its inherent limitations, internal control over financial reporting is not
intended to provide absolute assurance that a misstatement of our financial statements would be prevented or detected.

Management conducted an evaluation of the effectiveness of our internal control over financial reporting based on the framework in Internal Control –
Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission. Based on this evaluation, management
concluded  that  the  Company’s  internal  control  over  financial  reporting  was  effective  as  of  December  31,  2020.  There  were  no  changes  in  our  internal
control over financial reporting during the period ended December 31, 2020 that have materially affected, or are reasonably likely to materially affect, our
internal control over financial reporting. Farber Hass Hurley LLP has audited our internal control over financial reporting as of December 31, 2020; their
report is included elsewhere herein.

Item 9B.

Other Information

None.

56

 
 
 
 
 
 
 
 
 
 
 
 
 
 
Index

Item 10.

Directors, Executive Officers and Corporate Governance

PART III

The information required by this item will be contained in our definitive proxy statement to be filed with the SEC in connection with our 2020 Annual
Meeting of Stockholders (the “Proxy Statement”), which is expected to be filed not later than 120 days after the end of our fiscal year ended December 31,
2020 and is incorporated in this report by reference.

Item 11.

Executive Compensation

The information required by this item will be set forth in the Proxy Statement and is incorporated herein by reference.

Item 12.

Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters

The information required by this item will be set forth in the Proxy Statement and is incorporated herein by reference.

Securities Authorized for Issuance Under the Equity Compensation Plans

We have a stock incentive plan for employees and others called the “VirnetX Holding Corporation 2013 Stock Plan”, or the Plan, which has been approved
by our stockholders. The Plan provides for the granting of up to 16,624,469 shares of our common stock, including stock options and restricted stock units,
and will expire in 2023. As of December 31, 2020, there were 545,210 shares available to be granted under the Plan. We had 5,812,521 and 5,630,021
options outstanding at December 31, 2020 and December 31, 2019, respectively, with an average exercise price of $8.55 and $8.49, respectively. We had
504,323 and 498,489 restricted stock units outstanding at December 31, 2020 and December 31, 2019, respectively, with a weighted average grant price of
$5.69 and $4.71, respectively.

Plan Category

Equity compensation plans approved by security holders
Equity compensation plans not approved by security holders
Total

Weighted-
Average
Exercise Price
of
Outstanding
Options and
RSUs

Number of
Securities to
be
Issued Upon
Exercise of
Outstanding
Options and
RSUs
6,316,844    $
—     
6,316,844    $

Number of
Securities
Remaining
Available for
Future
Issuance
Under Equity
Compensation
Plans

8.32     
—     
8.32     

545,210 

545,210 

On  March  19,  2020,  the  Compensation  Committee  granted  240,000  options  to  the  employees  of  VirnetX,  Inc.  On  April  2,  2020,  the  Compensation
Committee granted 50,000 options to an employee of VirnetX Inc. On May 29, 2020, the Compensation Committee granted 37,500 options and 24,999
RSUs to members of the Board of Directors of VirnetX, Inc. On June 3, 2020, the Compensation Committee granted 290,000 options and 193,330 RSUs to
the employees of VirnetX, Inc On December 18, 2020, the Compensation Committee granted 120,000 options to an employee of VirnetX Inc. and 10,000
options to a consultant.

Item 13.

Certain Relationships and Related Transactions, and Director Independence

The information required by this item will be set forth in the Proxy Statement and is incorporated herein by reference.

Item 14.

Principal Accountant Fees and Services

The information required by this item will be set forth in the Proxy Statement and is incorporated herein by reference.

57

 
   
   
 
   
   
  
   
 
 
 
 
 
 
Index

PART IV

Item 15.

Exhibits and Financial Statement Schedules

(a) The following documents are filed as part of this Annual Report on Form 10-K

(1) Financial Statements: See the Index to Consolidated Financial Statements under Item 8 of this Annual Report on Form 10-K.

(2) Financial  Statement  Schedule:  Financial  statement  schedules  are  omitted  because  they  are  not  applicable,  or  the  required  information  is
shown in the financial statements or notes thereto. All other schedules are omitted because of the absence of conditions under which they are
required or because the required information is given in the financial statements or the notes thereto.

(3) Exhibits: The documents listed in the Exhibit Index of this Annual Report on Form 10-K are incorporated by reference or are filed with this

Annual Report on Form 10-K, in each case as indicated therein (numbered in accordance with Item 601 of Regulation S-K).

EXHIBIT INDEX

Exhibit
Number
3.1
3.2
4.1

4.2
4.3
4.4
4.5
4.6
10.1

10.2*
10.3*
10.4*

10.5*
10.6*
10.7*

10.8

10.9

Description

Certificate of Incorporation of the Company.
By Laws of the Company.
Form of Warrant Agency Agreement by and between the
Company and Corporate Stock Transfer, Inc. as Warrant Agent.
Form of Series I Warrant.
Specimen Common Stock Certificate.
Form of Senior Indenture
Form of Subordinated Indenture
Description of Capital Stock
Form of Indemnification Agreement by and between the Company
and each of Kendall Larsen, Robert D. Short III, Gary Feiner,
Michael F. Angelo, Thomas M. O’Brien and Richard Nance.
2007 Stock Plan, as amended on April 13, 2012.
Amended Form of Stock Option Agreement – 2007 Stock Plan.
Form of Restricted Stock Unit Award Agreement – 2007 Stock
Plan.
2013 Equity Incentive Plan.
Form of Stock Option Agreement – 2013 Equity Incentive Plan.
Form of Restricted Stock Unit Agreement – 2013 Equity Incentive
Plan.
Voting Agreement among the Company and certain of its
stockholders, dated as of December 12, 2007.
Securities Purchase Agreement, dated as of September 2, 2009, by
and between the Company and the Purchasers (as defined therein).

58

Incorporated by reference herein
Exhibit No.
3.1
3.2
4.1

11/01/2007   
11/01/2007   
01/16/2009   

Filing Date

Form
8-K
8-K
S-1/A

8-K
S-3
S-3
S-3

10-K

10-Q
10-Q
10-Q

4.1
4.1
4.2
4.4

10.1

10.2
4.5
10.3

DEF 14A
10-K
10-K

10-K

8-K

Appendix A  

10.6
10.7

10.11

10.1

File No.

000-26895 
000-26895 
333-153645 

001-33852 
333-226413 
333-226413 
333-226413 

09/03/2009   
07/30/2018   
07/30/2018   
07/30/2018   

03/18/2019   

001-33852 

05/10/2012   
05/10/2011   
05/10/2012   

04/12/2013   
03/02/2015   
03/02/2015   

001-33852 
001-33852 
001-33852 

001-33852 
001-33852 
001-33852 

03/31/2008   

001-33852 

09/03/2009   

001-33852 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
   
   
 
 
 
 
 
 
 
 
 
 
Index

Exhibit
Number
10.10

10.11

10.16

10.15

10.12

10.14

10.13

Description
Form of Registration Rights Agreement by and between the
Company and the Purchasers (as defined therein).
Form of Underwriting Agreement between VirnetX Holding
Corporation and Gilford Securities Incorporated.
Patent License and Assignment Agreement by and between the
Company and Leidos, Inc. (formerly Science Applications
International Corporation) dated as of August 12, 2005.
Amendment No. 1 to Patent License and Assignment
Agreement by and between the Company and Leidos, Inc.
dated as of November 2, 2006.
Amendment No. 2 to Patent License and Assignment
Agreement by and between VirnetX, Inc. and Leidos, Inc.
dated as of March 12, 2008.
Security Agreement by and between the Company and Leidos,
Inc. dated as of August 12, 2005.
Assignment Agreement between the Company and Leidos, Inc.
dated as of December 21, 2006.
Professional Services Agreement by and between the
Company and Leidos, Inc. dated as of August 12, 2005.
Engagement Letter dated June 8, 2009, by and between
McKool Smith, a professional corporation, and VirnetX, Inc.
Engagement Letter dated April 15, 2010, by and between
McKool Smith, a professional corporation, and VirnetX, Inc.
Settlement and License Agreement, by and between Microsoft
Corporation and VirnetX, Inc., dated May 14, 2010.
10.21*** Amended Settlement and License Agreement, by and between
Microsoft Corporation and VirnetX, Inc., dated December 17,
2014.
Employment Offer Letter from VirnetX, Inc. to Richard H.
Nance.
Amended and Restated Revenue Sharing Agreement by and
between VirnetX Holding Corporation and Public Intelligence
Technology Associates, dated October 18, 2017.

10.23**

10.18**

10.19**

10.20**

10.22*

10.17

59

Form
8-K

S-1/A

8-K

8-K

8-K

8-K

8-K

8-K

10-Q

10-Q

10-Q/A

Incorporated by reference herein

Exhibit No.
10.2

Filing Date

09/03/2009 

File No.
  001-33852 

1.1

10.4

10.6

10.1

10.5

10.7

10.8

10.1

10.1

10.1

01/16/2009 

07/12/2007 

333-
153645
  000-26895 

07/12/2007 

  000-26895 

03/18/2008 

  001-33852 

07/12/2007 

  000-26895 

07/12/2007 

  000-26895 

07/12/2007 

  000-26895 

08/10/2009 

  001-33852 

05/07/2010 

  001-33852 

01/31/2011 

  001-33852 

10-K

10.23

03/02/2015 

  001-33852 

10-Q

10-Q

10.4

10.1

05/10/2012 

  001-33852 

11/09/2017 

  001-33852 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Form
10-Q

Incorporated by reference herein
Exhibit No.
10.2

Filing Date

11/09/2017   

File No.

001-33852 

8-K

10.1

08/31/2018   

001-33852 

Index

Exhibit
Number

10.24**

10.25

21.1
23.1

24.1
31.1

31.2

32.1†

32.2†

Description
Amended and Restated Gabriel License Agreement by and
between VirnetX Holding Corporation and Public Intelligence
Technology Associates, dated October 18, 2017.
Sales Agreement, dated August 31, 2018, by and between
VirnetX Holding Corporation and Cowen and Company, LLC.
Subsidiaries of VirnetX Holding Corporation.
Consent of Farber Hass Hurley LLP, Independent Registered
Public Accounting Firm.
Power of Attorney (contained on signature page hereto)
Chief Executive Officer Certification pursuant to Rule 13a-
14(a) of the Securities Exchange Act.
Chief Financial Officer Certification pursuant to Rule 13a-
14(a) of the Securities Exchange Act.
Chief Executive Officer Certification pursuant to 18 U.S.C.
Section 1350 as adopted pursuant to Section 906 of the
Sarbanes-Oxley Act of 2002
Chief Financial Officer Certification pursuant to 18 U.S.C.
Section 1350 as adopted pursuant to Section 906 of the
Sarbanes-Oxley Act of 2002.
XBRL Instance Document

101.INS
101.SCH XBRL Taxonomy Extension Schema Document
101.CAL XBRL Taxonomy Extension Calculation Linkbase Document  
101.DEF XBRL Taxonomy Extension Definition Linkbase Document
101.LAB XBRL Taxonomy Extension Label Linkbase Document
101.PRE XBRL Taxonomy Extension Presentation Linkbase Document  

*

Indicates management contract or compensatory plan.

** Confidential treatment has been granted by the Securities and Exchange Commission as to certain portions of this Exhibit.

***

†

Portions  of  this  Exhibit  have  been  omitted  pending  a  determination  by  the  Securities  and  Exchange  Commission  as  to  whether  these  portions
should be granted confidential treatment.

The certifications attached as Exhibit 32.1 and 32.2 that accompany this Annual Report on Form 10-K are not deemed filed with the Securities and
Exchange Commission and are not to be incorporated by reference into any filing of VirnetX Holding Corporation under the Securities Act of 1933, as
amended, or the Securities Exchange Act of 1934, as amended, whether before or after the date of this Annual Report on Form 10-K, irrespective of
any general incorporation language contained in such filing.

60

 
 
 
 
 
 
  
   
 
 
 
 
  
   
 
 
 
 
  
   
 
 
 
 
  
   
 
 
 
 
  
   
 
 
 
 
  
   
 
 
 
 
  
   
 
 
 
 
  
   
 
 
 
 
  
   
 
 
 
  
   
 
 
 
 
  
   
 
 
 
 
  
   
 
 
 
  
   
 
 
 
 
 
  
   
 
 
 
 
 
 
 
Index

SIGNATURES

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this Annual Report on Form 10-
K to be signed on its behalf by the undersigned, thereunto duly authorized.

Dated: March 16, 2021

VirnetX Holding Corporation

By:

/s/ Kendall Larsen
Name: Kendall Larsen
Title: Chief Executive Officer and President

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Index

POWER OF ATTORNEY

KNOW  ALL  PERSONS  BY  THESE  PRESENTS,  that  each  person  whose  signature  appears  below  constitutes  and  appoints  Kendall  Larsen  his  or  her
attorney-in-fact, with full power of substitution, for him or her in any and all capacities, to sign any amendments to this Report on Form 10-K, and to file
the  same,  with  exhibits  thereto  and  other  documents  in  connection  therewith  with  the  Securities  and  Exchange  Commission,  hereby  ratifying  and
confirming all that said attorney-in-fact, or his or her substitute or substitutes may do or cause to be done by virtue hereof.

Pursuant to the requirements of the Securities Exchange Act of 1934, this Annual Report on Form 10-K has been signed below by the following persons on
behalf of the registrant and in the capacities indicated.

Name

/s/ Kendall Larsen
Kendall Larsen

/s/ Richard H. Nance
Richard H. Nance

/s/ Robert D. Short III
Robert D. Short III

/s/ Gary Feiner
Gary Feiner

/s/ Michael F. Angelo
Michael F. Angelo

/s/ Thomas M. O’Brien
Thomas M. O’Brien

Capacity

Date

  Director, Chief Executive Officer and President

  March 16, 2021

(Principal Executive Officer)

  Chief Financial Officer

(Principal Financial Officer and
Principal Accounting Officer)

  Director

  Director

  Director

  Director

  March 16, 2021

  March 16, 2021

  March 16, 2021

  March 16, 2021

  March 16, 2021

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
DESCRIPTION OF CAPITAL STOCK

Exhibit 4.6

The following description of the capital stock of VirnetX Holding Corporation (“us”, “our,” “we”, or the “Company”) is a
summary.    We  have  adopted  an  amended  and  restated  certificate  of  incorporation  and  amended  and  restated  bylaws,  and  this
description summarizes the provisions that are included in such documents. Because it is only a summary, it does not contain all
the information that may be important to you. For a complete description of the matters set forth in this Exhibit, you should refer
to  our  amended  and  restated  certificate  of  incorporation  and  amended  and  restated  bylaws,  each  previously  filed  with  the
Securities and Exchange Commission and incorporated by reference as exhibits to the Annual Report on Form 10-K of which this
Exhibit is a part, and to the applicable provisions of Delaware law.

General

Our  authorized  capital  stock  consists  of  100,000,000  shares  of  common  stock  with  a  $0.0001  par  value  per  share,  and
10,000,000 shares of preferred stock with a $0.0001 par value per share, all of which shares of preferred stock are undesignated. 
Our board of directors may establish the rights and preferences of the preferred stock from time to time.  All outstanding shares
of  our  common  stock  are  fully  paid  and  non-assessable.  The  rights,  preferences,  and  privileges  of  the  holders  of  our  common
stock are subject to, and may be adversely affected by, the rights of the holders of shares of any series of preferred stock that we
may designate and issue in the future.

Common Stock

We have one class of common stock.

Dividend Rights

Subject to any preferential rights of any outstanding preferred stock, holders of our common stock are entitled to receive
ratably  the  dividends,  if  any,  as  may  be  declared  from  time  to  time  by  the  board  of  directors  out  of  funds  legally  available
therefor.

Voting Rights

Each holder of our common stock is entitled to one vote for each share on all matters to be voted upon by the stockholders

and there are no cumulative rights.

Right to Receive Liquidation Distributions

If  there  is  a  liquidation,  dissolution  or  winding  up  of  our  company,  holders  of  our  common  stock  would  be  entitled  to

share in our assets remaining after the payment of liabilities and any preferential rights of any outstanding preferred stock.

No Preemptive or Similar Rights

Holders  of  our  common  stock  have  no  preemptive  or  conversion  rights  or  other  subscription  rights,  and  there  are  no

redemption or sinking fund provisions applicable to the common stock.

Preferred stock

Our board of directors is authorized to issue shares of preferred stock in one or more series without stockholder approval. 
Our board of directors has the discretion to determine the rights, preferences, privileges, and restrictions, including voting rights,
dividend rights, conversion rights, redemption privileges and liquidation preferences, of each series of preferred stock.  There are
no restrictions presently on the repurchase or redemption of any shares of our preferred stock.  We have no present plans to issue
any shares of preferred stock nor are any shares of our preferred stock presently outstanding.

Anti-Takeover Effects

Provisions  of  Delaware  law  and  our  amended  and  restated  certificate  of  incorporation  and  Bylaws  could  make  the
acquisition of our company through tender offer, a proxy context, or other means more difficult and could make the removal of
incumbent  officers  and  directors  more  difficult.    We  expect  these  provisions  to  discourage  coercive  takeover  practices  and
inadequate takeover bids and to encourage persons seeking to acquire control of our company to first negotiate with our board of
directors.    We  believe  that  the  benefits  provided  by  our  ability  to  negotiate  with  the  proponent  of  an  unfriendly  or  unsolicited
proposal outweigh the disadvantages of discouraging these proposals.  We believe the negotiation of an unfriendly or unsolicited
proposal could result in an improvement of its terms.

Amended and Restated Certificate of Incorporation and Bylaws

Our amended and restated certificate of incorporation and bylaws provide for the following:

•

•

•

•

•

•

Undesignated Preferred Stock.  The ability to authorize undesignated preferred stock makes it possible for our board of directors to issue
one or more series of preferred stock with voting or other rights or preferences that could impede the success of any attempt to change
control of our company.  These and other provisions may have the effect of deferring hostile takeovers or delaying changes in control or
management of our company.

Stockholder Meetings.  Our charter documents provide that a special meeting of stockholders may be called only by resolution adopted
by the board of directors.

Requirements for Advance Notification of Stockholder Nominations and Proposals.  Our bylaws establish advance notice procedures with
respect  to  stockholder  proposals  and  the  nomination  of  candidates  for  election  as  directors,  other  than  nominations  made  by  or  at  the
direction of the board of directors or a committee of the board of directors.

Board Classification.  Our board of directors is divided into three classes.  The directors in each class will serve for a three-year term, one
class being elected each year by our stockholders.  This system of electing and removing directors may tend to discourage a third party
from making a tender offer or otherwise attempting to obtain control of us, because it generally makes it more difficult for stockholders to
replace a majority of the directors.

Stockholder Meetings; Limits on Ability of Stockholders to Act by Written Consent.  We have provided in our certificate of incorporation
that our stockholders may not act by written consent.  This limit on the ability of our stockholders to act by written consent may lengthen
the amount of time required to take stockholder actions.  As a result, a holder controlling a majority of our capital stock would not be able
to amend our bylaws or remove directors without holding a meeting of our stockholders called in accordance with our bylaws.

Amendment of Bylaws.  Any amendment of our bylaws requires approval by holders of at least two-thirds of our outstanding capital stock
entitled to vote generally in the election of directors.

Delaware Anti-Takeover Statute

We are subject to Section 203 of the Delaware General Corporation Law, an anti-takeover law.  In general, Section 203
prohibits a publicly held Delaware corporation from engaging in a “business combination” with an “interested stockholder” for a
period of three years following the date the person became an interested stockholder, unless:

•

•

prior to the date of the transaction, the board of directors of the corporation approved either the business combination or the transaction
which resulted in the stockholder becoming an interested stockholder.

the stockholder owned at least 85% of the voting stock of the corporation outstanding at the time the transaction commenced, excluding
for purposes of determining the number of shares outstanding (a) shares owned by persons who are directors and also officers, and (b)
shares owned by employee stock plans in which employee participants do not have the right to determine confidentially whether shares
held subject to the plan will be tendered in a tender or exchange offer; or

•

on or subsequent to the date of the transaction, the business combination is approved by the board and authorized at an annual or special
meeting of stockholders, and not by written consent, by the affirmative vote of at least two-thirds of the outstanding voting stock that is
not owned by the interested stockholder.

Generally,  a  “business  combination”  includes  a  merger,  asset  or  stock  sale,  or  other  transaction  resulting  in  a  financial
benefit to the interested stockholder.  An “interested stockholder” is a person who, together with affiliates and associates, owns
or,  within  three  years  prior  to  the  determination  of  interested  stockholder  status,  did  own  15%  or  more  of  a  corporation’s
outstanding  voting  securities.    We  expect  the  existence  of  this  provision  to  have  an  anti-takeover  effect  with  respect  to
transactions  our  board  of  directors  does  not  approve  in  advance.    We  also  anticipate  that  Section  203  may  also  discourage
attempts that might result in a premium over the market price for the shares of common stock held by stockholders.

Transfer Agent and Registrar

The transfer agent and registrar for the common stock is Equiniti Trust Company.

Listing

Our common stock is listed on the NYSE under the symbol “VHC.”

Subsidiaries of Registrant

Name of Entity
VirnetX Japan Corporation
VirnetX Inc.

EXHIBIT 21.1

Jurisdiction of
Incorporation or
Organization
Japan
Delaware

 
 
 
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

We hereby consent to the incorporation by reference in the Registration Statements on Form S-3 (No. 333-226413) and Form S-8
(Nos.  333-149883,  333-196064,  and  333-218467)  of  our  reports  dated  March  16,  2021,  relating  to  the  consolidated  financial
statements  of  VirnetX  Holding  Corporation  (the  “Company”),  and  the  effectiveness  of  the  Company's  internal  control  over
financial reporting, appearing in this Annual Report on Form 10-K of the Company for the year ended December 31, 2020.

EXHIBIT 23.1

/s/ Farber Hass Hurley LLP

Chatsworth, California
March 16, 2021

 
 
 
 
EXHIBIT 31.1

I, Kendall Larsen, certify that:

CERTIFICATIONS

1.

I have reviewed this Annual Report on Form 10-K of VirnetX Holding Corporation for the fiscal year ended December 31, 2020;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the
statements made, in light  of  the  circumstances  under  which  such  statements  were  made,  not  misleading  with  respect  to  the  period  covered  by  this
report;

3. Based  on  my  knowledge,  the  financial  statements,  and  other  financial  information  included  in  this  report,  fairly  present  in  all  material  respects  the

financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The  registrant’s  other  certifying  officer  and  I  are  responsible  for  establishing  and  maintaining  disclosure  controls  and  procedures  (as  defined  in
Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f))
for the registrant and have:

(a) Designed  such  disclosure  controls  and  procedures,  or  caused  such  disclosure  controls  and  procedures  to  be  designed  under  our  supervision,  to
ensure  that  material  information  relating  to  the  registrant,  including  its  consolidated  subsidiaries,  is  made  known  to  us  by  others  within  those
entities, particularly during the period in which this report is being prepared;

(b) Designed  such  internal  control  over  financial  reporting,  or  caused  such  internal  control  over  financial  reporting  to  be  designed  under  our
supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external
purposes in accordance with generally accepted accounting principles;

(c) Evaluated  the  effectiveness  of  the  registrant’s  disclosure  controls  and  procedures  and  presented  in  this  report  our  conclusions  about  the

effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d) Disclosed  in  this  report  any  change  in  the  registrant’s  internal  control  over  financial  reporting  that  occurred  during  the  registrant’s  most  recent

fiscal quarter that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the

registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably

likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control

over financial reporting.

Date: March 16, 2021

/s/ Kendall Larsen
Kendall Larsen
President and Chief Executive Officer
(Principal Executive Officer)

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
EXHIBIT 31.2

I, Richard H. Nance, certify that:

CERTIFICATIONS

1.

I have reviewed this Annual Report on Form 10-K of VirnetX Holding Corporation for the fiscal year ended December 31, 2020;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the
statements made, in light  of  the  circumstances  under  which  such  statements  were  made,  not  misleading  with  respect  to  the  period  covered  by  this
report;

3. Based  on  my  knowledge,  the  financial  statements,  and  other  financial  information  included  in  this  report,  fairly  present  in  all  material  respects  the

financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The  registrant’s  other  certifying  officer  and  I  are  responsible  for  establishing  and  maintaining  disclosure  controls  and  procedures  (as  defined  in
Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f))
for the registrant and have:

(a) Designed  such  disclosure  controls  and  procedures,  or  caused  such  disclosure  controls  and  procedures  to  be  designed  under  our  supervision,  to
ensure  that  material  information  relating  to  the  registrant,  including  its  consolidated  subsidiaries,  is  made  known  to  us  by  others  within  those
entities, particularly during the period in which this report is being prepared;

(b) Designed  such  internal  control  over  financial  reporting,  or  caused  such  internal  control  over  financial  reporting  to  be  designed  under  our
supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external
purposes in accordance with generally accepted accounting principles;

(c) Evaluated  the  effectiveness  of  the  registrant’s  disclosure  controls  and  procedures  and  presented  in  this  report  our  conclusions  about  the

effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d) Disclosed  in  this  report  any  change  in  the  registrant’s  internal  control  over  financial  reporting  that  occurred  during  the  registrant’s  most  recent

fiscal quarter that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the

registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably

likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control

over financial reporting.

Date: March 16, 2021

/s/ Richard H. Nance
Richard H. Nance
Chief Financial Officer
(Principal Accounting and Financial Officer)

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

EXHIBIT 32.1

In connection with the Annual Report of VirnetX Holding Corporation (the “Company”) on Form 10-K for the fiscal year ended
December 31, 2020 as filed with the Securities and Exchange Commission on March 16, 2020 (the “Report”), I, Kendall Larsen,
President  and  Chief  Executive  Officer  of  the  Company,  certify,  pursuant  to  18  U.S.C.  Section  1350,  as  adopted  pursuant  to
Section 906 of the Sarbanes-Oxley Act of 2002, that, to my knowledge:

(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company.

Date: March 16, 2021

/s/ Kendall Larsen
Kendall Larsen
President and Chief Executive Officer
(Principal Executive Officer)

 
 
 
 
 
 
 
 
 
 
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

EXHIBIT 32.2

In connection with the Annual Report of VirnetX Holding Corporation (the “Company”) on Form 10-K for the fiscal year ended
December 31, 2020 as filed with the Securities and Exchange Commission on March 16, 2021 (the “Report”), I, Richard Nance,
Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the
Sarbanes-Oxley Act of 2002, that, to my knowledge:

(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company.

Date: March 16, 2021

/s/ Richard H. Nance
Richard H. Nance
Chief Financial Officer
(Principal Accounting and Financial Officer)